INGERSOLL RAND INC., 10-K filed on 2/19/2025
Annual Report
v3.25.0.1
Cover Page - USD ($)
$ in Billions
12 Months Ended
Dec. 31, 2024
Feb. 14, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38095    
Entity Registrant Name Ingersoll Rand Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-2393770    
Entity Address, Address Line One 525 Harbour Place Drive    
Entity Address, Address Line Two Suite 600    
Entity Address, City or Town Davidson    
Entity Address, State or Province NC    
Entity Address, Postal Zip Code 28036    
City Area Code 704    
Local Phone Number 655-4000    
Title of 12(b) Security Common Stock, $0.01 Par Value per share    
Trading Symbol IR    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 36.6
Entity Common Stock, Shares Outstanding   403,083,248  
Documents Incorporated by Reference
Portions of the Proxy Statement for the registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference in Part III of this report.
   
Entity Central Index Key 0001699150    
Amendment Flag false    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
v3.25.0.1
Audit Information
12 Months Ended
Dec. 31, 2024
Audit Information [Abstract]  
Auditor Name DELOITTE & TOUCHE LLP
Auditor Location Charlotte, NC
Auditor Firm ID 34
v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenues $ 7,235.0 $ 6,876.1 $ 5,916.3
Cost of sales 4,065.0 3,993.9 3,590.7
Gross Profit 3,170.0 2,882.2 2,325.6
Selling and administrative expenses 1,344.4 1,272.7 1,095.8
Amortization of intangible assets 373.0 367.5 347.6
Impairment of other intangible assets 13.9 0.0 0.0
Other operating expense, net 138.6 77.7 64.9
Operating Income 1,300.1 1,164.3 817.3
Interest expense 213.2 156.7 103.2
Loss on extinguishment of debt 3.0 13.5 1.1
Other income, net (48.9) (37.0) (29.2)
Income Before Income Taxes 1,132.8 1,031.1 742.2
Provision for income taxes 262.5 240.0 149.6
Income (loss) on equity method investments (24.0) (6.0) 0.7
Income from Continuing Operations 846.3 785.1 593.3
Income from discontinued operations, net of tax 0.0 0.0 15.2
Net Income 846.3 785.1 608.5
Less: Net income attributable to noncontrolling interests 7.7 6.4 3.8
Net Income Attributable to Ingersoll Rand Inc. 838.6 778.7 604.7
Amounts attributable to Ingersoll Rand Inc. common stockholders:      
Income from continuing operations, net of tax 838.6 778.7 589.5
Income from discontinued operations, net of tax 0.0 0.0 15.2
Net Income Attributable to Ingersoll Rand Inc. $ 838.6 $ 778.7 $ 604.7
Basic earnings per share of common stock:      
Earnings from continuing operations (in USD per share) $ 2.08 $ 1.92 $ 1.45
Earnings from discontinued operations (in USD per share) 0 0 0.04
Net earnings (in USD per share) 2.08 1.92 1.49
Diluted earnings per share of common stock:      
Earnings from continuing operations (in USD per share) 2.06 1.90 1.44
Earnings from discontinued operations (in USD per share) 0 0 0.04
Net earnings (in USD per share) $ 2.06 $ 1.90 $ 1.47
v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Comprehensive Income Attributable to Ingersoll Rand Inc.      
Net income attributable to Ingersoll Rand Inc. $ 838.6 $ 778.7 $ 604.7
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustments, net (231.6) 34.8 (252.9)
Unrecognized gain (loss) on cash flow hedges (9.1) (3.8) 16.0
Pension and other postretirement prior service cost and gain (loss), net (0.2) (6.9) 26.8
Other comprehensive income (loss), net of tax (240.9) 24.1 (210.1)
Comprehensive income attributable to Ingersoll Rand Inc. 597.7 802.8 394.6
Comprehensive Income (Loss) Attributable to Noncontrolling Interests      
Net income attributable to noncontrolling interests 7.7 6.4 3.8
Other comprehensive income (loss), net of tax:      
Foreign currency translation adjustments, net 2.7 1.7 (7.2)
Total other comprehensive income (loss), net of tax 2.7 1.7 (7.2)
Comprehensive income (loss) attributable to noncontrolling interests 10.4 8.1 (3.4)
Total Comprehensive Income $ 608.1 $ 810.9 $ 391.2
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 1,541.2 $ 1,595.5
Accounts receivable, net of allowance for credit losses of $57.3 and $53.8, respectively 1,335.4 1,234.2
Inventories 1,055.0 1,001.1
Other current assets 231.9 219.6
Total current assets 4,163.5 4,050.4
Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively 842.1 711.4
Goodwill 8,148.1 6,609.7
Other intangible assets, net 4,372.8 3,611.1
Deferred tax assets 26.1 31.5
Other assets 457.2 549.4
Total assets 18,009.8 15,563.5
Current liabilities    
Short-term borrowings and current maturities of long-term debt 3.1 30.6
Accounts payable 843.6 801.2
Accrued liabilities 972.2 995.5
Total current liabilities 1,818.9 1,827.3
Long-term debt, less current maturities 4,754.4 2,693.0
Pensions and other postretirement benefits 139.3 150.0
Deferred income tax liabilities 757.6 612.6
Other liabilities 294.3 433.9
Total liabilities 7,764.5 5,716.8
Commitments and contingencies (Note 22)
Stockholders’ equity    
Common stock, $0.01 par value; 1,000,000,000 shares authorized; 430,745,964 and 428,589,061 shares issued as of December 31, 2024 and 2023, respectively 4.3 4.3
Capital in excess of par value 9,633.6 9,550.8
Retained earnings 2,503.5 1,697.2
Accumulated other comprehensive loss (468.5) (227.6)
Treasury stock at cost; 27,865,885 and 25,241,667 shares as of December 31, 2024 and 2023, respectively (1,493.9) (1,240.9)
Total Ingersoll Rand Inc. stockholders’ equity 10,179.0 9,783.8
Noncontrolling interests 66.3 62.9
Total equity 10,245.3 9,846.7
Total liabilities and equity $ 18,009.8 $ 15,563.5
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowance for credit losses $ 57.3 $ 53.8
Accumulated depreciation on property, plant and equipment $ 567.5 $ 500.8
Common stock, par value (in USD per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 1,000,000,000 1,000,000,000
Common stock issued (in shares) 430,745,964 428,589,061
Treasury stock (in shares) 27,865,885 25,241,667
v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Total Ingersoll Rand Inc. Stockholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (shares) at Dec. 31, 2021     423,800,000          
Balance at beginning of period at Dec. 31, 2021 $ 9,071.2 $ 9,001.5 $ 4.3 $ 9,408.6 $ 378.6 $ (41.6) $ (748.4) $ 69.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 608.5 604.7     604.7     3.8
Dividends declared (32.4) (32.4)     (32.4)      
Issuance of common stock for stock-based compensation plans (in shares)     2,500,000          
Issuance of common stock for stock-based compensation plans 17.3 17.3 $ 0.0 17.3        
Purchases of treasury stock (261.1) (261.1)         (261.1)  
Issuance of treasury stock for stock-based compensation plans 2.2 2.2   (22.8)     25.0  
Stock-based compensation 73.7 73.7   73.7        
Other comprehensive income (loss), net of tax (217.3) (210.1)       (210.1)   (7.2)
Dividends attributable to noncontrolling interests (4.9)             (4.9)
Balance at end of period (shares) at Dec. 31, 2022     426,300,000          
Balance at end of period at Dec. 31, 2022 9,257.2 9,195.8 $ 4.3 9,476.8 950.9 (251.7) (984.5) 61.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 785.1 778.7     778.7     6.4
Dividends declared (32.4) (32.4)     (32.4)      
Issuance of common stock for stock-based compensation plans (in shares)     2,300,000          
Issuance of common stock for stock-based compensation plans 27.8 27.8   27.8        
Purchases of treasury stock (264.1) (264.1)         (264.1)  
Issuance of treasury stock for stock-based compensation plans 2.8 2.8   (4.9)     7.7  
Stock-based compensation 51.1 51.1   51.1        
Other comprehensive income (loss), net of tax 25.8 24.1       24.1   1.7
Dividends attributable to noncontrolling interests $ (6.6)             (6.6)
Balance at end of period (shares) at Dec. 31, 2023 403,347,394   428,600,000          
Balance at end of period at Dec. 31, 2023 $ 9,846.7 9,783.8 $ 4.3 9,550.8 1,697.2 (227.6) (1,240.9) 62.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 846.3 838.6     838.6     7.7
Dividends declared (32.3) (32.3)     (32.3)      
Issuance of common stock for stock-based compensation plans (in shares)     2,100,000          
Issuance of common stock for stock-based compensation plans 30.1 30.1   30.1        
Purchases of treasury stock (261.2) (261.2)         (261.2)  
Issuance of treasury stock for stock-based compensation plans 2.1 2.1   (6.1)     8.2  
Stock-based compensation 58.8 58.8   58.8        
Other comprehensive income (loss), net of tax (238.2) (240.9)       (240.9)   2.7
Dividends attributable to noncontrolling interests $ (7.0)             (7.0)
Balance at end of period (shares) at Dec. 31, 2024 402,880,079   430,700,000          
Balance at end of period at Dec. 31, 2024 $ 10,245.3 $ 10,179.0 $ 4.3 $ 9,633.6 $ 2,503.5 $ (468.5) $ (1,493.9) $ 66.3
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities      
Net Income $ 846.3 $ 785.1 $ 608.5
Income from discontinued operations, net of tax 0.0 0.0 15.2
Income from continuing operations 846.3 785.1 593.3
Adjustments to reconcile income from continuing operations to net cash provided by operating activities from continuing operations:      
Amortization of intangible assets 373.0 367.5 347.6
Depreciation 109.0 91.6 85.2
Impairment of other intangible assets 13.9 0.0 0.0
Non-cash restructuring charges 1.6 2.7 6.0
Stock-based compensation expense 58.8 51.9 78.9
Loss (income) on equity method investments 24.0 6.0 (0.7)
Foreign currency transaction losses (gains), net 3.2 5.1 (5.9)
Non-cash adjustments to carrying value of LIFO inventories 6.7 12.0 36.1
Loss on extinguishment of debt 3.0 13.5 1.1
Loss on sale of asbestos-related assets and liabilities 33.7 0.0 0.0
Deferred income taxes (33.1) (76.9) (85.8)
Other non-cash adjustments 7.7 8.3 7.0
Changes in assets and liabilities:      
Receivables (45.1) (48.6) (195.2)
Inventories 39.8 117.3 (225.6)
Accounts payable 13.3 (23.9) 120.4
Accrued liabilities (34.5) 94.8 101.2
Other assets and liabilities, net (24.6) (29.0) 1.8
Net cash provided by operating activities from continuing operations 1,396.7 1,377.4 865.4
Cash Flows From Investing Activities      
Capital expenditures (149.1) (105.4) (94.6)
Net cash paid in acquisitions (2,958.7) (963.0) (246.8)
Disposals of property, plant and equipment 6.1 7.6 0.0
Other investing (6.0) 0.3 4.1
Net cash used in investing activities from continuing operations (3,107.7) (1,060.5) (337.3)
Cash Flows From Financing Activities      
Principal payments on long-term debt (1,242.7) (1,518.0) (655.6)
Proceeds from long-term debt 3,296.9 1,490.4 0.0
Purchases of treasury stock (260.7) (263.0) (261.1)
Cash dividends on common stock (32.3) (32.4) (32.4)
Proceeds from stock option exercises 32.2 30.3 19.3
Payments to settle cross-currency swaps (19.9) 0.0 0.0
Payments of interest rate cap premiums 0.0 0.0 (13.4)
Payments of deferred and contingent acquisition consideration (23.4) (17.5) (4.6)
Payments of debt issuance costs (32.3) (18.5) 0.0
Other financing (10.3) (8.8) (6.2)
Net cash (used in) provided by financing activities from continuing operations 1,707.5 (337.5) (954.0)
Cash Flows Used In Discontinued Operations      
Net cash used in operating activities 0.0 0.0 (5.1)
Net cash provided by investing activities 0.0 0.0 4.4
Net cash used in discontinued operations 0.0 0.0 (0.7)
Effect of exchange rate changes on cash and cash equivalents (50.8) 3.1 (70.0)
Net decrease in cash and cash equivalents (54.3) (17.5) (496.6)
Cash and cash equivalents, beginning of year 1,595.5 1,613.0 2,109.6
Cash and cash equivalents, end of year 1,541.2 1,595.5 1,613.0
Supplemental Cash Flow Information      
Cash paid for income taxes, net of refunds 276.7 302.0 181.5
Cash paid for interest, net of interest rate derivative settlements $ 209.0 $ 100.5 $ 95.2
v3.25.0.1
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Overview and Basis of Presentation
Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).
Principles of Consolidation
The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation
Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition
The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations. See Note 16 “Revenue from Contracts with Customers” for additional information regarding revenue recognition.
Cost of Sales
Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and Administrative Expenses
Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents
Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value. As of December 31, 2024 and 2023, cash of $10.5 million and $1.2 million, respectively, was pledged to financial institutions as collateral to support the issuance of standby letters of credit and similar instruments on behalf of the Company.
Accounts Receivable
Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment.
Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories
Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment
Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value.
The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of
long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value.
The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
See Note 9 “Goodwill and Other Intangible Assets” for additional information related to impairment testing for goodwill and other intangible assets.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection.
The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves
Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation
Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model.
See Note 19 “Stock-Based Compensation Plans” for additional information regarding the Company’s equity compensation plans.
Pension and Other Postretirement Benefits
The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2024 and 2023 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
See Note 13 “Benefit Plans” for disclosures related to the Company’s benefit plans, including quantitative disclosures reflecting the impact that changes in certain assumptions would have on service and interest costs and benefit obligations.
Income Taxes
The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized.
Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed.
The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above). The Company recorded a tax expense of $4.6 million in 2024 for the GILTI provisions of the Tax Act.
Research and Development
For the years ended December 31, 2024, 2023 and 2022, the Company spent $116.6 million, $108.2 million, and $91.3 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments
All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument
may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations.
Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income
The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 15 “Accumulated Other Comprehensive Income (Loss).”
Restructuring Charges
The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.
A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred.
Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations
The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable
assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share
The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Leases
The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets.
At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.

The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material.
v3.25.0.1
New Accounting Standards
12 Months Ended
Dec. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]  
New Accounting Standards New Accounting Standards
Recently Adopted Accounting Standard Updates (“ASU”)
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 24 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual statements that have not yet been issued or made available for issuance. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however,
retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.
v3.25.0.1
Discontinued Operations
12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations Discontinued Operations
Discontinued operations consist of two formerly-owned businesses, Specialty Vehicle Technologies (“SVT” or “Club Car”) and High Pressure Solutions (“HPS”). The results of operations, financial positions and cash flows of these businesses are reported as discontinued operations for all periods presented in these consolidated financial statements.
Specialty Vehicle Technologies
On April 9, 2021, the Company entered into an agreement to sell Club Car to private equity firm Platinum Equity Advisors, LLC (“Platinum Equity”) for $1.68 billion in cash. The sale was substantially completed on June 1, 2021 and concluded in the third quarter of 2022.
High Pressure Solutions
On February 14, 2021, the Company entered into an agreement to sell its majority interest in High Pressure Solutions to private equity firm American Industrial Partners. In exchange for its majority interest of 55%, the Company received net cash proceeds of $278.3 million and retained a 45% common equity interest in the newly-formed entity comprising the HPS business. The Company expects to maintain this minority investment indefinitely and is unable to estimate when this interest may be disposed. This sale was substantially completed on April 1, 2021.
Financial information of discontinued operations
The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below:
Specialty Vehicle TechnologiesHigh Pressure SolutionsTotal
Revenues$6.6 $— $6.6 
Cost of sales6.5 — 6.5 
Gross Profit0.1 — 0.1 
Selling and administrative expenses0.1 — 0.1 
Gain on sale(2.8)— (2.8)
Other operating expense, net0.7 1.6 2.3 
Income from Discontinued Operations Before Income Taxes2.1 (1.6)0.5 
Provision for income taxes(13.2)(1.5)(14.7)
Income from Discontinued Operations, Net of Tax$15.3 $(0.1)$15.2 
The significant non-cash operating items and capital expenditures reflected in cash flows of discontinued operations for the year ended December 31, 2022 include a gain on sale of $2.8 million related to Specialty Vehicle Technologies.
v3.25.0.1
Acquisitions
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
2024 Acquisitions
On February 1, 2024, the Company completed the acquisition of Friulair S.r.l. (“Friulair”) for initial cash consideration of $143.3 million and contingent consideration of up to approximately $11.0 million. The business is a manufacturer of dryers, filters, aftercoolers, and accessories for the treatment of compressed air and its chiller product line. The acquisition is intended to increase the scale of the Company’s air dryer business and will add new chiller production capabilities. Friulair has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.
On April 1, 2024, the Company completed the acquisition of Controlled Fluidics, LLC (“Controlled Fluidics”) for initial cash consideration of $49.9 million and contingent consideration of up to $2.0 million. The business specializes in thermoplastic, high-performance plastic bonding and custom plastic assembly products for life sciences, medical, aerospace, and industrial applications. The acquisition will complement Ingersoll Rand’s current life sciences offerings and increase the Company’s
market share in high-growth, sustainable end markets. Controlled Fluidics has been reported within the Precision and Science Technologies segment.
On April 2, 2024, the Company completed the acquisition of Ethafilter s.r.l. (“Ethafilter”) for cash consideration of $15.5 million. The business primarily produces filters and filter elements that can be used with all major brands in the compressed air sector. The acquisition will expand Ingersoll Rand’s product portfolio, extend its reach in highly attractive end markets with the addition of sterile filter technology, and drive ongoing growth from aftermarket services and offerings. Ethafilter has been reported within the Industrial Technologies and Services segment.
On May 1, 2024, the Company completed the acquisition of Air Systems, LLC (“Air Systems”) for cash consideration of $34.9 million. The business is a provider of compressed air services. Air Systems has been reported within the Industrial Technologies and Services segment.
On May 31, 2024, the Company completed the acquisition of Complete Air and Power Solutions (“CAPS”) for cash consideration of $99.3 million. The business is a provider of compressed air and power generation services. The acquisition is expected to expand the Company’s channel within Australia. CAPS has been reported within the Industrial Technologies and Services segment.
On May 31, 2024, the Company completed the acquisition of Fruvac Ltd. (“Fruitland Manufacturing”) for cash consideration of $28.0 million. The business is a manufacturer of mobile and truck mounted vacuum pumps, systems, and peripheral parts. The acquisition is expected to expand the Company’s capabilities to include low flow applications in the mobile vacuum market. Fruitland Manufacturing has been reported within the Industrial Technologies and Services segment.
On June 1, 2024, the Company completed the acquisition of Del PD Pumps & Gear Pvt Ltd. (“Del Pumps”) for cash consideration of $25.2 million. The business is a manufacturer of rotary, twin, and triple gear pumps for the loading, unloading, transfer, and pressurization of liquids. The acquisition will complement the Company’s portfolio of mission critical, high margin pumping solutions across life science, food and beverage, medical, natural gas, and wastewater treatment industries. Del Pumps has been reported within the Precision and Science Technologies segment.
On June 3, 2024, the Company completed the acquisition of Astronaut Topco, LP and Astronaut Topco GP, LLC (collectively “ILC Dover”) for initial cash consideration of $2,349.7 million and contingent consideration of up to $75.0 million. ILC Dover’s offerings include solutions for biopharmaceutical, pharmaceutical, and medical device markets as well as products for the space industry and will be reported in the Precision and Science Technologies segment. The amount allocated to definite-lived intangible assets represents the estimated fair values of customer relationships of $621.0 million and technology of $142.0 million and will be amortized over the weighted average useful lives of 14 years and 8 years, respectively. The amount allocated to indefinite-lived intangible assets represents the estimated fair value of tradenames of $207.5 million and goodwill of $1,309.8 million. The goodwill arising from the acquisition is primarily attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. The majority of this goodwill is not expected to be deductible for tax purposes.
On October 1, 2024, the Company completed the acquisition of Air Power Systems Co LLC (“APSCO”) for cash consideration of $113.2 million. The business is a provider of hydraulic and pneumatic products and engineered solutions serving diverse specialty work truck vehicles. APSCO’s offerings include hydraulic coolers, systems, and components in addition to pneumatic consoles, cylinders, valves, and switches. The acquisition will expand Ingersoll Rand’s position in the dry and liquid bulk markets with energy efficient, innovative solutions. APSCO has been reported within the Industrial Technologies and Services segment. The majority of this goodwill is expected to be deductible for tax purposes.
On October 1, 2024, the Company completed the acquisition of Blutek S.r.l. (“Blutek”) for cash consideration of $9.6 million. The business specializes in the design and production of highly engineered solutions for compressed air and nitrogen generation in mission-critical environments. The acquisition will increase Ingersoll Rand’s ability to compete in high specification projects, adding technology capabilities, expertise, and aftermarket potential in high-growth end markets including biogas and carbon capture. Blutek has been reported within the Industrial Technologies and Services segment.
On October 1, 2024, the Company completed the acquisition of UT Pumps & Systems Private Ltd. (“UT Pumps”) for cash consideration of $11.7 million. The business is a manufacturer of screw pumps and triplex plunger pumps. The acquisition adds new pump technology to Ingersoll Rand’s portfolio. Its high-pressure pumps are mainly focused on attractive end markets including water, wastewater, food and beverage, pharmaceuticals, general industrial, and chemicals. UT Pumps has been reported within the Precision and Science Technologies segment.
On October 31, 2024, the Company completed the acquisition of Penn Valley Pump Co., LLC (“Penn Valley Pumps”) for cash consideration of $33.2 million. The business is a manufacturer of positive displacement pumps with its Double Disc Pump
technology for use in the municipal, industrial, chemical, and food industries. Penn Valley Pumps has been reported within the Precision and Science Technologies segment.
Other acquisitions completed during the year ended December 31, 2024 include several sales and service businesses and manufacturers of vacuum pumps and accessories, substantially all of which have been reported within the Industrial Technologies and Services segment. The aggregate consideration for these acquisitions was $55.6 million.
The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for Friulair is substantially complete and all other businesses acquired in 2024 are preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained.
ILC DoverFriulairAPSCOAll othersTotal Consideration
Accounts receivable$41.4 $14.2 $6.4 $37.8 $99.8 
Inventories84.0 13.2 7.5 46.3 151.0 
Other current assets35.1 0.5 0.5 4.7 40.8 
Property, plant and equipment90.8 7.2 2.3 18.5 118.8 
Goodwill1,309.8 69.2 51.6 237.6 1,668.2 
Other intangible assets973.1 84.5 48.1 80.5 1,186.2 
Other noncurrent assets15.8 — 3.5 6.0 25.3 
Total current liabilities(31.3)(11.6)(3.7)(54.4)(101.0)
Deferred tax liabilities(151.5)(24.6)— (8.0)(184.1)
Other noncurrent liabilities(17.5)(2.8)(3.0)(5.8)(29.1)
Total consideration$2,349.7 $149.8 $113.2 $363.2 $2,975.9 
Acquisition Revenues and Operating Income
The revenues and operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $349.6 million and $5.6 million, respectively, for the year ended December 31, 2024.
2023 Acquisitions
On January 3, 2023, the Company completed the acquisition of SPX FLOW’s Air Treatment business (“Air Treatment”) for cash consideration of $519.0 million. The business is a manufacturer of desiccant and refrigerated dryers, filtration systems and purifiers for dehydration in compressed air. The acquisition is intended to expand the Company’s offerings of compressor system components through globally recognized brands. The Air Treatment business has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. Substantially all of this goodwill is not expected to be deductible for tax purposes.
On February 1, 2023, the Company acquired Paragon Tank Truck Equipment (“Paragon”), a provider of solutions used for loading and unloading dry bulk and liquid tanks on and off of trucks, for cash consideration of $42.2 million. Paragon has been reported within the Industrial Technologies and Services segment.
On April 1, 2023, the Company acquired EcoPlant Technological Innovation Ltd. (“EcoPlant”), for initial cash consideration of $29.5 million and contingent consideration of up to $17.0 million. EcoPlant is a provider of a software-as-a-service platform that dynamically controls compressed air systems to optimize performance and resource consumption. EcoPlant has been reported within the Industrial Technologies and Services segment.
On August 18, 2023, the Company completed the acquisition of Howden Roots LLC (“Roots”), for cash consideration of $292.5 million. Roots is a leading manufacturer of engineered rotary and centrifugal blowers with an iconic brand developed over more than 160 years. The acquisition is intended to expand the Company’s blower product portfolio and benefit from Roots’ robust technical capabilities and exposure to growing sustainability-related applications. Roots has been reported within the Industrial Technologies and Services segment. The goodwill arising from the acquisition is attributable to revenue and cost synergies, anticipated growth of new and existing customers, and the assembled workforce. This goodwill is expected to be deductible for tax purposes.
The Company acquired 10 additional businesses in 2023 for aggregate consideration of $83.3 million. These primarily consist of manufacturers and distributors of existing and adjacent offerings in the Industrial Technologies and Services segment.
Of the goodwill recognized on our 2023 acquisitions, $159.9 million is expected to be deductible for tax purposes.
The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2023 acquisitions is complete.
Air TreatmentRootsAll OthersTotal
Accounts receivable$26.1 $14.5 $11.7 $52.3 
Inventories43.9 34.2 21.0 99.1 
Other current assets2.1 2.9 6.2 11.2 
Property, plant and equipment18.4 42.0 5.0 65.4 
Goodwill279.9 105.6 126.7 512.2 
Other intangible assets238.6 116.9 25.4 380.9 
Other noncurrent assets7.6 3.1 0.4 11.1 
Total current liabilities(35.9)(26.9)(19.5)(82.3)
Deferred tax liabilities(54.8)— (3.9)(58.7)
Other noncurrent liabilities(6.9)(2.3)(4.5)(13.7)
Total consideration$519.0 $290.0 $168.5 $977.5 
Acquisition Revenues and Operating Income
The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $408.0 million and $293.7 million, respectively, for the years ended December 31, 2024 and 2023. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $58.8 million and $16.1 million, respectively, for the years ended December 31, 2024 and 2023.
2022 Acquisitions
On February 1, 2022, the Company acquired Houdstermaatschappij Jorc B.V. (“Jorc”), a manufacturer of condensate management products, for aggregate cash consideration of $30.2 million. Jorc has been reported in the Industrial Technologies and Services segment from the date of acquisition.
On September 1, 2022, the Company acquired Westwood Technical Limited (“Westwood Technical”), a control and instrumentation specialist based in the United Kingdom with unique Industrial Internet of Things (IIoT) capabilities, for aggregate cash consideration of $8.1 million and contingent consideration of up to $9.3 million. Westwood Technical has been reported in the Precision and Science Technologies segment from the date of acquisition.
On September 1, 2022, the Company acquired Holtec Gas Systems LLC (“Holtec”), a nitrogen generator manufacturer, for cash consideration of $13.0 million. Holtec has been reported in the Industrial Technologies and Services segment from the date of acquisition.
On September 1, 2022, the Company acquired Hydro Prokav Pumps (India) Private Limited (“Hydro Prokav”) for cash consideration of $14.0 million. Hydro Prokav has been reported in the Precision and Science Technologies segment from the date of acquisition.
On October 1, 2022, the Company acquired Dosatron International LLC (“Dosatron International”), a technology solutions provider of water powered dosing pumps and systems, for cash consideration of $89.5 million and contingent consideration of up to $14.7 million. Dosatron International has been reported in the Precision and Science Technologies segment from the date of acquisition.
On November 1, 2022, the Company acquired Pedro Gil Construcciones Mecanicas, S.L. (“Pedro Gil”), a manufacturer of positive displacement blowers, pumps and vacuum systems in the Spanish market, for aggregate cash consideration of $18.4 million. Pedro Gil has been reported in the Industrial Technologies and Services segment from the date of acquisition.
On December 1, 2022, the Company acquired Everest Blowers Private Limited and Everest Blower Systems Private Limited (collectively, “Everest Group”), the Indian market leader for customized blower and vacuum pump solutions, for $75.3 million
aggregate cash consideration and estimated contingent consideration of $12.1 million. Everest Group has been reported in the Industrial Technologies and Services segment from the date of acquisition.
Other acquisitions completed during the year ended December 31, 2022 include multiple sales and service businesses and a manufacturer in the Industrial Technologies and Services segment. The aggregate consideration for these acquisitions was $19.9 million.
The following table summarizes the allocation of consideration for all businesses acquired in 2022 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2022 acquisitions is complete.
Dosatron InternationalAll othersTotal Consideration
Accounts receivable$1.8 $16.2 $18.0 
Inventories6.2 20.4 26.6 
Other current assets0.1 1.3 1.4 
Property, plant and equipment0.3 8.9 9.2 
Goodwill57.4 151.9 209.3 
Other intangible assets41.9 43.0 84.9 
Other noncurrent assets13.8 0.9 14.7 
Total current liabilities(3.5)(30.7)(34.2)
Deferred tax liabilities(13.8)(9.7)(23.5)
Other noncurrent liabilities— (1.9)(1.9)
Total consideration$104.2 $200.3 $304.5 
Acquisition Revenues and Operating Income
The revenues included in the consolidated financial statements for these acquisitions subsequent to their acquisition date were $132.3 million, $124.4 million and $38.4 million, respectively, for the years ended December 31, 2024, 2023 and 2022. The operating income included in the consolidated financial statements for these acquisitions subsequent to their acquisition date was $17.0 million, $19.5 million and $3.4 million, respectively, for the years ended December 31, 2024, 2023 and 2022.
v3.25.0.1
Restructuring
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
2024 and 2023 Actions
The Company continues to undertake restructuring actions to optimize our cost structure. Charges incurred from actions taken in 2024 and 2023 include workforce restructuring, facility consolidation and other exit and disposal costs.
2022 Actions
Subsequent to the acquisition of and merger with the Industrial business of Ingersoll-Rand plc (“Ingersoll Rand Industrial”) in 2020 (the “Merger”), the Company announced a restructuring program (“2020 Plan”) to create efficiencies and synergies, reduce the number of facilities and optimize operating margin within the merged Company. Charges incurred in 2022 relate to the 2020 Plan.
For the years ended December 31, 2024, 2023 and 2022, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following.
202420232022
Industrial Technologies and Services$20.6 $15.1 $20.1 
Precision and Science Technologies7.9 4.1 8.7 
Corporate2.7 0.7 0.5 
Restructuring charges, net$31.2 $19.9 $29.3 
The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2024 and 2023.
20242023
Balance at beginning of period$15.5 $14.9 
Charged to expense - termination benefits27.1 13.0 
Charged to expense - other(1)
2.5 4.2 
Payments(21.6)(17.1)
Foreign currency translation and other(1.2)0.5 
Balance at end of period$22.3 $15.5 
(1)Excludes $1.6 million and $2.7 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2024 and 2023, respectively.
v3.25.0.1
Allowance for Credit Losses
12 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
Allowance for Credit Losses Allowance for Credit Losses
The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2024, 2023 and 2022.
202420232022
Balance at beginning of period$53.8 $47.2 $42.3 
Provision charged to expense7.5 9.4 10.1 
Write-offs, net of recoveries(3.3)(3.3)(3.2)
Foreign currency translation and other(0.7)0.5 (2.0)
Balance at end of period$57.3 $53.8 $47.2 
v3.25.0.1
Inventories
12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories as of December 31, 2024 and 2023 consisted of the following.
20242023
Raw materials, including parts and subassemblies$675.1 $590.7 
Work-in-process116.3 145.1 
Finished goods342.8 337.8 
1,134.2 1,073.6 
LIFO reserve(79.2)(72.5)
Inventories$1,055.0 $1,001.1 
At December 31, 2024 and 2023, 34% and 37%, respectively, of total inventory is accounted for on a last-in, first-out (“LIFO”) basis.
v3.25.0.1
Property, Plant and Equipment
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Property, Plant and Equipment
Property, plant and equipment, net as of December 31, 2024 and 2023 consisted of the following.
20242023
Land and land improvements$62.3 $67.7 
Buildings385.6 337.1 
Machinery and equipment792.6 655.8 
Office furniture and equipment76.8 71.0 
Construction in progress92.3 80.6 
1,409.6 1,212.2 
Accumulated depreciation(567.5)(500.8)
Property, plant and equipment, net$842.1 $711.4 
v3.25.0.1
Goodwill and Other Intangible Assets
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
Goodwill
The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2024 and 2023 are as follows.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Balance as of December 31, 2022
$4,222.5 $1,841.7 $6,064.2 
Acquisitions509.1 2.4 511.5 
Foreign currency translation and other(1)
21.9 12.1 34.0 
Balance as of December 31, 2023
4,753.5 1,856.2 6,609.7 
Acquisitions263.9 1,404.3 1,668.2 
Foreign currency translation and other(1)
(86.7)(43.1)(129.8)
Balance as of December 31, 2024
$4,930.7 $3,217.4 $8,148.1 
(1)Includes measurement period adjustments.
The Company acquired multiple businesses during the year ended December 31, 2024. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The allocation of the purchase price was preliminary for certain of these acquisitions and is subject to refinement based on final fair values of the identified assets acquired and liabilities assumed. The goodwill attributable to these businesses is as follows. 
2024 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
ILC Dover$— $1,309.8 $1,309.8 
Friulair69.2 — 69.2 
APSCO51.6 — 51.6 
Other acquisitions143.1 94.5 237.6 
$263.9 $1,404.3 $1,668.2 
The Company acquired several businesses during the year ended December 31, 2023. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The goodwill attributable to these businesses is as follows. 
2023 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Air Treatment$279.9 $— $279.9 
Roots106.6 — 106.6 
Other acquisitions122.6 2.4 125.0 
$509.1 $2.4 $511.5 
As of December 31, 2024 and 2023, goodwill included a total of $220.6 million of accumulated impairment losses within the Industrial Technologies and Services segment related to impairments recognized in and prior to 2015.
Goodwill Impairment Tests
Consistent with our accounting policy described in Note 1, we performed our annual goodwill impairment testing as of the first day of our fiscal fourth quarters of 2024, 2023 and 2022. For the years ended December 31, 2024, 2023 and 2022, each reporting unit’s fair value was in excess of its net carrying value, and therefore, no goodwill impairment was recorded.
Other Intangible Assets
Other intangible assets as of December 31, 2024 and 2023 consisted of the following.
December 31, 2024December 31, 2023
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Amortized intangible assets:
Customer lists and relationships$4,010.1 $(1,830.1)$2,180.0 $3,279.3 $(1,585.4)$1,693.9 
Technology549.1 (243.3)305.8 413.8 (178.9)234.9 
Tradenames63.6 (32.4)31.2 52.2 (27.9)24.3 
Backlog4.3 (4.2)0.1 3.0 (1.3)1.7 
Other128.5 (112.1)16.4 117.1 (104.1)13.0 
Unamortized intangible assets:
Tradenames1,839.3 — 1,839.3 1,643.3 — 1,643.3 
Total other intangible assets$6,594.9 $(2,222.1)$4,372.8 $5,508.7 $(1,897.6)$3,611.1 
Amortization of intangible assets was $373.0 million, $367.5 million and $347.6 million for the years ended December 31, 2024, 2023 and 2022, respectively. Amortization of intangible assets is anticipated to be approximately $375 million in 2025, $315 million in each of 2026 and 2027, $275 million in 2028 and $220 million in 2029 based upon currency exchange rates as of December 31, 2024.
Other Intangible Asset Impairment Tests
Consistent with our accounting policy described in Note 1, we performed our annual indefinite-lived intangible asset impairment testing as of the first day of our fiscal fourth quarters of 2024, 2023 and 2022. For the years ended December 31, 2024, 2023 and 2022, each tradename’s fair value was in excess of its net carrying value, and therefore, no impairment was recorded.
During the fourth quarter of 2024, the Company decided to rationalize a business within the Precision and Science Technologies segment. Consistent with our accounting policy described in Note 1, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate an assets carrying amount may not be recoverable. As a result, the Company recognized an impairment of $13.9 million to reduce the carrying value of a technology asset.
v3.25.0.1
Supply Chain Finance Program
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Supply Chain Finance Program Supply Chain Finance Program
The Company has agreements with financial institutions to facilitate a supply chain finance program (the “SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company to the financial institution. Participating suppliers negotiate arrangements for sale of their receivables directly with the financial institution, and the terms of the Company’s payment obligations are not impacted by a supplier’s participation in the SCF Program. Once a qualifying supplier elects to participate in the SCF Program and reaches an agreement with the financial institution, the supplier elects which individual Company invoices they sell to the financial institution. However, all of the Company’s payments to participating suppliers are paid to the financial institution on the invoice due date, regardless of whether the individual invoice is sold by the supplier to the financial institution. The Company has not pledged any assets as security or provided other forms of guarantees. All outstanding amounts related to suppliers participating in the SCF Program are recorded within “Accounts payable” in our Consolidated Balance Sheets, and the associated payments are included in “Net cash provided by operating activities from continuing operations” within our Consolidated Statements of Cash Flows.
The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2024 and 2023.
20242023
Confirmed obligations outstanding at beginning of period$24.3 $9.7 
Invoices confirmed117.0 112.9 
Confirmed invoices paid(116.8)(98.3)
Confirmed obligations outstanding at end of period$24.5 $24.3 
v3.25.0.1
Accrued Liabilities
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Accrued Liabilities Accrued Liabilities
Accrued liabilities as of December 31, 2024 and 2023 consisted of the following:
20242023
Salaries, wages and related fringe benefits$229.5 $262.4 
Contract liabilities318.6 331.2 
Product warranty67.9 61.9 
Operating lease liabilities56.3 41.6 
Restructuring22.3 15.5 
Taxes72.5 78.4 
Accrued interest33.2 33.1 
Other171.9 171.4 
Total accrued liabilities$972.2 $995.5 
A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2024 and 2023 is as follows.
20242023
Balance at beginning of period$61.9 $46.2 
Product warranty accruals37.5 44.4 
Acquired warranty0.7 2.2 
Settlements(30.7)(31.2)
Foreign currency translation and other(1.5)0.3 
Balance at end of period$67.9 $61.9 
v3.25.0.1
Debt
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
Debt as of December 31, 2024 and 2023 consisted of the following.
20242023
Short-term borrowings$1.7 $1.0 
Long-term debt
Dollar Term Loan B, due February 2027(1)(2)
$— $347.7 
Dollar Term Loan, due February 2027(1)(2)
— 892.3 
5.197% Senior Notes due June 2027(1)
699.9 — 
5.400% Senior Notes due August 2028(1)
498.6 498.2 
5.176% Senior Notes due June 2029(1)
750.0 — 
5.314% Senior Notes due June 2031(1)
500.0 — 
5.700% Senior Notes due August 2033(1)
993.4 992.6 
5.450% Senior Notes due June 2034(1)
749.5 — 
5.700% Senior Notes due June 2054(1)
597.6 — 
Finance leases and other long-term debt14.1 15.2 
Swap valuation adjustments(0.3)— 
Unamortized debt issuance costs(47.0)(23.4)
Total long-term debt, net, including current maturities4,755.8 2,722.6 
Current maturities of long-term debt1.4 29.6 
Total long-term debt, net$4,754.4 $2,693.0 
(1)This amount is net of unamortized discounts. Total unamortized discounts were $11.0 million and $9.9 million as of December 31, 2024 and 2023, respectively.
(2)The weighted-average interest rate was 7.18% for the five month period prior to the loan repayment in May 2024, as discussed below.
Senior Notes
New Senior Notes
On May 10, 2024, the Company issued $3,300.0 million in aggregate principal amount of senior unsecured notes comprised of $700.0 million aggregate principal amount of 5.197% Senior Notes due 2027 (the “2027 Notes”), $750.0 million aggregate principal amount of 5.176% Senior Notes due 2029 (the “2029 Notes”), $500.0 million aggregate principal amount of 5.314% Senior Notes due 2031 (the “2031 Notes”), $750.0 million aggregate principal amount of 5.450% Senior Notes due 2034 (the “2034 Notes”) and $600.0 million aggregate principal amount of 5.700% Senior Notes due 2054 (the “2054 Notes” and, together with the 2027 Notes, 2029 Notes, 2031 Notes and 2034 Notes, the “New Notes,” and collectively with the Existing Senior Notes, the “Senior Notes”). The Company used the net proceeds of the 2034 Notes and the 2054 Notes to repay in full all indebtedness under, and terminate all commitments and discharge and release all guarantees in respect of, the Company’s former Senior Secured Credit Facilities (as described below) and used the remaining net proceeds of such New Notes for general corporate purposes. The Company used the net proceeds of the 2027 Notes, the 2029 Notes and the 2031 Notes to partially fund the cash consideration of the acquisition of ILC Dover, with any remaining cash consideration funded with cash on hand. The New Notes were issued pursuant to a base indenture, dated as of August 14, 2023 (the “Base Indenture”), between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”), as supplemented by the third supplemental indenture (the “Supplemental Indenture” and, together with the Base Indenture, the “New Indenture”) dated as of May 10, 2024, between the Company and the Trustee. The interest payment dates for the New Notes are June 15 and December 15 of each year, with interest payable in arrears. The New Notes mature on June 15 in their respective year of maturity.
Prior to (i) May 15, 2027, in the case of the 2027 Notes, (ii) May 15, 2029, in the case of the 2029 Notes, (iii) April 15, 2031, in the case of the 2031 Notes, (iv) March 15, 2034, in the case of the 2034 Notes, and (v) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the New Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) May 15, 2027, in the case of the 2027 Notes, (ii) May 15, 2029, in the case of the 2029 Notes, (iii) April 15, 2031, in the case of the 2031 Notes, (iv) March 15, 2034, in the case of the 2034 Notes, and (v) December 15, 2053, in the case of the 2054 Notes, the Company may redeem the New Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the New Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date.
Existing Senior Notes
On August 14, 2023, the Company completed its issuance of $1,500.0 million in aggregate principal amount of senior unsecured notes comprised of $500.0 million aggregate principal amount of 5.400% Senior Notes due August 2028 (the “2028 Senior Notes”) and $1,000.0 million aggregate principal amount of 5.700% Senior Notes due August 2033 (the “2033 Senior Notes” and, together with the 2028 Senior Notes, the “Existing Notes”). The Company used the proceeds of the offering of the Existing Notes to repay a portion of the amounts outstanding under its former Senior Secured Credit Facilities. The Existing Notes were issued pursuant to the Base Indenture, as supplemented by a 2028 Supplemental Indenture No. 1 with respect to the 2028 Senior Notes and a 2033 Senior Notes Supplemental Indenture No. 1 with respect to the 2033 Senior Notes, each dated as of August 14, 2023, between the Company and the Trustee (collectively, the “Existing Indenture”). The interest payment dates for the Senior Notes are February 14 and August 14 of each year, with interest payable in arrears.
Prior to (i) July 14, 2028, in the case of the 2028 Senior Notes, and (ii) May 14, 2033, in the case of the 2033 Senior Notes, the Company may redeem the Senior Notes of a series at its option, in whole or in part, at any time from time to time, at a “make-whole” premium, plus accrued and unpaid interest thereon to, but not including, the redemption date. On or after (i) July 14, 2028, in the case of the 2028 Senior Notes, and (ii) May 14, 2033, in the case of the 2033 Senior Notes, the Company may redeem the Senior Notes of a series at its option, in whole or in part, at any time from time to time, at a price equal to 100% of the principal amount of the Senior Notes of such series to be redeemed, plus accrued and unpaid interest thereon to, but not including, the redemption date.
All Senior Notes
The Senior Notes are senior unsecured obligations of the Company and rank equally in right of payment with all of the Company’s other senior unsecured indebtedness from time to time outstanding, senior in right of payment to all of the Company’s subordinated indebtedness from time to time outstanding, and effectively junior to all of the indebtedness and other liabilities of the Company’s subsidiaries from time to time outstanding and to all of the Company’s secured indebtedness from time to time outstanding to the extent of the value of the assets securing such secured indebtedness.
Additionally, if the Company experiences certain types of change of control transactions, the Company must offer to repurchase the Senior Notes at 101% of the aggregate principal amount of the Senior Notes repurchased (or such higher amount as the Company may determine) plus accrued and unpaid interest thereon to, but not including, the date of repurchase.
The Existing Indenture and New Indenture contain covenants that limit the Company’s (and its subsidiaries’) ability to, among other things: (i) create liens on certain assets; (ii) consolidate, merge, sell or otherwise dispose of all or substantially all of its consolidated assets; and (iii) enter into sale and leaseback transactions with respect to certain assets, as well as customary events of default and covenants for an issuer of investment grade debt securities.
Former Senior Secured Credit Facilities
The former Senior Secured Credit Facilities provided senior secured financing consisting of (i) a senior secured term loan facility denominated in U.S. dollars (as refinanced and otherwise modified from time to time prior to February 28, 2020, the “Original Dollar Term Loan”), (ii) a senior secured term loan facility denominated in U.S. dollars (entered into at the time of the Merger, the “Dollar Term Loan B”), and (iii) a senior secured revolving credit facility (as refinanced and otherwise modified from time to time, the “Revolving Credit Facility”). The Revolving Credit Facility was available to be drawn in U.S. dollars (“USD”), Euros (“EUR”), Great British Pounds (“GBP”) and other reasonably accepted foreign currencies, subject to certain sublimits for the foreign currencies.
On April 21, 2023, the Company entered into Amendment No. 9 to the Credit Agreement, which (a) extended the maturity date for the revolving credit commitments from June 28, 2024 to April 21, 2028, (b) increased the aggregate revolving credit commitments from $1,100.0 million to $2,000.0 million, and (c) made certain other corresponding changes and updates. The amendment resulted in the write-off of unamortized debt issuance costs of $0.9 million which was recognized in “Loss on extinguishment of debt” in the Condensed Consolidated Statements of Operations. In August 2023, the Company repaid a portion of the Dollar Term Loan B and in May 2024, the Company repaid the remaining portion of the Dollar Term Loan B and Dollar Term Loan. These repayments resulted in the write-off of unamortized discounts and debt issuance costs of $3.0 million and $12.6 million, respectively, for the years ended December 31, 2024 and 2023, which was recognized in “Loss on extinguishment of debt” in the Consolidated Statements of Operations.
New Revolving Credit Facility
On May 10, 2024, the Company entered into a credit agreement (the “New Revolving Credit Facility”), with the lenders party thereto and Citibank, N.A., as administrative agent. The New Revolving Credit Facility provides for a senior unsecured revolving facility in an aggregate committed amount of $2,600 million, a portion of which is available for the issuance of letters of credit in U.S. dollars, EUR or GBP. The New Revolving Credit Facility will mature on May 10, 2029, subject to up to two additional one-year extensions pursuant to the terms of the New Revolving Credit Facility.
Borrowings under the New Revolving Credit Facility (other than borrowings in EUR or GBP) bear interest at a rate determined, at the Company’s option, based on either (i) an alternate base rate or (ii) a Term SOFR rate with a 0.10% per annum Term SOFR adjustment, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the New Revolving Credit Facility in EUR (if any) bear interest at a EURIBOR rate, plus, in each case, an applicable margin that varies depending on the credit rating of the Company. Borrowings under the New Revolving Credit Facility in GBP (if any) bear interest at a daily simple SONIA rate plus, in each case, an applicable margin that varies depending on the credit rating of the Company.
The financial covenant in the New Revolving Credit Facility requires the Company to maintain, as of the last day of each fiscal quarter (beginning with the second fiscal quarter of 2024), a ratio of adjusted consolidated total net debt to consolidated adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) of not more than 3.50 to 1.00, provided that the Company may elect to increase such ratio to 4.00 to 1.00 following a qualified acquisition up to two times, each for a period of four fiscal quarters beginning with the quarter during which such qualified acquisition is consummated (and if the second election occurs during the first increase period, such increase will be effective for a total of eight consecutive fiscal quarters).
As of December 31, 2024, the aggregate amount of commitments under the New Revolving Credit Facility was $2,600.0 million and the capacity under the New Revolving Credit Facility to issue letters of credit was $200.0 million. As of December 31, 2024, the Company had no outstanding borrowings under the New Revolving Credit Facility, no outstanding letters of credit under the New Revolving Credit Facility and unused availability under the New Revolving Credit Facility of $2,600.0 million.
As of December 31, 2024, we were in compliance with all covenants under our Senior Notes and New Revolving Credit Facility.
Commercial Paper Program
On August 13, 2024, the Company established a commercial paper program (the “Commercial Paper Program”), pursuant to which it may issue short-term, unsecured commercial paper notes in a maximum aggregate principal amount of $2,600 million, with maturities of up to 397 days from the date of issuance. The proceeds of the notes issued under the Commercial Paper Program may be used for various purposes including acquisitions. The Company had no outstanding borrowings under the Commercial Paper Program as of December 31, 2024.
Fair Value of Debt
The fair value of the Company’s debt instruments was $4.9 billion and $2.8 billion at December 31, 2024 and 2023, respectively. The Company measures the fair value of its debt instruments for disclosure purposes based upon observable market prices quoted on public exchanges for similar assets. These fair value inputs are considered Level 2 within the fair value hierarchy. See Note 20, “Fair Value Measurements” for information on the fair value hierarchy.
Total Debt Maturities
Total debt maturities for the five years subsequent to December 31, 2024 and thereafter are $3.1 million, $1.7 million, $701.5 million, $501.5 million, $751.5 million and $2,856.5 million, respectively.
v3.25.0.1
Benefit Plans
12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Benefit Plans Benefit Plans
Pension and Postretirement Benefit Plans
The Company sponsors a number of pension and postretirement plans worldwide. Pension plan benefits are provided to employees under defined benefit pay-related and service-related plans, which are non-contributory in nature. The Company’s funding policy for the U.S. defined benefit pension plans is to contribute at least the minimum required contribution required by Employee Retirement Income Security Act (“ERISA”), as amended by the Pension Protection Act of 2016 (as amended by MAP-21, HAFTA, and BBA 15). The Company intends to make contributions, as necessary, to prevent benefit restrictions in the plans. The Company’s annual contributions to the non-U.S. pension plans are consistent with the requirements of applicable local laws.
The Company also provides postretirement healthcare and life insurance benefits to a limited group of current and retired employees, primarily in the United States. All of the Company’s postretirement benefit plans are unfunded.
The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202420232024202320242023
Reconciliation of Benefit Obligations:
Beginning balance$294.0 $319.8 $263.2 $247.5 $18.3 $21.0 
Service cost0.1 0.1 2.9 2.6 — — 
Interest cost13.4 15.7 10.7 11.1 0.8 0.9 
Participant contributions— — 0.2 — — — 
Plan amendments— — — 0.3 (10.9)— 
Actuarial losses (gains)(1)
(18.1)6.0 (11.3)3.3 0.2 (1.0)
Benefit payments(22.2)(16.1)(14.5)(13.6)(2.4)(2.7)
Acquisitions— — 10.2 — — — 
Plan settlements(2.5)(31.5)— — — — 
Other— — 0.6 — — — 
Effect of foreign currency exchange rate changes— — (10.6)12.0 (0.1)0.1 
Benefit obligations ending balance$264.7 $294.0 $251.4 $263.2 $5.9 $18.3 
Reconciliation of Fair Value of Plan Assets:
Beginning balance$237.5 $263.6 $206.0 $196.4 
Actual return on plan assets(6.0)18.7 (7.1)6.7 
Employer contributions0.1 2.8 6.5 6.6 
Participant contributions— — 0.2 — 
Acquisitions— — 8.5 — 
Benefit payments(22.2)(16.1)(14.5)(13.6)
Plan settlements(2.5)(31.5)— — 
Other— — 0.6 — 
Effect of foreign currency exchange rate changes— — (5.6)9.9 
Fair value of plan assets ending balance$206.9 $237.5 $194.6 $206.0 
Funded Status as of Period End$(57.8)$(56.5)$(56.8)$(57.2)$(5.9)$(18.3)
(1)Actuarial losses (gains) primarily resulted from changes in discount rates.
Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2024 and 2023 that have not been recognized as a component of net periodic benefit cost are presented in the following table.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202420232024202320242023
Net actuarial losses (gains)$(10.8)$(11.0)$7.6 $(1.1)$(3.2)$(4.3)
Prior service cost— — 2.7 2.9 (10.9)0.1 
Amounts included in accumulated other comprehensive income (loss)$(10.8)$(11.0)$10.3 $1.8 $(14.1)$(4.2)
Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2024 and 2023.
20242023
Other assets$18.5 $18.8 
Accrued liabilities(6.4)(6.2)
Pension and other postretirement benefits(132.6)(144.6)
The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023.
U.S. Pension PlansNon-U.S. Pension Plans
2024202320242023
Projected benefit obligations$264.7 $294.0 $119.7 $105.4 
Accumulated benefit obligation264.7 294.0 112.7 86.4 
Fair value of plan assets206.9 237.5 42.8 17.0 
The accumulated benefit obligation for all U.S. defined benefit pension plans was $264.7 million and $294.0 million as of December 31, 2024 and 2023, respectively. The accumulated benefit obligation for all non-U.S. defined benefit pension plans was $243.3 million and $254.8 million as of December 31, 2024 and 2023, respectively.
The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2024, 2023 and 2022.
U.S. Pension Plans
202420232022
Net Periodic Benefit Cost:
Service cost$0.1 $0.1 $4.4 
Interest cost13.4 15.7 11.3 
Expected return on plan assets(12.7)(13.2)(13.0)
Amortization of net actuarial loss— 0.1 — 
Net periodic benefit cost0.8 2.7 2.7 
Loss (gain) due to settlement0.4 (0.4)(0.5)
Total net periodic benefit cost recognized$1.2 $2.3 $2.2 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss$0.6 $0.5 $0.4 
Amortization of net actuarial gain (loss)(0.4)0.3 0.5 
Total recognized in other comprehensive income (loss)$0.2 $0.8 $0.9 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$1.4 $3.1 $3.1 
Non-U.S. Pension Plans
202420232022
Net Periodic Benefit Cost (Income):
Service cost$2.9 $2.6 $3.3 
Interest cost10.7 11.1 5.9 
Expected return on plan assets(11.2)(11.0)(11.8)
Amortization of prior service cost0.2 0.1 0.1 
Amortization of net actuarial loss(1.3)(1.7)0.3 
Total net periodic benefit cost (income) recognized$1.3 $1.1 $(2.2)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$7.0 $7.5 $(33.3)
Amortization of net actuarial gain (loss)1.3 1.7 (0.3)
Prior service cost— 0.3 — 
Amortization of prior service cost(0.2)(0.1)(0.1)
Effect of foreign currency exchange rate changes0.4 0.3 (3.2)
Total recognized in other comprehensive income (loss)$8.5 $9.7 $(36.9)
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$9.8 $10.8 $(39.1)
Other Postretirement Benefits
202420232022
Net Periodic Benefit Cost (Income):
Interest cost$0.8 $0.9 $0.7 
Amortization of prior service cost0.1 0.1 — 
Amortization of net actuarial loss(0.8)(1.1)— 
Total net periodic benefit cost (income) recognized$0.1 $(0.1)$0.7 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$0.2 $(1.0)$(5.0)
Amortization of net actuarial loss0.8 1.1 — 
Prior service cost(10.9)— — 
Amortization of prior service cost(0.1)(0.1)— 
Total recognized in other comprehensive income (loss)$(10.0)$— $(5.0)
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$(9.9)$(0.1)$(4.3)
The discount rate selected to measure the present value of the Company’s benefit obligations was derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under a plan. The Company selects the expected long-term rate of return on plan assets in consultation with the plans’ advisors. This rate is intended to reflect the expected average rate of earnings on the funds invested or to be invested to provide plan benefits and the Company’s most recent plan assets target allocations. In estimating the expected long-term rate of return on plan assets, appropriate consideration is given to historical performance of the major asset classes held or anticipated to be held by the plans and to current forecasts of future rates of return for those asset classes. Because assets are held in qualified trusts, expected returns are not adjusted for taxes.
The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2024, 2023 and 2022.
U.S. Pension PlansNon-U.S. Pension Plans
202420232022202420232022
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate5.0 %5.2 %2.7 %4.2 %4.5 %1.6 %
Expected long-term rate of return on plan assets5.8 %5.4 %3.5 %5.5 %5.5 %4.4 %
Rate of compensation increasesN/AN/A3.0 %5.0 %4.3 %4.3 %
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate5.5 %5.0 %5.2 %4.5 %4.2 %4.5 %
Rate of compensation increasesN/AN/AN/A5.0 %5.0 %4.3 %
The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2024, 2023 and 2022.
Other Postretirement Benefits
202420232022
Discount rate used to determine net periodic benefit cost
4.9% - 5.1%
4.9% - 5.2%
2.4% - 3.0%
Discount rate used to determine benefit obligations
4.4% - 5.4%
4.9% - 5.1%
4.9% - 5.2%
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:
Healthcare cost trend rate assumed for next year5.1 %6.8 %6.8 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.0 %4.4 %4.5 %
Year that the date reaches the ultimate trend rate204020352034
The following table reflects the estimated benefit payments for the next five years and for the years 2030 through 2034. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2024.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
2025$26.4 $14.7 $2.4 
202625.1 14.9 0.4 
202724.9 14.5 0.4 
202823.9 15.1 0.3 
202923.4 17.1 0.3 
Aggregate 2030-2034
98.3 86.0 1.3 
In 2025, the Company expects to contribute $5.2 million to the U.S. pension plans, $7.3 million to the non-U.S. pension plans, and $2.4 million to the other postretirement benefit plans.
Plan Asset Investment Strategy
The Company’s overall investment strategy and objectives for its pension plan assets is to (i) meet current and future benefit payment needs through diversification across asset classes, investing strategies and investment managers to achieve an optimal balance between risk and return and between income and growth of assets through capital appreciation, (ii) secure participant retirement benefits, (iii) minimize reliance on contributions as a source of benefit security, and (iv) maintain sufficient liquidity to pay benefit obligations and proper expenses. The composition of the actual investments in various securities changes over time based on short and long-term investment opportunities. None of the plan assets of Ingersoll Rand’s defined benefit plans are invested in the Company’s common stock. The Company uses both active and passive investment strategies.
Plan Asset Risk Management
The target financial objectives for the pension plans are established in conjunction with periodic comprehensive reviews of each plan’s liability structure. The Company’s asset allocation policy is based on detailed asset and liability model (“ALM”) analyses. A formal ALM study of each major plan is undertaken every 2-5 years or whenever there has been a material change in plan demographics, benefit structure, or funded status. In order to determine the recommended asset allocation, the advisors model varying return and risk levels for different theoretical portfolios, using a relative measure of excess return over treasury bills, divided by the standard deviation of the return (the “Sharpe Ratio”). The Sharpe Ratio for different portfolio options was used to compare each portfolio’s potential return, on a risk-adjusted basis. The Company selected a recommended portfolio that achieved the targeted composite return with the least amount of risk.
The Company’s primary pension plans are in the U.S. and UK which together comprise 76% of the total benefit obligations and 87% of total plan assets as of December 31, 2024. The following table presents the long-term target allocations for these plans as of December 31, 2024.
U.S. PlansUK Plan
Asset category:
Equity16 %12 %
Fixed income83 %56 %
Real estate and other%32 %
Total100 %100 %
Fair Value Measurements
The following tables present the fair values of the Company’s pension plan assets as of December 31, 2024 and 2023 by asset category within the ASC 820 hierarchy (as defined in Note 21 “Fair Value Measurements”).
December 31, 2024
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$5.1 $— $— $— $5.1 
Equity funds:
U.S. small-cap— — — 0.9 0.9 
U.S. mid-cap— — — 2.6 2.6 
U.S. large-cap— 2.5 — 11.6 14.1 
International equity(2)
— 23.2 — 26.5 49.7 
Total equity funds— 25.7 — 41.6 67.3 
Fixed income funds:
Corporate bonds - international— 23.8 — 15.8 39.6 
UK index-linked gilts— 66.0 — — 66.0 
U.S. fixed income - government securities— — — 20.5 20.5 
U.S. fixed income - short duration— — — 1.8 1.8 
U.S. fixed income - intermediate duration— — — 25.2 25.2 
U.S. fixed income - long duration— — — 122.7 122.7 
Global fixed income— — — 1.8 1.8 
Total fixed income funds— 89.8 — 187.8 277.6 
Other types of investments:
International real estate(3)
— 11.6 — — 11.6 
Other(4)
— 38.1 1.8 39.9 
Total$5.1 $127.1 $38.1 $231.2 $401.5 
December 31, 2023
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$7.1 $— $— $— $7.1 
Equity funds:
U.S. small-cap— — — 3.7 3.7 
U.S. large-cap— 2.0 — 17.5 19.5 
International equity(2)
14.2 10.5 — 17.2 41.9 
Total equity funds14.2 12.5 — 38.4 65.1 
Fixed income funds:
Corporate bonds - international— 26.9 — 15.8 42.7 
UK index-linked gilts— 78.7 — — 78.7 
U.S. fixed income - government securities— — — 43.2 43.2 
U.S. fixed income - short duration— — — 1.3 1.3 
U.S. fixed income - intermediate duration— — — 30.9 30.9 
U.S. fixed income - long corporate— — — 122.3 122.3 
Global fixed income— — — 7.2 7.2 
Total fixed income funds— 105.6 — 220.7 326.3 
Other types of investments:
International real estate(3)
— 15.4 — — 15.4 
Other(4)
— 29.6 — 29.6 
Total$21.3 $133.5 $29.6 $259.1 $443.5 
(1)Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets.
(2)The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors.
(3)International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties.
(4)Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services.
(5)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.
Defined Contribution Plans
The Company also sponsors defined contribution plans at various locations throughout the world. Benefits are determined and funded regularly based on terms of the plans or as stipulated in a collective bargaining agreement. The Company’s full-time salaried and hourly employees in the U.S. are eligible to participate in Company-sponsored defined contribution savings plans, which are qualified plans under the requirements of Section 401(k) of the Internal Revenue Code. The Company’s contributions to the savings plans are in the form of cash. The Company’s total contributions to all worldwide defined contribution plans for the years ended December 31, 2024, 2023, and 2022 were $49.1 million, $47.0 million and $46.6 million, respectively.
Other Benefit Plans
There are various other employment contracts, deferred compensation arrangements, covenants not to compete, and change in control agreements with certain employees and former employees. The Company offers a long-term service award program for qualified employees at certain of its non-U.S. locations. Under this program, qualified employees receive a service gratuity (“Jubilee”) payment once they have achieved a certain number of years of service. The liabilities associated with such arrangements are not material to the Company’s consolidated financial statements.
v3.25.0.1
Stockholders' Equity and Noncontrolling Interests
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Stockholders' Equity and Noncontrolling Interests Stockholders’ Equity and Noncontrolling Interests
Stockholders’ Equity
As of December 31, 2024 and 2023, 1,000,000,000 shares of voting common stock were authorized. Shares of common stock outstanding wer402,880,079 and 403,347,394 as of December 31, 2024 and 2023, respectively. The Company is governed by the General Corporation Law of the State of Delaware. All authorized shares of voting common stock have a par value of $0.01. Shares of common stock reacquired are considered issued and reported as Treasury shares.
Noncontrolling Interests
The Company has a controlling interest of approximately 75% of the common shares of Ingersoll-Rand India Limited. The remaining shares are owned by unaffiliated shareholders and traded on India stock exchanges regulated by Securities and Exchange Board of India.
Share Repurchase Program
On August 24, 2021, the Board of Directors of Ingersoll Rand authorized a share repurchase program pursuant to which the Company may repurchase up to $750.0 million of its common stock, and on April 25, 2024, the Company announced that our Board of Directors approved an incremental $1.0 billion increase to the share repurchase authorization (the “Repurchase Program”). Under the repurchase program, Ingersoll Rand is authorized to repurchase shares through open market purchases, privately-negotiated transactions or otherwise in accordance with all applicable securities laws and regulations, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Securities Exchange Act of 1934, as amended.
Under the Repurchase Program, the Company repurchased 2,665,262 shares, 3,963,243 shares, and 5,673,937 shares during the years ended December 31, 2024, 2023, and 2022, respectively, at an average price per share of $93.80, $62.98, and $45.36 for an aggregate value of $250.0 million, $249.6 million, and $257.3 million, respectively.
v3.25.0.1
Accumulated Other Comprehensive Income (Loss)
12 Months Ended
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The Company’s other comprehensive income (loss) consists of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and certain hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes. See Note 13 “Benefit Plans” and Note 20 “Hedging Activities, Derivative Instruments and Credit Risk.”
The before tax income (loss) and related income tax effect are as follows.
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2021$(29.9)$— $(11.7)$(41.6)
Before tax income (loss)(237.1)21.3 41.0 (174.8)
Income tax effect(15.8)(5.3)(14.2)(35.3)
Other comprehensive income (loss)(252.9)16.0 26.8 (210.1)
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Before tax income (loss)23.0 (5.1)(10.5)7.4 
Income tax effect11.8 1.3 3.6 16.7 
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Before tax income (loss)(218.6)(14.1)1.3 (231.4)
Income tax effect(13.0)5.0 (1.5)(9.5)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
The tables above include only the other comprehensive income (loss), net of tax, attributable to Ingersoll Rand Inc. Other comprehensive income (loss), net, attributable to noncontrolling interest holders was $2.7 million, $1.7 million and $(7.2)
million for the years ended December 31, 2024, 2023 and 2022, respectively, and related entirely to foreign currency translation adjustments.
Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table(1).
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2021$(29.9)$— $(11.7)$(41.6)
Other comprehensive income (loss) before reclassifications(244.3)13.9 26.9 (203.5)
Amounts reclassified from accumulated other comprehensive income (loss)(8.6)2.1 (0.1)(6.6)
Other comprehensive income (loss)(252.9)16.0 26.8 (210.1)
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Other comprehensive income (loss) before reclassifications49.0 7.9 (4.7)52.2 
Amounts reclassified from accumulated other comprehensive income (loss)(14.2)(11.7)(2.2)(28.1)
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Other comprehensive income (loss) before reclassifications(218.3)2.7 0.8 (214.8)
Amounts reclassified from accumulated other comprehensive income (loss)(13.3)(11.8)(1.0)(26.1)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
(1)All amounts are net of tax. Amounts in parentheses indicate debits.
Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the following table.
Amount Reclassified from Accumulated Other Comprehensive Income (Loss)
Details about Accumulated Other Comprehensive Income (Loss) Components202420232022Affected Line(s) in the Statement Where Net Income is Presented
Cash flow hedges (interest rate swaps and caps)$(15.7)$(15.6)$2.8 Interest expense
Provision (benefit) for income taxes3.9 3.9 (0.7)Provision for income taxes
Cash flow hedges (interest rate swaps and caps), net of tax$(11.8)$(11.7)$2.1 
Net investment hedges$(17.7)$(19.0)$(11.5)Interest expense
Provision for income taxes4.4 4.8 2.9 Provision for income taxes
Net investment hedges, net of tax$(13.3)$(14.2)$(8.6)
Amortization of defined benefit pension and other postretirement benefit items(1)
$(1.4)$(2.9)$(0.1)
Cost of sales and Selling and administrative expenses
Provision for income taxes0.4 0.7 — Provision for income taxes
Amortization of defined benefit pension and other postretirement benefit items, net of tax$(1.0)$(2.2)$(0.1)
Total reclassifications for the period$(26.1)$(28.1)$(6.6)
(1)These components are included in the computation of net periodic benefit cost. See Note 13 “Benefit Plans” for additional details.
v3.25.0.1
Revenue from Contracts with Customers
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Overview
The Company recognizes revenue when it has satisfied its obligation and control is transferred to the customer. The amount of revenue recognized includes adjustments for any variable consideration, such as rebates, sales discounts and liquidated damages, which are included in the transaction price, and allocated to each performance obligation. The variable consideration is estimated throughout the course of the contract using the Company’s best estimates. Judgements impacting variable consideration related to material rebate and sales discount programs, and significant contracts containing liquidated damage clauses are governed by management review processes.
The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered.
The Company has certain long duration engineered to order (“ETO”) contracts that require highly-engineered solutions designed to customer specific applications. For contracts where the contractual deliverables have no alternative use and the contract termination clauses provide for the recovery of cost plus a reasonable margin, revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations, generally measured as the ratio of actual costs incurred to date to the estimated total costs to complete the contract. For contracts with termination provisions that do not provide for recovery of cost and a reasonable margin, revenue is recognized at a point in time, generally at shipment or delivery to the customer. Identification of performance obligations, determination of alternative use, assessment of contractual language regarding termination provisions, and estimation of total project costs are all significant judgments required in the application of ASC 606.
Contractual specifications and requirements may be modified. The Company considers contract modifications to exist when the modification either creates new or changes the existing enforceable rights and obligations. In the event a contract modification is for goods or services that are not distinct in the contract, and therefore, form part of a single performance obligation that is partially satisfied as of the modification date, the effect of the contract modification on the transaction price and the Company’s measure of progress for the performance obligation to which it relates, is recognized on a cumulative catch-up basis.
Taxes assessed by a government authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from revenue. Sales commissions are due at either collection of payment from customers or recognition of revenue. Applying the practical expedient from ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs are included in “Selling and administrative expenses” in the Consolidated Statements of Operations.
Disaggregation of Revenue
The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2024 and 2023.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202420232024202320242023
Primary Geographic Markets
United States$2,461.2 $2,328.0 $651.1 $567.2 $3,112.3 $2,895.2 
Other Americas452.9 373.1 88.3 29.0 541.2 402.1 
Total Americas2,914.1 2,701.1 739.4 596.2 3,653.5 3,297.3 
EMEIA1,854.9 1,800.8 520.0 466.7 2,374.9 2,267.5 
China680.8 785.7 113.8 138.9 794.6 924.6 
Other Asia Pacific368.3 345.2 43.7 41.5 412.0 386.7 
Total Asia Pacific1,049.1 1,130.9 157.5 180.4 1,206.6 1,311.3 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
Product Categories
Original equipment(1)
$3,494.0 $3,425.9 $1,110.2 $990.9 $4,604.2 $4,416.8 
Aftermarket(2)
2,324.1 2,206.9 306.7 252.4 2,630.8 2,459.3 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
Pattern of Revenue Recognition
Revenue recognized at point in time(3)
$5,295.6 $5,147.2 $1,376.4 $1,236.2 $6,672.0 $6,383.4 
Revenue recognized over time(4)
522.5 485.6 40.5 7.1 563.0 492.7 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
(1)Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment.
(2)Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment.
(3)Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered.
(4)Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Performance Obligations
The majority of the Company’s contracts have a single performance obligation as the promise to transfer goods and/or services. For contracts with multiple performance obligations, the Company utilizes observable prices to determine standalone selling price or cost plus margin if a standalone price is not available. The Company has elected to account for shipping and handling activities as fulfillment costs and not a separate performance obligation. If control transfers and related revenue is recognized for the related good before the shipping and handling activities occur, the related costs of those shipping and handling activities are accrued.
The Company’s primary performance obligations include delivering standard or configured to order (“CTO”) goods to customers, designing and manufacturing a broad range of equipment customized to a customer’s specifications in ETO arrangements, rendering of services (maintenance and repair contracts), and certain extended or service type warranties. For incidental items that are immaterial in the context of the contract, costs are expensed as incurred or accrued at delivery.
As of December 31, 2024, for contracts with an original duration greater than one year, the Company expects to recognize revenue in the future related to unsatisfied (or partially satisfied) performance obligations of $742.6 million in the next twelve months and $788.6 million in periods thereafter. The performance obligations that are unsatisfied (or partially satisfied) are primarily related to orders for goods or services that were placed prior to the end of the reporting period and have not been delivered to the customer, on-going work on ETO contracts where revenue is recognized over time and service contracts with an original duration greater than one year.
Contract Balances
The following table provides the contract balances as of December 31, 2024 and 2023 presented in the Consolidated Balance Sheets.
December 31, 2024December 31, 2023
Accounts receivable, net$1,335.4 $1,234.2 
Contract assets111.2 85.6 
Contract liabilities - current318.6 331.2 
Contract liabilities - noncurrent0.9 1.0 
Accounts receivable, net – Amounts due where the Company’s right to receive cash is unconditional. Customer receivables are recorded at face amount less an allowance for credit losses. The Company maintains an allowance for credit losses as a result of customers’ inability to make required payments. Management evaluates the aging of customer receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of customer receivables that may not be collected in the future and records the appropriate provision.
Contract assets – The Company’s rights to consideration for the satisfaction of performance obligations subject to constraints apart from timing. Contract assets are transferred to receivables when the right to collect consideration becomes unconditional. Contract assets are presented net of progress billings and related advances from customers.
Contract liabilities – Advance payments received from customers for contracts for which revenue is not yet recognized. Contract liability balances are generally recognized in revenue within twelve months. Of the $332.2 million in contract liabilities as of December 31, 2023, we recognized substantially all as revenue in the year ended December 31, 2024.
Contract assets and liabilities are reported on the Consolidated Balance Sheets on a contract-by-contract basis at the end of each reporting period. Contract assets and liabilities are presented net on a contract level, where required.
Payments from customers are generally due 30 to 60 days after invoicing. Invoicing for sales of standard products generally coincides with shipment or delivery of goods. Invoicing for CTO and ETO contracts typically follows a schedule for billing at contractual milestones. Payment milestones normally include down payments upon the contract signing, completion of product design, completion of customer’s preliminary inspection, shipment or delivery, completion of installation, and customer’s on-site inspection. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets) and customer advances and deposits (contract liabilities) on the Consolidated Balance Sheets.
The Company has elected the practical expedient from ASC 606-10-32-18 and does not adjust the transaction price for the effects of a financing component if, at contract inception, the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income before income taxes for the years ended December 31, 2024, 2023 and 2022 consisted of the following.
202420232022
U.S.$383.7 $356.0 $267.5 
Non-U.S.749.1 675.1 474.7 
Income before income taxes$1,132.8 $1,031.1 $742.2 
The following table details the components of the Provision for income taxes for the years ended December 31, 2024, 2023 and 2022.
202420232022
Current:
U.S. federal$87.5 $111.5 $66.5 
U.S. state and local22.8 23.7 21.5 
Non-U.S.185.3 181.7 147.4 
Deferred:
U.S. federal(9.7)(44.0)(37.3)
U.S. state and local(5.7)(6.9)(5.5)
Non-U.S.(17.7)(26.0)(43.0)
Provision for income taxes$262.5 $240.0 $149.6 
Certain prior period amounts within this Note have been reclassified to conform to the current period presentation.
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024, 2023 and 2022 as follows.
202420232022
U.S. federal corporate statutory rate21.0 %21.0 %21.0 %
State and local taxes, less federal tax benefit1.4 1.3 2.0 
Net effects of foreign tax rate differential2.5 1.8 1.5 
Withholding tax1.3 1.5 2.1 
Repatriation cost(1.5)(2.0)(3.2)
Global Intangible Low-Tax Income (“GILTI”)0.4 0.7 0.3 
ASC 740-30 (formerly APB 23)1.5 1.7 1.9 
Valuation allowance changes0.4 1.7 0.5 
Uncertain tax positions0.9 0.9 0.2 
Equity compensation(1.3)(0.6)(0.6)
Nondeductible acquisition costs0.3 0.4 0.4 
Foreign Derived Intangible Income (“FDII”) deduction(1.1)(1.4)(1.6)
Tax credits(0.6)(0.7)(1.1)
Income not subject to tax(0.3)(1.6)(3.5)
Amortization of goodwill and other intangible assets(1.3)(0.8)— 
Interest on equity(1.8)(0.7)(0.4)
Return to provision adjustment(0.2)0.1 — 
Loss on sale1.1 — — 
Other, net0.5 — 0.7 
Effective income tax rate23.2 %23.3 %20.2 %
The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 are as follows.
20242023
Deferred Tax Assets:
Reserves and accruals$83.4 $80.1 
Allowance for credit losses7.4 7.8 
Inventory reserve9.0 5.9 
Pension and postretirement benefit plans
20.0 25.3 
Tax loss carryforwards112.4 81.3 
Deferred taxes recorded in other comprehensive income1.4 13.4 
Foreign tax credit carryforwards50.7 57.9 
Other22.4 32.2 
Total deferred tax assets306.7 303.9 
Valuation allowance(125.6)(115.7)
Deferred Tax Liabilities:
LIFO inventory(20.3)(20.2)
Investment in partnership(30.2)(35.7)
Property, plant and equipment(50.0)(42.5)
Intangible assets(770.4)(635.4)
Unremitted foreign earnings(41.8)(35.5)
Total deferred tax liabilities(912.7)(769.3)
Net deferred income tax liability$(731.6)$(581.1)
The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2024 were as follows.
Tax BenefitValuation AllowanceCarryforward Period Ends
Tax Attributes to be Carried Forward
U.S. federal net operating loss$13.3 $(0.1)2032-2038
U.S. federal capital loss0.6 (0.6)2029
U.S. federal tax credit50.8 (50.8)2025-2034
Alternative minimum tax credit0.5 (0.1)Unlimited
U.S. state and local net operating losses4.9 (2.1)2026-2041
U.S. state capital loss0.3 (0.1)2028
Non U.S. net operating losses62.6 (36.5)Unlimited
Non U.S. capital losses0.6 (0.6)Unlimited
Excess interest30.0 (29.7)Unlimited
Other deferred tax assets5.0 (5.0)Unlimited
Total tax carryforwards$168.6 $(125.6)
A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023 and 2022 are as follows.
202420232022
Beginning balance$115.7 $107.3 $106.4 
Revaluation or additions due to acquisitions or mergers(1)
22.9 — — 
Charged to tax expense(10.8)6.4 3.1 
Charged to other accounts(2.2)2.0 (2.2)
Ending balance$125.6 $115.7 $107.3 
(1)Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance.
Total unrecognized tax benefits were $26.4 million, $19.1 million and $10.8 million for the years ended December 31, 2024, 2023 and 2022, respectively. The net increase in this balance primarily relates to current year additions to previously established reserves. Included in total unrecognized benefits at December 31, 2024 is $26.4 million of unrecognized tax benefits that would affect the Company’s effective tax rate if recognized. The balance of total unrecognized tax benefits is not expected to significantly increase or decrease within the next twelve months. Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2024, 2023 and 2022.
202420232022
Beginning balance$19.1 $10.8 $21.1 
Gross increases for tax positions of prior years0.8 0.4 0.4 
Gross decreases for tax positions of prior years(0.3)— (3.7)
Gross increases for tax positions of current year8.1 7.9 4.1 
Settlements— — (9.9)
Lapse of statute of limitations(0.6)(0.2)(0.1)
Changes due to currency fluctuations(0.7)0.2 (1.1)
Ending balance$26.4 $19.1 $10.8 
The Company includes interest expense and penalties related to unrecognized tax benefits as part of the provision for income taxes. The Company’s income tax liabilities at December 31, 2024 and 2023 include accrued interest and penalties of $3.2 million and $2.0 million, respectively.
The statutes of limitations for U.S. Federal tax returns are open beginning with the 2020 tax year, and state returns are open beginning with the 2014 tax year. The Company is currently under audit for the 2020 tax year. The Internal Revenue Service (“IRS”) has largely completed its examination of the 2020 tax year and no material adjustments were proposed. The Company was notified during 2024 of a new U.S. Federal income tax audit for the tax years 2021 and 2022. There are no known issues as the audit will start in 2025.
The Company is subject to income tax in 48 jurisdictions outside the U.S. The statute of limitations varies by jurisdiction with 2013 being the oldest year still open. The Company’s significant operations outside the U.S. are located in the United Kingdom, Germany, China, Ireland, Switzerland, and Singapore. In Germany, a tax audit covering tax years 2011-2014 was closed in Q4 2024. Note that any other liabilities arising from pre-merger tax years for legacy Ingersoll Rand Industrial entities would be indemnified.
The Company does not assert the ASC 740-30 (formerly APB 23) indefinite reinvestment of the Company’s historical non-U.S. earnings or future non-U.S. earnings. The Company records a deferred foreign tax liability to cover all estimated withholding, state income tax and foreign income tax associated with repatriating all non-U.S. earnings back to the United States. The Company’s deferred income tax liability as of December 31, 2024 was $41.8 million
v3.25.0.1
Leases
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Leases Leases
The components of lease expense for the years ended December 31, 2024 and 2023 are as follows.
20242023
Operating lease cost$64.5 $53.7 
Finance lease cost
Amortization of right-of-use assets$1.5 $1.5 
Interest on lease liabilities0.9 0.9 
Total finance lease cost$2.4 $2.4 
Short-term lease cost$2.2 $1.9 
Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows.
20242023
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$63.8 $53.7 
Operating cash flows from finance leases0.9 1.0 
Financing cash flows from finance leases1.3 1.2 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities96.2 62.5 
Supplemental balance sheet information related to leases is as follows.
December 31, 2024December 31, 2023
Operating leases
Other assets$226.6 $164.4 
Accrued liabilities$56.3 $41.6 
Other liabilities165.5 116.9 
Total operating lease liabilities$221.8 $158.5 
Finance Leases
Property, plant and equipment$11.1 $12.3 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities12.6 13.6 
Total finance lease liabilities$13.9 $14.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.25.1
Finance leases9.410.3
Weighted Average Discount Rate
Operating leases4.1 %3.6 %
Finance leases6.5 %6.4 %
Maturities of lease liabilities as of December 31, 2024 are as follows.
Operating LeasesFinance Leases
2025$63.6 $2.2 
202655.1 2.1 
202741.3 2.1 
202829.4 2.1 
202917.7 2.1 
Thereafter39.2 8.5 
Total lease payments$246.3 $19.1 
Less imputed interest(24.5)(5.2)
Total$221.8 $13.9 
Leases Leases
The components of lease expense for the years ended December 31, 2024 and 2023 are as follows.
20242023
Operating lease cost$64.5 $53.7 
Finance lease cost
Amortization of right-of-use assets$1.5 $1.5 
Interest on lease liabilities0.9 0.9 
Total finance lease cost$2.4 $2.4 
Short-term lease cost$2.2 $1.9 
Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows.
20242023
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$63.8 $53.7 
Operating cash flows from finance leases0.9 1.0 
Financing cash flows from finance leases1.3 1.2 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities96.2 62.5 
Supplemental balance sheet information related to leases is as follows.
December 31, 2024December 31, 2023
Operating leases
Other assets$226.6 $164.4 
Accrued liabilities$56.3 $41.6 
Other liabilities165.5 116.9 
Total operating lease liabilities$221.8 $158.5 
Finance Leases
Property, plant and equipment$11.1 $12.3 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities12.6 13.6 
Total finance lease liabilities$13.9 $14.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.25.1
Finance leases9.410.3
Weighted Average Discount Rate
Operating leases4.1 %3.6 %
Finance leases6.5 %6.4 %
Maturities of lease liabilities as of December 31, 2024 are as follows.
Operating LeasesFinance Leases
2025$63.6 $2.2 
202655.1 2.1 
202741.3 2.1 
202829.4 2.1 
202917.7 2.1 
Thereafter39.2 8.5 
Total lease payments$246.3 $19.1 
Less imputed interest(24.5)(5.2)
Total$221.8 $13.9 
v3.25.0.1
Stock-Based Compensation Plans
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Plans Stock-Based Compensation Plans
The Company has outstanding stock-based compensation awards granted under the 2013 Stock Incentive Plan (“2013 Plan”) and the 2017 Omnibus Incentive Plan, (as amended by the First Amendment, dated April 27, 2021, “2017 Plan”). Following the
Company’s initial public offering, the Company grants stock-based compensation awards pursuant to the 2017 Plan and ceased granting new awards pursuant to the 2013 Plan.
2017 Omnibus Incentive Plan
In May 2017, the Company’s Board approved the 2017 Plan, and in February 2020, the Company’s stockholders approved the amendment and restatement of the 2017 Plan. Under the terms of the Plan, the Company’s Board may grant up to 19.6 million stock based and other incentive awards. Any shares of common stock subject to outstanding awards granted under the Company’s 2013 plan that, after the effective date of the 2017 Plan, expire or are otherwise forfeited or terminated in accordance with their terms are also available for grant under the 2017 Plan. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards typically vest over four years or five years and expire ten years from the date of grant.
2013 Stock Incentive Plan
The Company adopted the 2013 Plan on October 14, 2013 as amended on April 27, 2015 under which the Company had the ability to grant stock-based compensation awards to employees, directors and advisors. The total number of shares available for grant under the 2013 Plan and reserved for issuance was 20.9 million shares. All stock options were granted to employees, directors and advisors with an exercise price equal to the fair value of the Company’s per share common stock at the date of grant. Stock option awards vested over either five years, four years, or three years with 50% of each award vesting based on time and 50% of each award vesting based on the achievement of certain financial targets.
Stock-Based Compensation Expense
Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and is only related to continuing operations.
202420232022
Equity awards granted under the 2013 Plan and 2017 Plan(1)
$58.8 $51.1 $80.0 
Increase (decrease) in the liability for stock appreciation rights (“SAR”)— 0.8 (1.1)
Total stock-based compensation expense$58.8 $51.9 $78.9 
(1) In 2022, of the $80.0 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $39.5 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020.
As of December 31, 2024, there was $110.6 million of total unrecognized compensation expense related to outstanding stock option, restricted stock unit and performance share unit awards granted to employees and non-employee directors, as well as 300,000 conditional stock options awarded during the third quarter of 2022 to our Chairman and CEO in which the service date precedes the grant date, and will be granted upon achievement of certain performance targets. These 300,000 stock options have not been included in the Stock Option Awards section below since the grant date has not occurred.
SARs, granted under the 2013 Plan, were settled in cash and were accounted for as liability awards. As of December 31, 2024 and 2023, there were no SARs outstanding.
Stock Option Awards
A summary of the Company’s stock option activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Exercise Price
(per share)
Wtd. Avg. Remaining Contractual Term (years)Aggregate Intrinsic Value of In-The-Money Options
(in millions)
Outstanding at December 31, 20235,282 $31.09 
Granted
610 90.55 
Exercised or Settled(1,615)19.96 
Forfeited
(88)65.08 
Expired
(4)40.22 
Outstanding at December 31, 20244,185 43.33 5.5$197.4 
Vested at December 31, 20242,708 29.34 4.1$165.5 
The per-share weighted average grant date fair value of stock options granted during the years ended December 31, 2024, 2023 and 2022 was $38.97, $25.28 and $21.24, respectively.
The intrinsic value of stock options exercised was $114.8 million, $75.0 million and $27.7 million during the years ended December 31, 2024, 2023 and 2022, respectively.
The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2024, 2023 and 2022.
202420232022
Expected life of options (in years)
6.3 - 7.5
6.3 - 7.5
6.3
Risk-free interest rate
3.7% - 4.3%
3.8% - 4.6%
1.9% - 3.9%
Assumed volatility
34.9% - 35.2%
35.6% - 36.6%
37.1% - 38.3%
Expected dividend rate
0.1%
0.0% - 0.1%
0.1% - 0.2%
Restricted Stock Unit Awards
Restricted stock units are typically granted in the first quarter of the year to employees and non-employee directors based on the market price of the Company’s common stock on the grant date and recognized in compensation expense over the vesting period. Eligible employees were also granted restricted stock units, during the third quarter of 2020, that vested ratably over two years, subject to the passage of time and the employee’s continued employment during such period. In some instances, such as death, awards may vest concurrently with or following an employee’s termination.
A summary of the Company’s restricted stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2023957 $52.18 
Granted433 90.94 
Vested(469)47.96 
Forfeited(87)68.20 
Non-vested as of December 31, 2024834 73.00 
Performance Share Unit Awards (“PSUs”)
Annually, during the first quarter, the Company grants TSR PSUs to certain employees in which the number of shares issued at the end of the performance period is determined by the Company’s total shareholder return percentile rank versus the S&P 500 index for the three year performance period. The grant date fair value of these awards is determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a three year period.
During the third quarter of 2022, the Company granted Special TSR PSUs to its Chairman and CEO under which the market condition is achieved on the first date during the five year performance period on which the sum of (i) the 60-day volume-weighted average closing price of the Company’s common stock, plus (ii) the cumulative value of any dividends paid during the five year performance period equals or exceeds $81.85. Vesting of this award is conditional upon the service condition even though the market condition was achieved prior to the end of the performance period. The grant date fair value of these awards was determined using a Monte Carlo simulation pricing model and compensation cost is recognized straight-line over a five year period. The Company also granted its Chairman and CEO Special EPS PSUs that are eligible to vest based on the level of compounded annual growth rate of the Company’s Adjusted EPS during the five year performance period. The grant date fair value of these awards is based on the market price of the Company’s common stock on the grant date and recognized as a compensation expense over a 4.3 year period.
A summary of the Company’s performance stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 20231,380 $49.53 
Granted87 132.98 
Change in units based on performance122 55.84 
Vested(244)55.84 
Forfeited(6)71.81 
Non-vested as of December 31, 20241,339 54.28 
The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2024, 2023 and 2022 using the Monte Carlo simulation pricing model.
202420232022
Expected term (in years)
2.8
2.9
2.9 - 5.0
Risk-free interest rate
4.5%
4.4%
1.7% - 3.4%
Assumed volatility
28.9%
31.8%
35.0% - 36.4%
Expected dividend rate0.1 %0.1 %0.2 %
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Activities, Derivative Instruments and Credit Risk Hedging Activities, Derivative Instruments and Credit Risk
Hedging Activities
The Company is exposed to certain market risks during the normal course of its business arising from adverse changes in interest rates and foreign currency exchange rates. The Company selectively uses derivative financial instruments (“derivatives”), including cross-currency interest rate swap and foreign currency forward contracts, and interest rate swap and cap contracts, to manage the risks from fluctuations in foreign currency exchange rates and interest rates, respectively. The Company does not purchase or hold derivatives for trading or speculative purposes. Fluctuations in interest rates and foreign currency exchange rates can be volatile, and the Company’s risk management activities do not totally eliminate these risks. Consequently, these fluctuations could have a significant effect on the Company’s financial results.
The Company manages its debt centrally, considering tax consequences and its overall financing strategies. The Company manages its exposure to interest rate risk by using interest rate derivatives as cash flow hedges of variable rate debt or fair value hedges of fixed rate debt in order to adjust the relative fixed and variable proportion. The Company’s exposure to interest rate risk results primarily from its fixed rate to floating rate interest rate swap contracts.
A substantial portion of the Company’s operations is conducted by its subsidiaries outside of the United States in currencies other than the USD. Almost all of the Company’s non-U.S. subsidiaries conduct their business primarily in their local currencies, which are also their functional currencies. The USD, the EUR, GBP, Chinese Renminbi, and Indian rupee are the principal currencies in which the Company and its subsidiaries enter into transactions. The Company is exposed to the impacts of changes in foreign currency exchange rates on the translation of its non-U.S. subsidiaries’ assets, liabilities and earnings into USD. The Company manages this exposure by having certain U.S. subsidiaries borrow in currencies other than the USD or utilizing cross-currency interest rate swaps as net investment hedges.
The Company and its subsidiaries are also subject to the risk that arises when they, from time to time, enter into transactions in currencies other than their functional currency. To mitigate this risk, the Company and its subsidiaries typically settle intercompany trading balances at least quarterly. The Company also selectively uses forward currency contracts to manage this risk. These contracts for the sale or purchase of European and other currencies generally mature within one year.
Derivative Instruments
The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2024 and 2023.
December 31, 2024
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsFair value$750.0 $— $1.4 $0.9 $0.9 
Cross-currency interest rate swap contractsNet investment1,074.3 11.5 15.8 — — 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$124.3 $1.8 $— $— $— 
Foreign currency forwardsFair value69.0 — — 1.2 — 
December 31, 2023
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsCash flow$528.5 $8.2 $1.2 $— $— 
Cross-currency interest rate swap contractsNet investment1,054.2 15.7 — — 63.1 
(1)Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Payments to settle cross-currency swaps and payments of interest rate cap premiums are classified as financing cash flows in the Condensed Consolidated Statements of Cash Flows. All other cash flows related to derivatives are classified as operating cash flows in the Condensed Consolidated Statements of Cash Flows.
There were no off-balance sheet derivative instruments as of December 31, 2024 or 2023.
Interest Rate Swap Contracts Designated as Fair Value Hedges
As of December 31, 2024, the Company was the variable rate payor on four interest rate swap contracts that effectively convert a total of $400.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in May 2029. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $400.0 million of the 2029 Notes, and were considered to be perfectly effective under the shortcut method.
As of December 31, 2024, the Company was the variable rate payor on two interest rate swap contracts that effectively convert a total of $250.0 million of the Company’s fixed rate borrowings to variable rate borrowings. These contracts expire in April 2031. These swap agreements qualify as hedging instruments and have been designated as fair value hedges of $250.0 million of the 2031 Notes, and were considered to be perfectly effective under the shortcut method.
As of December 31, 2024, the Company was the variable rate payor on one interest rate swap contract that effectively convert a total of $100.0 million of the Company’s fixed rate borrowings to variable rate borrowings. This contract expires in March 2034. This swap agreement qualifies as a hedging instrument and has been designated as a fair value hedge of $100.0 million of the 2034 Notes, and were considered to be perfectly effective under the shortcut method.
December 31, 2024December 31, 2023
Long-term debt:
Carrying amount of hedged debt$749.7 $— 
Cumulative hedging adjustments, included in carrying amount(0.3)— 
Interest Rate Swap and Cap Contracts Designated as Cash Flow Hedges
In April 2024, the Company entered into forward-starting interest rate swap agreements to hedge against changes in future cash flows resulting from changes in interest rates from the trade date through the forecasted issuance date of debt. During the year ended December 31, 2024, the Company entered into and terminated cash flow hedges with notional value of $750.0 million in connection with the 2034 Notes and $500.0 million in connection with the 2054 Notes, both of which were issued on May 10, 2024. The swaps were terminated on May 7, 2024, with a loss of $2.1 million on the swaps associated with the 2034 Notes and $2.3 million on the swaps associated with the 2054 Notes. These losses will be amortized as an increase to interest expense over the term of the respective notes.
The Company was previously the fixed rate payor on two interest rate swap contracts that effectively fix the SOFR-based index used to determine the interest rates charged on a total of $528.5 million of the Company’s SOFR-based variable rate borrowings. These contracts carry a fixed rate of 3.2%. The Company and its counterparties terminated these contracts in May 2024. Prior to their termination, these swap agreements qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. The forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination will be reclassified into earnings over the remaining period of the original term of the contracts, ending in June 2025. The unrecognized gain remaining in accumulated other comprehensive income (“AOCI”) as of December 31, 2024 was $4.8 million, all of which is expected to be reclassified into earnings as a reduction to interest expense during the next 12 months.
The Company was previously a party to interest rate cap contracts that effectively limited the SOFR-based interest rates charged on a portion of the Company’s variable rate borrowings to 4.0%. The Company and its counterparties terminated these contracts in August 2023. Prior to their termination, these cap contracts qualified as hedging instruments and were designated as cash flow hedges of forecasted interest payments. These forecasted interest payments are still expected to occur as specified in the Company’s hedge designations; therefore, the unrecognized gain at the time of termination will be reclassified into earnings over the remaining period of original term of the contracts, ending in June 2025. The unrecognized gain remaining in AOCI as of December 31, 2024 was $1.3 million, all of which is expected to be reclassified into earnings during the next 12 months.
Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below.
202420232022
Gain recognized in OCI on derivatives$1.6 $10.5 $18.3 
Gain (loss) reclassified from AOCI into income (effective portion)(1)
15.7 15.6 (2.8)
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Cross-Currency Interest Rate Swap Contracts Designated as Net Investment Hedges
As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.4% on a total of $428.9 million with a fixed rate of 3.7% on a total of €400.0 million. These contracts expire in May 2027 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2029 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
As of December 31, 2024, the Company was the fixed rate payor on three cross-currency interest rate swap contracts that replace a fixed rate of 5.7% on a total of $322.7 million with a fixed rate of 4.1% on a total of €300.0 million. These contracts expire in May 2031 and have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
The Company was previously the fixed rate payor on two cross-currency interest rate swap contracts that replaced a fixed rate of 3.2% on a total of $528.5 million with a fixed rate of 1.6% on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $10.0 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Condensed Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies.
The Company was previously a party to three cross-currency interest rate swap contracts where we receive SOFR on a total of $525.7 million and pay EURIBOR on a total of €500.0 million. These contracts were designated as net investment hedges of our Euro denominated subsidiaries until May 10, 2024 when they were terminated for $9.9 million. The payments to settle the termination of the cross currency interest rate swaps are included in “Payments to settle cross-currency swaps” within our Condensed Consolidated Statements of Cash Flows. The recorded AOCI at the termination of the cross-currency interest rate swaps will remain in AOCI until there is a substantial liquidation of the Company’s net investment in subsidiaries with EUR functional currencies.
Gains (losses) on derivatives designated as net investment hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below.
202420232022
Gain (loss) recognized in OCI on derivatives$72.5 $(17.5)$0.6 
Gain reclassified from AOCI into income (effective portion)(1)
17.7 19.0 11.5 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Foreign Currency Forwards Not Designated as Hedging Instruments
The Company had nine foreign currency forward contracts outstanding as of December 31, 2024 with notional amounts ranging from $7.7 million to $68.2 million. These contracts are sometimes used to hedge the change in fair value of recognized foreign currency denominated assets or liabilities caused by changes in currency exchange rates. The changes in the fair value of these contracts generally offset the changes in the fair value of a corresponding amount of the hedged items, both of which are included within “Other operating expense, net” in the Consolidated Statements of Operations. The Company’s foreign currency forward contracts are subject to master netting arrangements or agreements between the Company and each counterparty for the net settlement of all contracts through a single payment in a single currency in the event of default on or termination of any one contract with that certain counterparty. It is the Company’s practice to recognize the gross amounts in the Consolidated Balance Sheets. The amount available to be netted is not material.
The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Foreign currency forward contracts gains0.1 0.3 3.4 
Total foreign currency transaction gains (losses), net(3.2)(5.1)5.9 
Foreign Currency Denominated Debt Designated as a Net Investment Hedge
In February 2020, the Company designated its Euro Term Loan, which had a principal balance at that time of €601.2 million, as a hedge of the Company’s net investment in subsidiaries with a functional currency of euro. This loan was repaid in June 2022 and the hedge has been discontinued. The Company’s gains, net of income tax, associated with changes in the value of debt for the year ended December 31, 2022 was $36.4 million.
Credit Risk
Credit risk related to derivatives arises when amounts receivable from a counterparty exceed those payable. Because the notional amount of the derivative instruments only serves as a basis for calculating amounts receivable or payable, the risk of loss with any counterparty is limited to a fraction of the notional amount. The Company minimizes the credit risk related to derivatives by transacting only with multiple, high-quality counterparties that are major financial institutions with investment-grade credit ratings. The Company has not experienced any financial loss as a result of counterparty nonperformance in the past. The majority of the derivative contracts to which the Company is a party, settle monthly or quarterly, or mature within one
year. Because of these factors, the Company believes it has minimal credit risk related to derivative contracts as of December 31, 2024.
Concentrations of credit risk with respect to trade receivables are limited due to the wide variety of customers and industries to which the Company’s products and services are sold, as well as their dispersion across many different geographic areas. As a result, the Company does not believe it has any significant concentrations of credit risk as of December 31, 2024 or 2023.
v3.25.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
A financial instrument is defined as cash or cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company’s financial instruments consist primarily of cash and cash equivalents, trade accounts receivables, trade accounts payables, deferred compensation assets and obligations, derivatives and debt instruments. The carrying values of cash and cash equivalents, trade accounts receivables, trade accounts payables, and variable rate debt instruments are a reasonable estimate of their respective fair values.
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or more advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows.
Level 1    Quoted prices (unadjusted) in active markets for identical assets or liabilities as of the reporting date.
Level 2    Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.
Level 3    Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Refer to Note 1 “Summary of Significant Accounting Policies” for a discussion of the valuation assumptions utilized in the valuation of goodwill and indefinite-lived intangible assets.
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis.
December 31, 2024
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$21.0 $— $— $21.0 
Interest rate swaps(2)
— 1.4 — 1.4 
Cross-currency interest rate swaps(3)
— 27.3 — 27.3 
Foreign currency forwards(4)
— 1.8 — 1.8 
Total$21.0 $30.5 $— $51.5 
Financial Liabilities
Deferred compensation plan(1)
$28.7 $— $— $28.7 
Interest rate swaps(2)
— 1.8 — 1.8 
Contingent consideration(5)
— — 22.2 22.2 
Foreign currency forwards(4)
— 1.2 — 1.2 
Total$28.7 $3.0 $22.2 $53.9 
December 31, 2023
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$16.8 $— $— $16.8 
Interest rate swaps(5)
— 9.4 — 9.4 
Cross-currency interest rate swaps(3)
— 15.7 — 15.7 
Total$16.8 $25.1 $— $41.9 
Financial Liabilities
Deferred compensation plan(1)
$24.7 $— $— $24.7 
Cross-currency interest rate swaps(3)
— 63.1 — 63.1 
Contingent consideration(5)
— — 42.2 42.2 
Total$24.7 $63.1 $42.2 $130.0 
(1)Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method.
(2)Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties.
(3)Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties.
(4)Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates.
(5)Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets.
Contingent Consideration
Certain of the Company’s acquisitions may result in payments of consideration in future periods that are contingent upon the achievement of certain targets, generally measures of revenue and EBITDA. As part of the initial accounting for the acquisition, a liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is re-measured at each reporting period, and the change in fair value is recognized within “Other operating expense, net” in the Consolidated Statements of Operations. This fair value measurement of contingent consideration is categorized within Level 3 of the fair value hierarchy, as the measurement amount is based primarily on significant inputs that are not observable in the market.
The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2024 and 2023.
20242023
Balance at beginning of period$42.2 $43.9 
Acquisitions6.7 13.5 
Changes in fair value(15.3)7.3 
Payments(10.0)(23.2)
Foreign currency translation and other(1.4)0.7 
Balance at end of period$22.2 $42.2 
As of December 31, 2024, all contingent consideration is included in “Other liabilities” on the Consolidated Balance Sheet
v3.25.0.1
Contingencies
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
The Company is a party to various legal proceedings, lawsuits and administrative actions, which are of an ordinary or routine nature for a company of its size and sector. The Company believes that such proceedings, lawsuits and administrative actions will not materially adversely affect its operations, financial condition, liquidity or competitive position. A more detailed discussion of certain of these proceedings, lawsuits and administrative actions is set forth below.
Asbestos and Silica Related Litigation
Prior to the divestiture described below, “Accrued liabilities” and “Other liabilities” of the Condensed Consolidated Balance Sheets included a total litigation reserve of $126.9 million as of December 31, 2023, with regards to potential liability arising
from the Company’s asbestos-related litigation. The Company had an insurance recovery receivable for probable asbestos related recoveries of $157.7 million as of December 31, 2023, which was included in “Other assets” in the Condensed Consolidated Balance Sheets.
On June 5, 2024, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Onyx TopCo LLC (the “Buyer”), a wholly owned subsidiary of Delticus Holdings LLC (“Delticus”), which is an entity owned by entities affiliated with Third Point LLC. Under the Purchase Agreement, the Company transferred 100% of the equity interests of three wholly-owned subsidiaries that hold asbestos liabilities and certain assets, including the related insurance assets, to the Buyer, effective as of June 10, 2024. In connection with the divestiture (the “Asbestos Portfolio Sale”), the divested entities were capitalized with a total of $188.5 million, including $143.5 million from insurance settlement proceeds, $35.0 million from affiliates of Delticus, and $10.0 million from Ingersoll Rand. As these subsidiaries were the obligors for the Company’s asbestos-related liabilities and policyholders of the related insurance assets, the rights and obligations related to these items transferred upon the sale. The divested subsidiaries have agreed to indemnify us and our affiliates for their asbestos-related liabilities, which encompassed all of our consolidated asbestos-related liabilities and contingent liabilities immediately prior to the sale. The Purchase Agreement contains customary representations and warranties with respect to the divested subsidiaries, the Company, and Delticus. Pursuant to the Purchase Agreement, the Company and Delticus will each indemnify the other for breaches of representation and warranties or breaches of covenants, subject to certain limitations as set forth in the agreement. In connection with the sale, the Company and its Board of Directors received a solvency opinion from an independent advisory firm that the divested entities were solvent and adequately capitalized immediately prior to, at the time of, and after giving effect to, the sale.
Following the completion of the transfer, the Company no longer has any obligation with respect to pending and future asbestos claims. As such, the divested entities have been deconsolidated from the financial results of the Company as we no longer maintain control of the entities. Therefore, all associated assets and liabilities are no longer reported on the Consolidated Balance Sheet. The transaction resulted in a pre-tax loss of $58.8 million, recorded to “Other operating expense, net.” Additionally, the Company recorded a tax benefit as a result of the reversal of previously recorded net deferred tax liabilities of $7.6 million, resulting in an after-tax loss of $51.2 million recorded in the second quarter of 2024.
The following table summarizes the impacts of the divestiture.
Assets divested:
Cash and cash equivalents$153.5 
Insurance recovery receivable13.9 
Liabilities divested:
Asbestos indemnity liability - current(12.3)
Asbestos indemnity liability - noncurrent(111.4)
Loss on Asbestos Sale, before transaction costs43.7 
Transaction costs15.1 
Loss on Asbestos Sale58.8 
Income tax benefit(7.6)
Loss on Asbestos Sale, net of tax$51.2 
Environmental Matters
The Company has been identified as a potentially responsible party (“PRP”) with respect to several sites designated for cleanup under U.S. federal “Superfund” or similar state laws that impose liability for cleanup of certain waste sites and for related natural resource damages. Persons potentially liable for such costs and damages generally include the site owner or operator and persons that disposed or arranged for the disposal of hazardous substances found at those sites. Although these laws impose joint and several liability on PRPs, in application the PRPs typically allocate the investigation and cleanup costs based upon the volume of waste contributed by each PRP. Based on currently available information, the Company was only a small contributor to these waste sites, and the Company has, or is attempting to negotiate, de minimis settlements for their cleanup. The cleanup of the remaining sites is substantially complete and the Company’s future obligations entail a share of the sites’ ongoing operating and maintenance expense. The Company is also addressing several on-site cleanups for which it is the primary responsible party.
The Company has undiscounted liabilities of $13.6 million and $16.7 million as of December 31, 2024 and 2023, respectively, on its Consolidated Balance Sheets to the extent costs are known or can be reasonably estimated for its remaining financial obligations for the environmental matters discussed above and does not anticipate that any of these matters will result in material additional costs beyond amounts accrued. Based upon consideration of currently available information, the Company does not anticipate any material adverse effect on its results of operations, financial condition, liquidity or competitive position as a result of compliance with federal, state, local or foreign environmental laws or regulations, or cleanup costs relating to these matters.
v3.25.0.1
Other Operating Expense, Net
12 Months Ended
Dec. 31, 2024
Other Income and Expenses [Abstract]  
Other Operating Expense, Net Other Operating Expense, Net
The components of “Other operating expense, net” for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Other Operating Expense, Net
Foreign currency transaction losses (gains), net$3.2 $5.1 $(5.9)
Restructuring charges, net(1)
31.2 19.9 29.3 
Acquisition and other transaction related expenses(2)
47.1 52.2 38.7 
Loss on asbestos sale(3)
58.8 — — 
Other, net
(1.7)0.5 2.8 
Total other operating expense, net$138.6 $77.7 $64.9 
(1)See Note 5 “Restructuring.”
(2)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(3)See Note 22 “Contingencies.”
v3.25.0.1
Segment Reporting
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
A description of the Company’s two reportable segments, including the specific products manufactured and sold follows below.
In the Industrial Technologies and Services segment, the Company designs, manufactures, markets and services a broad range of compression and vacuum equipment as well as fluid transfer equipment and loading systems. The Company’s compression and vacuum products are used worldwide in industrial manufacturing, transportation, chemical processing, food and beverage production, clean energy, environmental and other applications. In addition to equipment sales, the Company offers a broad portfolio of service options tailored to customer needs and complete range of aftermarket parts, air treatment equipment, controls and other accessories. The Company’s engineered loading systems and fluid transfer equipment ensure the safe handling and transfer of crude oil, liquefied natural gas, compressed natural gas, chemicals, and bulk materials.
In the Precision and Science Technologies segment, the Company designs, manufactures and markets a broad range of specialized positive displacement pumps, fluid management equipment, single-use powder handling systems, and contract design and production services for silicone, thermoplastic, and specialty components and assemblies for medical devices. These products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, agriculture and other markets. The Company’s products are used for a diverse set of applications including precision dosing, liquid and solid transfer, dispensing, gas compression, gas sampling, pressure management, flow control, and powder handling, amongst other applications. The Company sells primarily through a broad global network of specialized and national distributors and original equipment manufacturers who integrate the Company’s products into their devices and systems.
Ingersoll Rand’s Chief Operating Decision Maker (“CODM”) is our Chief Executive Officer. The CODM evaluates the performance of the Company’s segments based on Segment Adjusted EBITDA. The CODM closely monitors the Segment Adjusted EBITDA of each segment to evaluate past performance and actions required to improve profitability. Inter-segment sales and transfers are not significant. Certain administrative expenses related to the Company’s corporate offices and shared service centers in the United States and Europe, which includes transaction processing, accounting and other business support functions, are allocated to the segments and are included in Segment selling and administrative expenses. Certain other administrative expenses, including senior management compensation, treasury, internal audit, tax compliance, certain information technology, and other corporate functions, are not allocated to the segments to determine Segment Adjusted EBITDA.
The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes for the years ended December 31, 2024, 2023 and 2022.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202420232022202420232022202420232022
Revenue$5,818.1 $5,632.8 $4,705.1 1,416.9 1,243.3 1,211.2 $7,235.0 $6,876.1 $5,916.3 
Segment cost of sales(1)
3,193.3 3,225.0 2,785.5 736.2 648.8 652.4 3,929.5 3,873.8 3,437.9 
Segment selling and administrative expenses(2)
868.5 818.5 702.5 264.6 222.5 212.6 1,133.1 1,041.0 915.1 
Other segment items(3)
1.5 2.0 3.1 (2.7)(0.8)(1.3)(1.2)1.2 1.8 
Segment Adjusted EBITDA$1,754.8 $1,587.3 $1,214.0 418.8 372.8 347.5 2,173.6 1,960.1 1,561.5 
(1)Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(2)Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(3)Other miscellaneous segment expenses.
202420232022
Total Segment Adjusted EBITDA2,173.6 1,960.1 1,561.5 
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:
Corporate expenses not allocated to segments
155.5 173.3 126.7 
Interest expense213.2 156.7 103.2 
Depreciation and amortization expense(1)
478.0 455.4 429.4 
Impairment of other intangible assets
13.9 — — 
Restructuring and related business transformation costs(2)
32.3 22.9 32.3 
Acquisition and other transaction related expenses and non-cash charges(3)
59.8 63.9 40.7 
Stock-based compensation(4)
58.8 51.9 85.6 
Foreign currency transaction losses (gains), net3.2 5.1 (5.9)
Loss on extinguishment of debt
3.0 13.5 1.1 
Adjustments to LIFO inventories6.7 12.0 36.1 
Cybersecurity incident costs0.5 2.3 — 
Loss on asbestos sale58.8 — — 
Gain on settlement of post-acquisition contingencies(5)
— — (6.2)
Interest income on cash and cash equivalents(43.3)(28.8)(8.0)
Other adjustments(6)
0.4 0.8 (15.7)
Income from Continuing Operations Before Income Taxes$1,132.8 $1,031.1 $742.2 
(1)Depreciation and amortization expense excludes $4.0 million, $3.7 million and $3.4 million of depreciation of rental equipment for the years ended December 31, 2024, 2023 and 2022, respectively.
(2)Restructuring and related business transformation costs consist of the following.
202420232022
Restructuring charges$31.2 $19.9 $29.3 
Facility reorganization, relocation and other costs1.1 3.0 3.0 
Total restructuring and related business transformation costs$32.3 $22.9 $32.3 
(3)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(4)Represents stock-based compensation expense recognized for the year ended December 31, 2022 of $78.9 million and associated employer taxes of $6.7 million.
(5)Represents gains from settling post-acquisition contingencies related to the Merger outside of the measurement period.
(6)Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments.
The following tables provide summarized information about the Company’s reportable segments.
Depreciation and Amortization Expense
202420232022
Industrial Technologies and Services$296.0 $313.8 $294.7 
Precision and Science Technologies177.1 135.4 133.6 
Corporate and other8.9 9.9 4.5 
Total depreciation and amortization expense$482.0 $459.1 $432.8 
Capital Expenditures
202420232022
Industrial Technologies and Services$83.0 $83.9 $66.3 
Precision and Science Technologies21.3 18.5 17.7 
Corporate and other44.8 3.0 10.6 
Total capital expenditures$149.1 $105.4 $94.6 
Identifiable Assets
20242023
Industrial Technologies and Services$10,369.6 $10,138.8 
Precision and Science Technologies5,884.1 3,464.7 
Corporate and other1,756.1 1,960.0 
Total identifiable assets$18,009.8 $15,563.5 
The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2024, and 2023.
20242023
United States$381.8 $286.0 
Other Americas38.1 12.8 
Total Americas419.9 298.8 
EMEIA(1)
256.5 245.7 
China152.3 160.9 
Other Asia Pacific13.4 6.0 
Total Asia Pacific165.7 166.9 
Total$842.1 $711.4 
(1)Europe, Middle East, India and Africa (“EMEIA”)
v3.25.0.1
Earnings Per Share
12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The calculation of earnings per share is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all potentially dilutive shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the dilutive effect of outstanding share-based compensation awards. The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Weighted-average shares outstanding - Basic403.4 404.8 405.3 
Dilutive effect of outstanding share-based compensation awards3.8 4.2 4.9 
Weighted-average shares outstanding - Diluted407.2 409.0 410.2 
For the years ended December 31, 2024, 2023 and 2022, there were 0.5 million, 1.3 million and 1.8 million anti-dilutive shares that were not included in the computation of diluted earnings per share, respectively.
v3.25.0.1
Subsequent Events
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On February 3, 2025, the Company completed the acquisition of four businesses for aggregate purchase consideration of approximately $168 million, subject to customary post-closing purchase price adjustments.
On February 11, 2025, the Company entered into two cross-currency interest rate swap contracts on a total of €250.0 million. These contracts have been designated as net investment hedges of our Euro denominated subsidiaries and require an exchange of the notional amounts at maturity.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure      
Net income attributable to Ingersoll Rand Inc. $ 838.6 $ 778.7 $ 604.7
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
The Company has implemented controls based on the National Institute of Standards and Technology Cybersecurity Framework (the “NIST CSF”) and the Sarbanes-Oxley Act of 2002. Our Information Technology organization is led by the Chief Information Officer (“CIO”) who is responsible for cybersecurity risk management. The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually. Directors with experience in cybersecurity and technology play crucial oversight roles for our digital and cybersecurity strategies.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee of the Board of Directors is tasked with oversight of our overall enterprise risk management program, including cybersecurity, and receives recurring cybersecurity updates throughout the year with at least two cybersecurity reports to the full Board of Directors annually.
Cybersecurity Risk Role of Management [Text Block]
Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets. Risks and controls are monitored by the CISO and CIO and their evaluation of our overall program drives the nature and scope of our cybersecurity investments. Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity. The CISO reports to the Audit Committee on the effectiveness of the Company’s cybersecurity program controls aligned to the NIST CSF framework. We periodically engage external subject matter experts who provide independent qualitative and quantitative assessments of the cybersecurity program maturity and response readiness. We also use processes to oversee and identify material risks from cybersecurity threats associated with our use of third-party technology and systems. In addition, the Company leverages a monthly cybersecurity awareness training program for all employees that is further reinforced through frequent phishing simulations.
Quarterly updates are provided by the CISO to the Cybersecurity Governance Committee comprised of cross functional senior management regarding the effectiveness of cybersecurity program and its ability to monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. Our Cybersecurity Governance Committee is responsible for monitoring and coordinating enterprise cybersecurity policy and strategy, and for providing guidance to key management and oversight bodies. Our cybersecurity program includes a risk-based incident response plan that provides a documented framework for handling incidents including coordination across multiple parts of the Company.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our cybersecurity program is overseen by the Company’s Chief Information Security Officer (“CISO”) and is designed to protect and preserve the confidentiality, integrity and availability of our information technology assets.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our CISO reports directly to the CIO and has 20 years of IT experience including leadership roles at various companies with enterprise responsibility for IT audit, IT infrastructure, and cybersecurity.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Quarterly updates are provided by the CISO to the Cybersecurity Governance Committee comprised of cross functional senior management regarding the effectiveness of cybersecurity program and its ability to monitor the prevention, detection, mitigation, and remediation of cybersecurity incidents. Our Cybersecurity Governance Committee is responsible for monitoring and coordinating enterprise cybersecurity policy and strategy, and for providing guidance to key management and oversight bodies. Our cybersecurity program includes a risk-based incident response plan that provides a documented framework for handling incidents including coordination across multiple parts of the Company.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Overview and Basis of Presentation
Overview and Basis of Presentation
Ingersoll Rand Inc. is a global provider of mission-critical flow creation products and life science and industrial solutions. The accompanying consolidated financial statements include the accounts of Ingersoll Rand Inc. and its consolidated subsidiaries (collectively referred to herein as “Ingersoll Rand” or the “Company”).
Principles of Consolidation
Principles of Consolidation
The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions and accounts have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates the estimates and assumptions related to the allowance for credit losses, inventory valuation, warranty reserves, fair value of stock-based awards, goodwill, intangible asset, and long-lived asset valuations, employee benefit plan liabilities, over time revenue recognition, income tax liabilities and deferred tax assets and related valuation allowances, uncertain tax positions, restructuring reserves, and litigation and other loss contingencies. Actual results could differ materially and adversely from those estimates and assumptions, and such results could affect the Company’s consolidated net income, financial position, or cash flows.
Foreign Currency Translation
Foreign Currency Translation
Assets and liabilities of the Company’s foreign subsidiaries, where the functional currency is not the U.S. Dollar (“USD”), are translated at the exchange rate in effect at the balance sheet date, while revenues and expenses are translated at average rates prevailing during the year. Adjustments resulting from the translation of the assets and liabilities of foreign operations into USD are excluded from the determination of net income, and are reported in accumulated other comprehensive loss, a separate component of stockholders’ equity, and included as a component of other comprehensive income (loss). Assets and liabilities of subsidiaries that are denominated in currencies other than the subsidiaries’ functional currency are remeasured into the functional currency using end of period exchange rates, or historical rates for certain balances, where applicable. Gains and losses related to these remeasurements are recorded within the Consolidated Statements of Operations as a component of “Other operating expense, net.”
Revenue Recognition
Revenue Recognition
The Company recognizes revenue when the Company has satisfied its obligation and control is transferred to the customer. The majority of the Company’s revenues are derived from short duration contracts and revenue is recognized at a single point in time when control is transferred to the customer, generally at shipment or when delivery has occurred or services have been rendered. The Company also has certain contracts in which revenue is recognized over time based on the Company’s progress in satisfying the contractual performance obligations.
Cost of Sales
Cost of Sales
Cost of sales includes the costs the Company incurs, including purchased materials, labor and overhead related to manufactured products and aftermarket parts sold during a period. Depreciation related to manufacturing equipment and facilities is included in cost of sales. Purchased materials represent the majority of costs of sales, with steel, aluminum, copper and partially finished castings representing the most significant materials inputs. Cost of sales for services includes the direct costs the Company incurs including direct labor, parts and other overhead costs including depreciation of equipment and facilities to deliver repair, maintenance, and other field services to the Company’s customers.
Selling and Administrative Expenses
Selling and Administrative Expenses
Selling and administrative expenses consist of (i) employee related salary, stock-based compensation expense, benefits and other expenses for selling, administrative functions and other activities not associated with the manufacture of products or delivery of services to customers; (ii) the costs of marketing and direct costs of selling products and services to customers including internal and external sales commissions; (iii) facilities costs including office rent, maintenance, depreciation, and insurance for selling and administrative activities; (iv) research and development expenditures; (v) professional and consultant fees; and (vi) other miscellaneous expenses.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents are highly liquid investments primarily consisting of demand deposits and have original maturities of three months or less. Accordingly, the carrying amount of such instruments is considered a reasonable estimate of fair value.
Accounts Receivable
Accounts Receivable
Trade accounts receivable consist of amounts owed for products shipped to or services performed for customers. Reviews of customers’ creditworthiness are performed prior to order acceptance or order shipment.
Trade accounts receivable are recorded net of an allowance for expected credit losses. The allowance for credit losses is based on the Company’s assessment of losses that will result from its customers’ inability or unwillingness to pay amounts owed to the Company. The allowance is determined using a combination of factors, including historical credit loss experience and the length of time that the trade receivables are past due, supplemented by the Company’s knowledge of customer-specific information, current market conditions and reasonable and supportable forecasts of future events and economic conditions.
Inventories
Inventories
Inventories, which consist primarily of raw materials and finished goods, are carried at the lower of cost or net realizable value. Fixed manufacturing overhead is allocated to the cost of inventory based on the normal capacity of production facilities. Unallocated overhead during periods of abnormally low production levels is recognized as cost of sales in the period in which it is incurred.
Property, Plant and Equipment
Property, Plant and Equipment
Property, plant and equipment includes the historical cost of land, buildings, equipment, and significant improvements to existing plant and equipment or in the case of acquisitions, a fair market value of assets at the time of acquisition. Repair and maintenance costs that do not extend the useful life of an asset are recorded as an expense as incurred. Depreciation is provided using the straight-line method over the estimated useful lives of the assets, which are generally as follows: buildings — 10 to 30 years, machinery and equipment — 7 to 10 years, and office furniture and equipment — 3 to 10 years.
Goodwill and Indefinite-Lived Intangible Assets
Goodwill and Indefinite-Lived Intangible Assets
Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired, liabilities assumed, and non-controlling interests, if any. Intangible assets, including goodwill, are assigned to the Company’s reporting units based upon their fair value at the time of acquisition. Goodwill and indefinite-lived intangibles such as tradenames are not subject to amortization but are assessed for impairment annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired or that there is a probable reduction in the fair value of a reporting unit below its aggregate carrying value.
The Company tests goodwill for impairment annually in the fourth quarter of each year using data as of October 1 of that year and whenever events or changes in circumstances indicate the carrying value may not be recoverable. The impairment test consists of comparing the fair value of the reporting unit to the carrying value of the reporting unit. An impairment charge is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; provided, the loss recognized cannot exceed the total amount of goodwill allocated to the reporting unit. If applicable, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss. The Company determined fair values for each of the reporting units using a combination of the income and market multiple approaches which are weighted 75% and 25%, respectively.
Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. The Company uses its internal forecasts to estimate future cash flows and includes an estimate of
long-term future growth rates based on its most recent views of the long-term outlook for each reporting unit. Actual results may differ from those assumed in the Company’s forecasts. The Company derives its discount rates using a capital asset pricing model and analyzing published rates for industries relevant to its reporting units to estimate the cost of equity financing. The Company uses discount rates that are commensurate with the risks and uncertainty inherent in the respective businesses and in its internally developed forecasts. Under the market approach, the Company applies performance multiples from comparable public companies, adjusted for relative risk, profitability, and growth considerations, to the reporting units to estimate fair value.
The Company tests intangible assets with indefinite lives annually for impairment using a relief from royalty discounted cash flow fair value model. The quantitative impairment test for indefinite-lived intangible assets involves a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value of the intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The relief from royalty method requires the Company to estimate forecasted revenues and determine appropriate discount rates, royalty rates, and terminal growth rates.
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Long-Lived Assets Including Intangible Assets With Finite Useful Lives
Intangible assets with finite useful lives are amortized on a straight-line basis over their estimated useful lives, which vary depending on the type of intangible assets. In determining the estimated useful lives of definite-lived intangibles, we consider the nature, competitive position, life cycle position and historical and expected future operating cash flows of each acquired assets, as well as our commitment to support these assets through continued investment and legal infringement protection.
The Company reviews long-lived assets, including identified intangible assets with finite useful lives and subject to amortization for impairment, whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. Determining whether an impairment loss occurred requires comparing the carrying amount to the sum of undiscounted cash flows expected to be generated by the asset. Such events and circumstances include the occurrence of an adverse change in the market involving the business employing the related long-lived assets or a situation in which it is more likely than not that the Company will dispose of such assets. If the comparison indicates that there is impairment, the impairment loss to be recognized as a non-cash charge to earnings is measured by the amount by which the carrying amount of the assets exceeds their fair value and the impaired assets are written down to their fair value or, if fair value is not readily determinable, to an estimated fair value based on discounted expected future cash flows. Assets to be disposed are reported at the lower of the carrying amount or fair value, less costs to dispose.
Warranty Reserves
Warranty Reserves
Most of the Company’s product sales are covered by warranty provisions that generally provide for the repair or replacement of qualifying defective items for a specified period after the time of sale, typically 12 months. The Company establishes reserves for estimated product warranty costs at the time revenue is recognized based upon historical warranty experience and additionally for any known product warranty issues. The Company’s warranty obligation has been and may in the future be affected by product failure rates, repair or field replacement costs, and additional costs incurred in correcting any product failure.
Stock-Based Compensation
Stock-Based Compensation
Stock-based compensation is measured for all stock-based equity awards made to employees and non-employee directors based on the estimated fair value as of the grant date. The determination of the fair values of stock-based awards at the grant date requires judgment, including estimating the expected term of the relevant stock-based payment awards and the expected volatility of the Company’s stock. The fair value of each stock option grant under the stock-based compensation plans is estimated on the date of grant or modification using the Black-Scholes-Merton option-pricing model. The expected stock volatility assumption was based on an average of the historical volatility over the expected term of the stock options. Forfeitures of stock options are accounted for as they occur. Restricted stock units and performance share units with internal performance metrics (i.e. EPS) are valued at the share price on the date of grant. The grant date fair value of performance share units with external performance metrics (i.e. TSR) is determined using a Monte Carlo simulation pricing model.
Pension and Other Postretirement Benefits
Pension and Other Postretirement Benefits
The Company sponsors a number of pension plans and other postretirement benefit plans worldwide. The calculation of the pension and other postretirement benefit obligations and net periodic benefit cost under these plans requires the use of actuarial valuation methods and assumptions. These assumptions include the discount rates used to value the projected benefit obligations, future rate of compensation increases, expected rates of return on plan assets and expected healthcare cost trend rates. The discount rates selected to measure the present value of the Company’s benefit obligations as of December 31, 2024 and 2023 were derived by examining the rates of high-quality, fixed income securities whose cash flows or duration match the timing and amount of expected benefit payments under the plans. In accordance with GAAP, actual results that differ from the Company’s assumptions are recorded in accumulated other comprehensive income (loss) and amortized through net periodic benefit cost over future periods. While management believes that the assumptions are appropriate, differences in actual experience or changes in assumptions may affect the Company’s pension and other postretirement benefit obligations and future net periodic benefit cost.
Income Taxes
Income Taxes
The Company has determined income tax expense and other deferred income tax information based on the asset and liability method. Deferred income tax liabilities are provided on temporary differences between assets and liabilities for financial and tax reporting purposes as measured by enacted tax rates expected to apply when temporary differences are settled or realized. A valuation allowance is established for the portion of deferred tax assets for which it is not more likely than not that a tax benefit will be realized.
Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate settlement. Unrecognized tax benefits are tax benefits claimed in the Company’s tax returns that do not meet these recognition and measurement standards. The Company believes that its income tax liabilities, including related interest, are adequate in relation to the potential for additional tax assessments. There is a risk, however, that the amounts ultimately paid upon resolution of audits could be materially different from the amounts previously included in income tax expense and, therefore, could have a material impact on the Company’s tax provision, net income, and cash flows. The Company reviews its liabilities quarterly, and may adjust such liabilities due to proposed assessments by tax authorities, changes in facts and circumstances, issuance of new regulations or new case law, negotiations between tax authorities of different countries concerning transfer prices, the resolution of audits, or the expiration of statutes of limitations. Adjustments are most likely to occur in the year during which major audits are closed.
The Tax Cuts and Jobs Act (“Tax Act”), enacted on December 22, 2017, created a new requirement that certain income (i.e., Global intangible low taxed income (“GILTI”)) earned by controlled foreign corporations (“CFC”) must be included currently in the gross income of the CFCs’ U.S. shareholder. GILTI is the excess of the shareholder’s “net CFC tested income” over the net deemed tangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income.
Under U.S. GAAP, the Company is allowed to make an accounting policy choice of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into a company’s measurement of its deferred taxes (the “deferred method”). The Company has determined that it will follow the period cost method (option 1 above).
Research and Development
Research and Development
For the years ended December 31, 2024, 2023 and 2022, the Company spent $116.6 million, $108.2 million, and $91.3 million, respectively, on research activities relating to the development of new products and new product applications. All such expenditures were funded by the Company, expensed as incurred and recorded to “Selling and administrative expenses” in the Consolidated Statements of Operations.
Derivative Financial Instruments
Derivative Financial Instruments
All derivative financial instruments are reported on the balance sheet at fair value. For derivative instruments that are not designated as hedges, any gain or loss on the derivatives is recognized in earnings in the current period. A derivative instrument
may be designated as a hedge of the exposure to: (1) changes in the fair value of an asset, liability, or firm commitment, (2) variability in expected future cash flows, if the hedging relationship is expected to be highly effective in offsetting changes in fair value or cash flows attributable to the hedged risk during the period of designation or (3) as a hedge of a net investment in a foreign operation. If a derivative is designated as a fair value hedge, the gain or loss on the derivative and the offsetting loss or gain on the hedged asset, liability, or firm commitment are recognized in earnings. For derivative instruments designated as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified to earnings in the same period that the hedged transaction affects earnings. For derivative instruments designated as net investment in a foreign operation, gains or losses are reported as currency translation adjustments. The ineffective portion of the gain or loss is immediately recognized in earnings. Gains or losses on derivative instruments recognized in earnings are reported in the same line item as the associated hedged transaction in the Consolidated Statements of Operations.
Hedge accounting is discontinued prospectively when (1) it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (2) the derivative is sold, terminated, or exercised; (3) the hedged item no longer meets the definition of a firm commitment; or (4) it is unlikely that a forecasted transaction will occur within two months of the originally specified time period.
When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the derivative continues to be carried on the balance sheet at its fair value, and the changes in the fair value of the hedged asset or liability is recorded to the Consolidated Statements of Operations. When cash flow hedge accounting is discontinued because the derivative is sold, terminated, or exercised, the net gain or loss remains in accumulated other comprehensive income and is reclassified into earnings in the same period that the hedged transaction affects earnings or until it becomes unlikely that a hedged forecasted transaction will occur within two months of the originally scheduled time period. When hedge accounting is discontinued because a hedged item no longer meets the definition of a firm commitment, the derivative continues to be carried on the Consolidated Balance Sheet at its fair value, and any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized as a gain or loss currently in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur within two months of the originally specified time period, the derivative continues to be carried on the balance sheet at its fair value, and gains and losses reported in accumulated other comprehensive income are recognized immediately in the Consolidated Statements of Operations.
Comprehensive Income
Comprehensive Income
The Company’s comprehensive income consists of net income (loss) and other comprehensive income (loss), consisting of (i) unrealized foreign currency net gains and losses on the translation of the assets and liabilities of its foreign operations; (ii) realized and unrealized foreign currency gains and losses on intercompany notes of a long-term nature and hedges of net investments in foreign operations, net of income taxes; (iii) unrealized gains and losses on cash flow hedges, net of income taxes; and (iv) pension and other postretirement prior service cost and actuarial gains or losses, net of income taxes.
Restructuring Charges
Restructuring Charges
The Company incurs costs in connection with workforce reductions, facility consolidations and other actions. Such costs include employee termination benefits (one-time arrangements and benefits attributable to prior service), termination of contractual obligations, non-cash asset charges and other direct incremental costs.
A liability is established through a charge to operations for (i) one-time employee termination benefits when management commits to a plan of termination; (ii) employee termination benefits that accumulate or vest based on prior service when it becomes probable that such termination benefits will be paid and the amount of the payment can be reasonably estimated; and (iii) contract termination costs when the contract is terminated or the Company becomes contractually obligated to make such payment. Other direct incremental costs are charged to operations as incurred.
Charges recorded in connection with restructuring plans are included in “Other operating expense, net” in the Consolidated Statements of Operations.
Business Combinations
Business Combinations
The Company accounts for business combinations by applying the acquisition method. The Company’s consolidated financial statements include the operating results of acquired entities from the respective dates of acquisition. The Company recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date at fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable
assets acquired, liabilities assumed, and any non-controlling interest is recognized as goodwill in the Consolidated Balance Sheets. Costs incurred by the Company to effect a business combination other than costs related to the issuance of debt or equity securities are included in the Consolidated Statements of Operations in the period the costs are incurred.
Earnings per Share
Earnings per Share
The calculation of earnings per share (“EPS”) is based on the weighted-average number of the Company’s shares outstanding for the applicable period. The calculation of diluted earnings per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding share-based compensation awards.
Leases
Leases
The Company has operating and financing leases for real estate, vehicles, IT equipment, office equipment and production equipment. The Company determines if an arrangement is a lease and identifies the classification of the lease as a financing lease or an operating lease at inception. Operating leases are recorded as operating lease right-of-use assets (“ROU assets”) in “Other assets” and operating lease liabilities in “Accrued liabilities” and “Other liabilities” in the Consolidated Balance Sheets. Financing leases are recorded as financing ROU assets in “Property, plant and equipment” and lease liabilities in “Short-term borrowings and current maturities of long-term debt” and “Long-term debt, less current maturities” in the Consolidated Balance Sheets.
At the date of commencement, lease liabilities are recorded at the present value of the future minimum lease payments over the lease term. The lease term is equal to the initial term at commencement plus any renewal or extension options that the Company is reasonably certain will be exercised. ROU assets at the date of commencement are equal to the amount of the initial lease liability, the initial direct costs incurred by the Company and any prepaid lease payments less any incentives received. An incremental borrowing rate is used in the determination of the present value of future lease payments. Incremental borrowing rates for a lease are based on the lease term, lease currency and the Company’s credit spread.

The Company does not recognize leases with an original term of less than 12 months on its balance sheet and continues to expense such leases. The Company also elected the practical expedient allowing the Company to account for each separate lease component of a contract and its associated non-lease component as a single lease component. This practical expedient was applied to all underlying asset classes. Variable lease expense was not material.
Recently Adopted Accounting Standards Updates ("ASU") & Recently Issued Accounting Pronouncements
Recently Adopted Accounting Standard Updates (“ASU”)
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segments expenses. The amendments in this update are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The amendments in this update were applied retrospectively to all prior periods presented in the financial statements. The segment expense categories and amounts disclosed in the prior periods were based on the significant segment expense categories identified and disclosed in Note 24 “Segment Reporting.” The adoption has modified our disclosures but has not had a material effect on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which addresses investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. The amendments in this update are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual statements that have not yet been issued or made available for issuance. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The adoption will modify our disclosures but is not expected to have a material effect on our consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure of additional disaggregated information about significant expenses within relevant income statement captions, such as purchases of inventory, employee compensation, depreciation, amortization, and depletion. The amendment is effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The amendment should be applied prospectively; however,
retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.
v3.25.0.1
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations
The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below:
Specialty Vehicle TechnologiesHigh Pressure SolutionsTotal
Revenues$6.6 $— $6.6 
Cost of sales6.5 — 6.5 
Gross Profit0.1 — 0.1 
Selling and administrative expenses0.1 — 0.1 
Gain on sale(2.8)— (2.8)
Other operating expense, net0.7 1.6 2.3 
Income from Discontinued Operations Before Income Taxes2.1 (1.6)0.5 
Provision for income taxes(13.2)(1.5)(14.7)
Income from Discontinued Operations, Net of Tax$15.3 $(0.1)$15.2 
The following table summarizes the impacts of the divestiture.
Assets divested:
Cash and cash equivalents$153.5 
Insurance recovery receivable13.9 
Liabilities divested:
Asbestos indemnity liability - current(12.3)
Asbestos indemnity liability - noncurrent(111.4)
Loss on Asbestos Sale, before transaction costs43.7 
Transaction costs15.1 
Loss on Asbestos Sale58.8 
Income tax benefit(7.6)
Loss on Asbestos Sale, net of tax$51.2 
v3.25.0.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the allocation of consideration for all businesses acquired in 2024 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for Friulair is substantially complete and all other businesses acquired in 2024 are preliminary, and amounts assigned to acquired assets and liabilities assumed are subject to change as information necessary to complete the analysis is obtained.
ILC DoverFriulairAPSCOAll othersTotal Consideration
Accounts receivable$41.4 $14.2 $6.4 $37.8 $99.8 
Inventories84.0 13.2 7.5 46.3 151.0 
Other current assets35.1 0.5 0.5 4.7 40.8 
Property, plant and equipment90.8 7.2 2.3 18.5 118.8 
Goodwill1,309.8 69.2 51.6 237.6 1,668.2 
Other intangible assets973.1 84.5 48.1 80.5 1,186.2 
Other noncurrent assets15.8 — 3.5 6.0 25.3 
Total current liabilities(31.3)(11.6)(3.7)(54.4)(101.0)
Deferred tax liabilities(151.5)(24.6)— (8.0)(184.1)
Other noncurrent liabilities(17.5)(2.8)(3.0)(5.8)(29.1)
Total consideration$2,349.7 $149.8 $113.2 $363.2 $2,975.9 
The following table summarizes the allocation of consideration for all businesses acquired in 2023 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2023 acquisitions is complete.
Air TreatmentRootsAll OthersTotal
Accounts receivable$26.1 $14.5 $11.7 $52.3 
Inventories43.9 34.2 21.0 99.1 
Other current assets2.1 2.9 6.2 11.2 
Property, plant and equipment18.4 42.0 5.0 65.4 
Goodwill279.9 105.6 126.7 512.2 
Other intangible assets238.6 116.9 25.4 380.9 
Other noncurrent assets7.6 3.1 0.4 11.1 
Total current liabilities(35.9)(26.9)(19.5)(82.3)
Deferred tax liabilities(54.8)— (3.9)(58.7)
Other noncurrent liabilities(6.9)(2.3)(4.5)(13.7)
Total consideration$519.0 $290.0 $168.5 $977.5 
The following table summarizes the allocation of consideration for all businesses acquired in 2022 to the fair values of identifiable assets acquired and liabilities assumed at the acquisition dates. Initial accounting for all 2022 acquisitions is complete.
Dosatron InternationalAll othersTotal Consideration
Accounts receivable$1.8 $16.2 $18.0 
Inventories6.2 20.4 26.6 
Other current assets0.1 1.3 1.4 
Property, plant and equipment0.3 8.9 9.2 
Goodwill57.4 151.9 209.3 
Other intangible assets41.9 43.0 84.9 
Other noncurrent assets13.8 0.9 14.7 
Total current liabilities(3.5)(30.7)(34.2)
Deferred tax liabilities(13.8)(9.7)(23.5)
Other noncurrent liabilities— (1.9)(1.9)
Total consideration$104.2 $200.3 $304.5 
v3.25.0.1
Restructuring (Tables)
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Activity
For the years ended December 31, 2024, 2023 and 2022, “Restructuring charges, net” were recognized within “Other operating expense, net” in the Consolidated Statements of Operations and consisted of the following.
202420232022
Industrial Technologies and Services$20.6 $15.1 $20.1 
Precision and Science Technologies7.9 4.1 8.7 
Corporate2.7 0.7 0.5 
Restructuring charges, net$31.2 $19.9 $29.3 
The following table summarizes the activity associated with the Company’s restructuring programs (included in “Accrued liabilities” in the Consolidated Balance Sheets) for the years ended December 31, 2024 and 2023.
20242023
Balance at beginning of period$15.5 $14.9 
Charged to expense - termination benefits27.1 13.0 
Charged to expense - other(1)
2.5 4.2 
Payments(21.6)(17.1)
Foreign currency translation and other(1.2)0.5 
Balance at end of period$22.3 $15.5 
(1)Excludes $1.6 million and $2.7 million of non-cash charges that impacted restructuring expense but not the restructuring liabilities during the years ended December 31, 2024 and 2023, respectively.
v3.25.0.1
Allowance for Credit Losses (Tables)
12 Months Ended
Dec. 31, 2024
Receivables [Abstract]  
Schedule of Allowance for Credit Losses
The following table summarized the activity associated with allowance for credit losses for the years ended December 31, 2024, 2023 and 2022.
202420232022
Balance at beginning of period$53.8 $47.2 $42.3 
Provision charged to expense7.5 9.4 10.1 
Write-offs, net of recoveries(3.3)(3.3)(3.2)
Foreign currency translation and other(0.7)0.5 (2.0)
Balance at end of period$57.3 $53.8 $47.2 
v3.25.0.1
Inventories (Tables)
12 Months Ended
Dec. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories as of December 31, 2024 and 2023 consisted of the following.
20242023
Raw materials, including parts and subassemblies$675.1 $590.7 
Work-in-process116.3 145.1 
Finished goods342.8 337.8 
1,134.2 1,073.6 
LIFO reserve(79.2)(72.5)
Inventories$1,055.0 $1,001.1 
v3.25.0.1
Property, Plant, and Equipment (Tables)
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Property, plant and equipment, net as of December 31, 2024 and 2023 consisted of the following.
20242023
Land and land improvements$62.3 $67.7 
Buildings385.6 337.1 
Machinery and equipment792.6 655.8 
Office furniture and equipment76.8 71.0 
Construction in progress92.3 80.6 
1,409.6 1,212.2 
Accumulated depreciation(567.5)(500.8)
Property, plant and equipment, net$842.1 $711.4 
v3.25.0.1
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill attributable to each reportable segment for the years ended December 31, 2024 and 2023 are as follows.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Balance as of December 31, 2022
$4,222.5 $1,841.7 $6,064.2 
Acquisitions509.1 2.4 511.5 
Foreign currency translation and other(1)
21.9 12.1 34.0 
Balance as of December 31, 2023
4,753.5 1,856.2 6,609.7 
Acquisitions263.9 1,404.3 1,668.2 
Foreign currency translation and other(1)
(86.7)(43.1)(129.8)
Balance as of December 31, 2024
$4,930.7 $3,217.4 $8,148.1 
(1)Includes measurement period adjustments.
Schedule of Goodwill by Acquisition The goodwill attributable to these businesses is as follows. 
2024 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
ILC Dover$— $1,309.8 $1,309.8 
Friulair69.2 — 69.2 
APSCO51.6 — 51.6 
Other acquisitions143.1 94.5 237.6 
$263.9 $1,404.3 $1,668.2 
The Company acquired several businesses during the year ended December 31, 2023. The excess of the purchase price over the estimated fair values of intangible assets, identifiable assets and assumed liabilities was recorded as goodwill. The goodwill attributable to these businesses is as follows. 
2023 Acquisitions
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
Air Treatment$279.9 $— $279.9 
Roots106.6 — 106.6 
Other acquisitions122.6 2.4 125.0 
$509.1 $2.4 $511.5 
Schedule of Other Intangible Assets
Other intangible assets as of December 31, 2024 and 2023 consisted of the following.
December 31, 2024December 31, 2023
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
Amortized intangible assets:
Customer lists and relationships$4,010.1 $(1,830.1)$2,180.0 $3,279.3 $(1,585.4)$1,693.9 
Technology549.1 (243.3)305.8 413.8 (178.9)234.9 
Tradenames63.6 (32.4)31.2 52.2 (27.9)24.3 
Backlog4.3 (4.2)0.1 3.0 (1.3)1.7 
Other128.5 (112.1)16.4 117.1 (104.1)13.0 
Unamortized intangible assets:
Tradenames1,839.3 — 1,839.3 1,643.3 — 1,643.3 
Total other intangible assets$6,594.9 $(2,222.1)$4,372.8 $5,508.7 $(1,897.6)$3,611.1 
v3.25.0.1
Supply Chain Finance Program (Tables)
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Supplier Finance Obligations
The following table summarizes the activity associated with the Company’s SCF Program for the years ended December 31, 2024 and 2023.
20242023
Confirmed obligations outstanding at beginning of period$24.3 $9.7 
Invoices confirmed117.0 112.9 
Confirmed invoices paid(116.8)(98.3)
Confirmed obligations outstanding at end of period$24.5 $24.3 
v3.25.0.1
Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued liabilities as of December 31, 2024 and 2023 consisted of the following:
20242023
Salaries, wages and related fringe benefits$229.5 $262.4 
Contract liabilities318.6 331.2 
Product warranty67.9 61.9 
Operating lease liabilities56.3 41.6 
Restructuring22.3 15.5 
Taxes72.5 78.4 
Accrued interest33.2 33.1 
Other171.9 171.4 
Total accrued liabilities$972.2 $995.5 
Schedule of Product Warranty Liability
A reconciliation of the changes in the accrued product warranty liability for the years ended December 31, 2024 and 2023 is as follows.
20242023
Balance at beginning of period$61.9 $46.2 
Product warranty accruals37.5 44.4 
Acquired warranty0.7 2.2 
Settlements(30.7)(31.2)
Foreign currency translation and other(1.5)0.3 
Balance at end of period$67.9 $61.9 
v3.25.0.1
Debt (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
Debt as of December 31, 2024 and 2023 consisted of the following.
20242023
Short-term borrowings$1.7 $1.0 
Long-term debt
Dollar Term Loan B, due February 2027(1)(2)
$— $347.7 
Dollar Term Loan, due February 2027(1)(2)
— 892.3 
5.197% Senior Notes due June 2027(1)
699.9 — 
5.400% Senior Notes due August 2028(1)
498.6 498.2 
5.176% Senior Notes due June 2029(1)
750.0 — 
5.314% Senior Notes due June 2031(1)
500.0 — 
5.700% Senior Notes due August 2033(1)
993.4 992.6 
5.450% Senior Notes due June 2034(1)
749.5 — 
5.700% Senior Notes due June 2054(1)
597.6 — 
Finance leases and other long-term debt14.1 15.2 
Swap valuation adjustments(0.3)— 
Unamortized debt issuance costs(47.0)(23.4)
Total long-term debt, net, including current maturities4,755.8 2,722.6 
Current maturities of long-term debt1.4 29.6 
Total long-term debt, net$4,754.4 $2,693.0 
(1)This amount is net of unamortized discounts. Total unamortized discounts were $11.0 million and $9.9 million as of December 31, 2024 and 2023, respectively.
(2)The weighted-average interest rate was 7.18% for the five month period prior to the loan repayment in May 2024, as discussed below.
v3.25.0.1
Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Reconciliation of Benefit Obligations
The following table provides a reconciliation of the changes in the benefit obligations and in the fair value of the plan assets for the periods described below.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202420232024202320242023
Reconciliation of Benefit Obligations:
Beginning balance$294.0 $319.8 $263.2 $247.5 $18.3 $21.0 
Service cost0.1 0.1 2.9 2.6 — — 
Interest cost13.4 15.7 10.7 11.1 0.8 0.9 
Participant contributions— — 0.2 — — — 
Plan amendments— — — 0.3 (10.9)— 
Actuarial losses (gains)(1)
(18.1)6.0 (11.3)3.3 0.2 (1.0)
Benefit payments(22.2)(16.1)(14.5)(13.6)(2.4)(2.7)
Acquisitions— — 10.2 — — — 
Plan settlements(2.5)(31.5)— — — — 
Other— — 0.6 — — — 
Effect of foreign currency exchange rate changes— — (10.6)12.0 (0.1)0.1 
Benefit obligations ending balance$264.7 $294.0 $251.4 $263.2 $5.9 $18.3 
Reconciliation of Fair Value of Plan Assets:
Beginning balance$237.5 $263.6 $206.0 $196.4 
Actual return on plan assets(6.0)18.7 (7.1)6.7 
Employer contributions0.1 2.8 6.5 6.6 
Participant contributions— — 0.2 — 
Acquisitions— — 8.5 — 
Benefit payments(22.2)(16.1)(14.5)(13.6)
Plan settlements(2.5)(31.5)— — 
Other— — 0.6 — 
Effect of foreign currency exchange rate changes— — (5.6)9.9 
Fair value of plan assets ending balance$206.9 $237.5 $194.6 $206.0 
Funded Status as of Period End$(57.8)$(56.5)$(56.8)$(57.2)$(5.9)$(18.3)
(1)Actuarial losses (gains) primarily resulted from changes in discount rates.
Schedule of Component of Accumulated Other Comprehensive (Loss) Income
Amounts recognized as a component of accumulated other comprehensive income (loss) as of December 31, 2024 and 2023 that have not been recognized as a component of net periodic benefit cost are presented in the following table.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
202420232024202320242023
Net actuarial losses (gains)$(10.8)$(11.0)$7.6 $(1.1)$(3.2)$(4.3)
Prior service cost— — 2.7 2.9 (10.9)0.1 
Amounts included in accumulated other comprehensive income (loss)$(10.8)$(11.0)$10.3 $1.8 $(14.1)$(4.2)
Schedule of Pension and Other Postretirement Benefit Liabilities included in Balance Sheets
Pension and other postretirement benefit liabilities and assets are included in the following captions in the Consolidated Balance Sheets as of December 31, 2024 and 2023.
20242023
Other assets$18.5 $18.8 
Accrued liabilities(6.4)(6.2)
Pension and other postretirement benefits(132.6)(144.6)
Schedule of Pension plans with an Accumulated Benefit Obligation in Excess of Plan Assets
The following table provides information for pension plans with an accumulated benefit obligation in excess of plan assets as of December 31, 2024 and 2023.
U.S. Pension PlansNon-U.S. Pension Plans
2024202320242023
Projected benefit obligations$264.7 $294.0 $119.7 $105.4 
Accumulated benefit obligation264.7 294.0 112.7 86.4 
Fair value of plan assets206.9 237.5 42.8 17.0 
Schedule of Components of Net Periodic Benefit Cost (Income) and Other Amounts Recognized in Other Comprehensive (Loss) Income, Before Income Tax Effects
The following tables provide the components of net periodic benefit cost (income) and other amounts recognized in other comprehensive income (loss), before income tax effects, for the years ended December 31, 2024, 2023 and 2022.
U.S. Pension Plans
202420232022
Net Periodic Benefit Cost:
Service cost$0.1 $0.1 $4.4 
Interest cost13.4 15.7 11.3 
Expected return on plan assets(12.7)(13.2)(13.0)
Amortization of net actuarial loss— 0.1 — 
Net periodic benefit cost0.8 2.7 2.7 
Loss (gain) due to settlement0.4 (0.4)(0.5)
Total net periodic benefit cost recognized$1.2 $2.3 $2.2 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss$0.6 $0.5 $0.4 
Amortization of net actuarial gain (loss)(0.4)0.3 0.5 
Total recognized in other comprehensive income (loss)$0.2 $0.8 $0.9 
Total recognized in net periodic benefit cost and other comprehensive income (loss)$1.4 $3.1 $3.1 
Non-U.S. Pension Plans
202420232022
Net Periodic Benefit Cost (Income):
Service cost$2.9 $2.6 $3.3 
Interest cost10.7 11.1 5.9 
Expected return on plan assets(11.2)(11.0)(11.8)
Amortization of prior service cost0.2 0.1 0.1 
Amortization of net actuarial loss(1.3)(1.7)0.3 
Total net periodic benefit cost (income) recognized$1.3 $1.1 $(2.2)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$7.0 $7.5 $(33.3)
Amortization of net actuarial gain (loss)1.3 1.7 (0.3)
Prior service cost— 0.3 — 
Amortization of prior service cost(0.2)(0.1)(0.1)
Effect of foreign currency exchange rate changes0.4 0.3 (3.2)
Total recognized in other comprehensive income (loss)$8.5 $9.7 $(36.9)
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$9.8 $10.8 $(39.1)
Other Postretirement Benefits
202420232022
Net Periodic Benefit Cost (Income):
Interest cost$0.8 $0.9 $0.7 
Amortization of prior service cost0.1 0.1 — 
Amortization of net actuarial loss(0.8)(1.1)— 
Total net periodic benefit cost (income) recognized$0.1 $(0.1)$0.7 
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):
Net actuarial loss (gain)$0.2 $(1.0)$(5.0)
Amortization of net actuarial loss0.8 1.1 — 
Prior service cost(10.9)— — 
Amortization of prior service cost(0.1)(0.1)— 
Total recognized in other comprehensive income (loss)$(10.0)$— $(5.0)
Total recognized in net periodic benefit cost (income) and other comprehensive income (loss)$(9.9)$(0.1)$(4.3)
Schedule of Assumptions Used
The following actuarial assumptions were used to determine net periodic benefit cost (income) and benefit obligations for the years ended December 31, 2024, 2023 and 2022.
U.S. Pension PlansNon-U.S. Pension Plans
202420232022202420232022
Weighted-average actuarial assumptions used to determine net periodic benefit cost:
Discount rate5.0 %5.2 %2.7 %4.2 %4.5 %1.6 %
Expected long-term rate of return on plan assets5.8 %5.4 %3.5 %5.5 %5.5 %4.4 %
Rate of compensation increasesN/AN/A3.0 %5.0 %4.3 %4.3 %
Weighted-average actuarial assumptions used to determine benefit obligations:
Discount rate5.5 %5.0 %5.2 %4.5 %4.2 %4.5 %
Rate of compensation increasesN/AN/AN/A5.0 %5.0 %4.3 %
The following actuarial assumptions were used to determine other postretirement benefit plans costs and obligations for the years ended December 31, 2024, 2023 and 2022.
Other Postretirement Benefits
202420232022
Discount rate used to determine net periodic benefit cost
4.9% - 5.1%
4.9% - 5.2%
2.4% - 3.0%
Discount rate used to determine benefit obligations
4.4% - 5.4%
4.9% - 5.1%
4.9% - 5.2%
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:
Healthcare cost trend rate assumed for next year5.1 %6.8 %6.8 %
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)4.0 %4.4 %4.5 %
Year that the date reaches the ultimate trend rate204020352034
Schedule of Expected Benefit Payments
The following table reflects the estimated benefit payments for the next five years and for the years 2030 through 2034. The estimated benefit payments for the non-U.S. pension plans were calculated using foreign exchange rates as of December 31, 2024.
Pension BenefitsOther Postretirement Benefits
U.S. PlansNon-U.S. Plans
2025$26.4 $14.7 $2.4 
202625.1 14.9 0.4 
202724.9 14.5 0.4 
202823.9 15.1 0.3 
202923.4 17.1 0.3 
Aggregate 2030-2034
98.3 86.0 1.3 
Schedule of Allocation of Plan Assets The following table presents the long-term target allocations for these plans as of December 31, 2024.
U.S. PlansUK Plan
Asset category:
Equity16 %12 %
Fixed income83 %56 %
Real estate and other%32 %
Total100 %100 %
Schedule of Changes in Fair Value of Plan Assets
The following tables present the fair values of the Company’s pension plan assets as of December 31, 2024 and 2023 by asset category within the ASC 820 hierarchy (as defined in Note 21 “Fair Value Measurements”).
December 31, 2024
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$5.1 $— $— $— $5.1 
Equity funds:
U.S. small-cap— — — 0.9 0.9 
U.S. mid-cap— — — 2.6 2.6 
U.S. large-cap— 2.5 — 11.6 14.1 
International equity(2)
— 23.2 — 26.5 49.7 
Total equity funds— 25.7 — 41.6 67.3 
Fixed income funds:
Corporate bonds - international— 23.8 — 15.8 39.6 
UK index-linked gilts— 66.0 — — 66.0 
U.S. fixed income - government securities— — — 20.5 20.5 
U.S. fixed income - short duration— — — 1.8 1.8 
U.S. fixed income - intermediate duration— — — 25.2 25.2 
U.S. fixed income - long duration— — — 122.7 122.7 
Global fixed income— — — 1.8 1.8 
Total fixed income funds— 89.8 — 187.8 277.6 
Other types of investments:
International real estate(3)
— 11.6 — — 11.6 
Other(4)
— 38.1 1.8 39.9 
Total$5.1 $127.1 $38.1 $231.2 $401.5 
December 31, 2023
Quoted Prices in Active Markets for Identical Assets
(Level 1)
Significant Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Investments Measured at NAV (5)
Total
Asset Category
Cash and cash equivalents(1)
$7.1 $— $— $— $7.1 
Equity funds:
U.S. small-cap— — — 3.7 3.7 
U.S. large-cap— 2.0 — 17.5 19.5 
International equity(2)
14.2 10.5 — 17.2 41.9 
Total equity funds14.2 12.5 — 38.4 65.1 
Fixed income funds:
Corporate bonds - international— 26.9 — 15.8 42.7 
UK index-linked gilts— 78.7 — — 78.7 
U.S. fixed income - government securities— — — 43.2 43.2 
U.S. fixed income - short duration— — — 1.3 1.3 
U.S. fixed income - intermediate duration— — — 30.9 30.9 
U.S. fixed income - long corporate— — — 122.3 122.3 
Global fixed income— — — 7.2 7.2 
Total fixed income funds— 105.6 — 220.7 326.3 
Other types of investments:
International real estate(3)
— 15.4 — — 15.4 
Other(4)
— 29.6 — 29.6 
Total$21.3 $133.5 $29.6 $259.1 $443.5 
(1)Cash and cash equivalents consist of traditional domestic and foreign highly liquid short-term securities with the goal of providing liquidity and preservation of capital while maximizing return on assets.
(2)The International category consists of investment funds focused on companies operating in developed and emerging markets outside of the U.S. These investments target broad diversification across large and mid/small-cap companies and economic sectors.
(3)International real estate consists primarily of equity and debt investments made, directly or indirectly, in various interests in unimproved and improved real properties.
(4)Other investments consist of insurance and reinsurance contracts securing the retirement benefits. The fair value of these contracts was calculated at the discount value of premiums paid by the Company, less expenses charged by the insurance providers. The insurance providers with which the Company has placed these contracts are well-known financial institutions with an established history of providing insurance services.
(5)Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy.
v3.25.0.1
Accumulated Other Comprehensive Income (Loss) (Tables)
12 Months Ended
Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Other Comprehensive Income (Loss)
The before tax income (loss) and related income tax effect are as follows.
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2021$(29.9)$— $(11.7)$(41.6)
Before tax income (loss)(237.1)21.3 41.0 (174.8)
Income tax effect(15.8)(5.3)(14.2)(35.3)
Other comprehensive income (loss)(252.9)16.0 26.8 (210.1)
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Before tax income (loss)23.0 (5.1)(10.5)7.4 
Income tax effect11.8 1.3 3.6 16.7 
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Before tax income (loss)(218.6)(14.1)1.3 (231.4)
Income tax effect(13.0)5.0 (1.5)(9.5)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income (loss) by component for the periods described below are presented in the following table(1).
Foreign Currency Translation Adjustments, NetCash Flow HedgesPension and Other Postretirement Benefit PlansTotal
Balance as of December 31, 2021$(29.9)$— $(11.7)$(41.6)
Other comprehensive income (loss) before reclassifications(244.3)13.9 26.9 (203.5)
Amounts reclassified from accumulated other comprehensive income (loss)(8.6)2.1 (0.1)(6.6)
Other comprehensive income (loss)(252.9)16.0 26.8 (210.1)
Balance as of December 31, 2022$(282.8)$16.0 $15.1 $(251.7)
Other comprehensive income (loss) before reclassifications49.0 7.9 (4.7)52.2 
Amounts reclassified from accumulated other comprehensive income (loss)(14.2)(11.7)(2.2)(28.1)
Other comprehensive income (loss)34.8 (3.8)(6.9)24.1 
Balance as of December 31, 2023$(248.0)$12.2 $8.2 $(227.6)
Other comprehensive income (loss) before reclassifications(218.3)2.7 0.8 (214.8)
Amounts reclassified from accumulated other comprehensive income (loss)(13.3)(11.8)(1.0)(26.1)
Other comprehensive loss(231.6)(9.1)(0.2)(240.9)
Balance as of December 31, 2024$(479.6)$3.1 $8.0 $(468.5)
(1)All amounts are net of tax. Amounts in parentheses indicate debits.
Schedule of Reclassification out of Accumulated Other Comprehensive Income (Loss)
Reclassifications out of accumulated other comprehensive income (loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the following table.
Amount Reclassified from Accumulated Other Comprehensive Income (Loss)
Details about Accumulated Other Comprehensive Income (Loss) Components202420232022Affected Line(s) in the Statement Where Net Income is Presented
Cash flow hedges (interest rate swaps and caps)$(15.7)$(15.6)$2.8 Interest expense
Provision (benefit) for income taxes3.9 3.9 (0.7)Provision for income taxes
Cash flow hedges (interest rate swaps and caps), net of tax$(11.8)$(11.7)$2.1 
Net investment hedges$(17.7)$(19.0)$(11.5)Interest expense
Provision for income taxes4.4 4.8 2.9 Provision for income taxes
Net investment hedges, net of tax$(13.3)$(14.2)$(8.6)
Amortization of defined benefit pension and other postretirement benefit items(1)
$(1.4)$(2.9)$(0.1)
Cost of sales and Selling and administrative expenses
Provision for income taxes0.4 0.7 — Provision for income taxes
Amortization of defined benefit pension and other postretirement benefit items, net of tax$(1.0)$(2.2)$(0.1)
Total reclassifications for the period$(26.1)$(28.1)$(6.6)
(1)These components are included in the computation of net periodic benefit cost. See Note 13 “Benefit Plans” for additional details.
v3.25.0.1
Revenue from Contracts with Customers (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table provides disaggregated revenue by reportable segment for the years ended December 31, 2024 and 2023.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202420232024202320242023
Primary Geographic Markets
United States$2,461.2 $2,328.0 $651.1 $567.2 $3,112.3 $2,895.2 
Other Americas452.9 373.1 88.3 29.0 541.2 402.1 
Total Americas2,914.1 2,701.1 739.4 596.2 3,653.5 3,297.3 
EMEIA1,854.9 1,800.8 520.0 466.7 2,374.9 2,267.5 
China680.8 785.7 113.8 138.9 794.6 924.6 
Other Asia Pacific368.3 345.2 43.7 41.5 412.0 386.7 
Total Asia Pacific1,049.1 1,130.9 157.5 180.4 1,206.6 1,311.3 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
Product Categories
Original equipment(1)
$3,494.0 $3,425.9 $1,110.2 $990.9 $4,604.2 $4,416.8 
Aftermarket(2)
2,324.1 2,206.9 306.7 252.4 2,630.8 2,459.3 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
Pattern of Revenue Recognition
Revenue recognized at point in time(3)
$5,295.6 $5,147.2 $1,376.4 $1,236.2 $6,672.0 $6,383.4 
Revenue recognized over time(4)
522.5 485.6 40.5 7.1 563.0 492.7 
Total$5,818.1 $5,632.8 $1,416.9 $1,243.3 $7,235.0 $6,876.1 
(1)Revenues from sales of capital equipment within the Industrial Technologies and Services segment and sales of components to original equipment manufacturers in the Precision and Science Technologies segment.
(2)Revenues from sales of spare parts, accessories, other components and services in support of maintaining customer owned, installed base of the Company’s original equipment.
(3)Revenues from short and long duration product and service contracts recognized at a point in time when control is transferred to the customer generally when product delivery has occurred and services have been rendered.
(4)Revenues primarily from long duration ETO product contracts, certain multi-year service contracts, and certain contracts for the delivery of a significant volume of substantially similar products recognized over time as contractual performance obligations are completed.
Schedule of Contract Balances
The following table provides the contract balances as of December 31, 2024 and 2023 presented in the Consolidated Balance Sheets.
December 31, 2024December 31, 2023
Accounts receivable, net$1,335.4 $1,234.2 
Contract assets111.2 85.6 
Contract liabilities - current318.6 331.2 
Contract liabilities - noncurrent0.9 1.0 
v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income (Loss) Before Income Taxes
Income before income taxes for the years ended December 31, 2024, 2023 and 2022 consisted of the following.
202420232022
U.S.$383.7 $356.0 $267.5 
Non-U.S.749.1 675.1 474.7 
Income before income taxes$1,132.8 $1,031.1 $742.2 
Schedule of Components of Provision (Benefit) for Income Taxes
The following table details the components of the Provision for income taxes for the years ended December 31, 2024, 2023 and 2022.
202420232022
Current:
U.S. federal$87.5 $111.5 $66.5 
U.S. state and local22.8 23.7 21.5 
Non-U.S.185.3 181.7 147.4 
Deferred:
U.S. federal(9.7)(44.0)(37.3)
U.S. state and local(5.7)(6.9)(5.5)
Non-U.S.(17.7)(26.0)(43.0)
Provision for income taxes$262.5 $240.0 $149.6 
Schedule of Effective Income Tax Rate Reconciliation
The U.S. federal corporate statutory rate is reconciled to the Company’s effective income tax rate for the years ended December 31, 2024, 2023 and 2022 as follows.
202420232022
U.S. federal corporate statutory rate21.0 %21.0 %21.0 %
State and local taxes, less federal tax benefit1.4 1.3 2.0 
Net effects of foreign tax rate differential2.5 1.8 1.5 
Withholding tax1.3 1.5 2.1 
Repatriation cost(1.5)(2.0)(3.2)
Global Intangible Low-Tax Income (“GILTI”)0.4 0.7 0.3 
ASC 740-30 (formerly APB 23)1.5 1.7 1.9 
Valuation allowance changes0.4 1.7 0.5 
Uncertain tax positions0.9 0.9 0.2 
Equity compensation(1.3)(0.6)(0.6)
Nondeductible acquisition costs0.3 0.4 0.4 
Foreign Derived Intangible Income (“FDII”) deduction(1.1)(1.4)(1.6)
Tax credits(0.6)(0.7)(1.1)
Income not subject to tax(0.3)(1.6)(3.5)
Amortization of goodwill and other intangible assets(1.3)(0.8)— 
Interest on equity(1.8)(0.7)(0.4)
Return to provision adjustment(0.2)0.1 — 
Loss on sale1.1 — — 
Other, net0.5 — 0.7 
Effective income tax rate23.2 %23.3 %20.2 %
Schedule of Deferred Tax Assets and Liabilities
The principal items that gave rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 are as follows.
20242023
Deferred Tax Assets:
Reserves and accruals$83.4 $80.1 
Allowance for credit losses7.4 7.8 
Inventory reserve9.0 5.9 
Pension and postretirement benefit plans
20.0 25.3 
Tax loss carryforwards112.4 81.3 
Deferred taxes recorded in other comprehensive income1.4 13.4 
Foreign tax credit carryforwards50.7 57.9 
Other22.4 32.2 
Total deferred tax assets306.7 303.9 
Valuation allowance(125.6)(115.7)
Deferred Tax Liabilities:
LIFO inventory(20.3)(20.2)
Investment in partnership(30.2)(35.7)
Property, plant and equipment(50.0)(42.5)
Intangible assets(770.4)(635.4)
Unremitted foreign earnings(41.8)(35.5)
Total deferred tax liabilities(912.7)(769.3)
Net deferred income tax liability$(731.6)$(581.1)
Schedule of Tax Attributes and Related Valuation Allowance
The Company believes that it is more likely than not that it will realize its deferred tax assets through the reduction of future taxable income, other than for the deferred tax assets reflected below. Tax attributes and related valuation allowances as of December 31, 2024 were as follows.
Tax BenefitValuation AllowanceCarryforward Period Ends
Tax Attributes to be Carried Forward
U.S. federal net operating loss$13.3 $(0.1)2032-2038
U.S. federal capital loss0.6 (0.6)2029
U.S. federal tax credit50.8 (50.8)2025-2034
Alternative minimum tax credit0.5 (0.1)Unlimited
U.S. state and local net operating losses4.9 (2.1)2026-2041
U.S. state capital loss0.3 (0.1)2028
Non U.S. net operating losses62.6 (36.5)Unlimited
Non U.S. capital losses0.6 (0.6)Unlimited
Excess interest30.0 (29.7)Unlimited
Other deferred tax assets5.0 (5.0)Unlimited
Total tax carryforwards$168.6 $(125.6)
Schedule of Valuation Allowance
A reconciliation of the changes in the valuation allowance for deferred tax assets for the years ended December 31, 2024, 2023 and 2022 are as follows.
202420232022
Beginning balance$115.7 $107.3 $106.4 
Revaluation or additions due to acquisitions or mergers(1)
22.9 — — 
Charged to tax expense(10.8)6.4 3.1 
Charged to other accounts(2.2)2.0 (2.2)
Ending balance$125.6 $115.7 $107.3 
(1)Revaluation for the tax year ended December 31, 2024 relates to the inclusion of ILC Dover’s opening balance sheet beginning valuation allowance.
Schedule of Unrecognized Tax Benefits Roll Forward Below is a tabular reconciliation of the changes in total unrecognized tax benefits during the years ended December 31, 2024, 2023 and 2022.
202420232022
Beginning balance$19.1 $10.8 $21.1 
Gross increases for tax positions of prior years0.8 0.4 0.4 
Gross decreases for tax positions of prior years(0.3)— (3.7)
Gross increases for tax positions of current year8.1 7.9 4.1 
Settlements— — (9.9)
Lapse of statute of limitations(0.6)(0.2)(0.1)
Changes due to currency fluctuations(0.7)0.2 (1.1)
Ending balance$26.4 $19.1 $10.8 
v3.25.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Components of Lease Expense
The components of lease expense for the years ended December 31, 2024 and 2023 are as follows.
20242023
Operating lease cost$64.5 $53.7 
Finance lease cost
Amortization of right-of-use assets$1.5 $1.5 
Interest on lease liabilities0.9 0.9 
Total finance lease cost$2.4 $2.4 
Short-term lease cost$2.2 $1.9 
Schedule of Supplemental Cash Flow Information Related to Leases
Supplemental cash flow information related to leases for the years ended December 31, 2024 and 2023 is as follows.
20242023
Supplemental Cash Flows Information
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Operating cash flows from operating leases$63.8 $53.7 
Operating cash flows from finance leases0.9 1.0 
Financing cash flows from finance leases1.3 1.2 
Leased Assets Obtained in Exchange for New Operating Lease Liabilities96.2 62.5 
Schedule of Supplemental Balance Sheet Information Related to Leases
Supplemental balance sheet information related to leases is as follows.
December 31, 2024December 31, 2023
Operating leases
Other assets$226.6 $164.4 
Accrued liabilities$56.3 $41.6 
Other liabilities165.5 116.9 
Total operating lease liabilities$221.8 $158.5 
Finance Leases
Property, plant and equipment$11.1 $12.3 
Short-term borrowings and current maturities of long-term debt$1.3 $1.3 
Long-term debt, less current maturities12.6 13.6 
Total finance lease liabilities$13.9 $14.9 
Weighted Average Remaining Lease Term (in years)
Operating leases5.25.1
Finance leases9.410.3
Weighted Average Discount Rate
Operating leases4.1 %3.6 %
Finance leases6.5 %6.4 %
Schedule of Maturities of Operating Lease Liabilities
Maturities of lease liabilities as of December 31, 2024 are as follows.
Operating LeasesFinance Leases
2025$63.6 $2.2 
202655.1 2.1 
202741.3 2.1 
202829.4 2.1 
202917.7 2.1 
Thereafter39.2 8.5 
Total lease payments$246.3 $19.1 
Less imputed interest(24.5)(5.2)
Total$221.8 $13.9 
Schedule of Maturities of Finance Lease Liabilities
Maturities of lease liabilities as of December 31, 2024 are as follows.
Operating LeasesFinance Leases
2025$63.6 $2.2 
202655.1 2.1 
202741.3 2.1 
202829.4 2.1 
202917.7 2.1 
Thereafter39.2 8.5 
Total lease payments$246.3 $19.1 
Less imputed interest(24.5)(5.2)
Total$221.8 $13.9 
v3.25.0.1
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Stock-based compensation expense for the years ended December 31, 2024, 2023 and 2022 is included in “Cost of sales” and “Selling and administrative expenses” in the Consolidated Statements of Operations and is only related to continuing operations.
202420232022
Equity awards granted under the 2013 Plan and 2017 Plan(1)
$58.8 $51.1 $80.0 
Increase (decrease) in the liability for stock appreciation rights (“SAR”)— 0.8 (1.1)
Total stock-based compensation expense$58.8 $51.9 $78.9 
(1) In 2022, of the $80.0 million of expense for equity awards granted under the 2013 Plan and 2017 Plan, $39.5 million related to the $150 million equity grant to nearly 16,000 employees worldwide announced in the third quarter of 2020.
Schedule of Stock Option Awards
A summary of the Company’s stock option activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Exercise Price
(per share)
Wtd. Avg. Remaining Contractual Term (years)Aggregate Intrinsic Value of In-The-Money Options
(in millions)
Outstanding at December 31, 20235,282 $31.09 
Granted
610 90.55 
Exercised or Settled(1,615)19.96 
Forfeited
(88)65.08 
Expired
(4)40.22 
Outstanding at December 31, 20244,185 43.33 5.5$197.4 
Vested at December 31, 20242,708 29.34 4.1$165.5 
Schedule of Fair Value Assumptions
The following assumptions were used to estimate the fair value of options granted during the years ended December 31, 2024, 2023 and 2022.
202420232022
Expected life of options (in years)
6.3 - 7.5
6.3 - 7.5
6.3
Risk-free interest rate
3.7% - 4.3%
3.8% - 4.6%
1.9% - 3.9%
Assumed volatility
34.9% - 35.2%
35.6% - 36.6%
37.1% - 38.3%
Expected dividend rate
0.1%
0.0% - 0.1%
0.1% - 0.2%
The following assumptions were used to estimate the fair value of performance share units granted during the year ended December 31, 2024, 2023 and 2022 using the Monte Carlo simulation pricing model.
202420232022
Expected term (in years)
2.8
2.9
2.9 - 5.0
Risk-free interest rate
4.5%
4.4%
1.7% - 3.4%
Assumed volatility
28.9%
31.8%
35.0% - 36.4%
Expected dividend rate0.1 %0.1 %0.2 %
Schedule of Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 2023957 $52.18 
Granted433 90.94 
Vested(469)47.96 
Forfeited(87)68.20 
Non-vested as of December 31, 2024834 73.00 
Schedule of Performance Stock Unit Activity
A summary of the Company’s performance stock unit activity for the year ended December 31, 2024 is presented in the following table (underlying shares in thousands).
SharesWeighted-Average Grant-Date Fair Value
Non-vested as of December 31, 20231,380 $49.53 
Granted87 132.98 
Change in units based on performance122 55.84 
Vested(244)55.84 
Forfeited(6)71.81 
Non-vested as of December 31, 20241,339 54.28 
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk (Tables)
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The following table summarizes the notional amounts, fair values and classification of the Company’s outstanding derivatives by risk category and instrument type within the Consolidated Balance Sheets as of December 31, 2024 and 2023.
December 31, 2024
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsFair value$750.0 $— $1.4 $0.9 $0.9 
Cross-currency interest rate swap contractsNet investment1,074.3 11.5 15.8 — — 
Derivatives Not Designated as Hedging Instruments
Foreign currency forwardsFair value$124.3 $1.8 $— $— $— 
Foreign currency forwardsFair value69.0 — — 1.2 — 
December 31, 2023
Derivative Classification
Notional Amount(1)
Fair Value(1) Other Current Assets
Fair Value(1) Other Assets
Fair Value(1) Accrued Liabilities
Fair Value(1) Other Liabilities
Derivatives Designated as Hedging Instruments
Interest rate swap contractsCash flow$528.5 $8.2 $1.2 $— $— 
Cross-currency interest rate swap contractsNet investment1,054.2 15.7 — — 63.1 
(1)Notional amounts represent the gross contract amounts of the outstanding derivatives excluding the total notional amount of positions that have been effectively closed through offsetting positions. The net gains and net losses associated with positions that have been effectively closed through offsetting positions but not yet settled are included in the asset and liability derivatives fair value columns, respectively.
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
December 31, 2024December 31, 2023
Long-term debt:
Carrying amount of hedged debt$749.7 $— 
Cumulative hedging adjustments, included in carrying amount(0.3)— 
Schedule of Cash Flow Hedges Included in Comprehensive (Loss) Income
Gains on derivatives designated as cash flow hedges included in the Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below.
202420232022
Gain recognized in OCI on derivatives$1.6 $10.5 $18.3 
Gain (loss) reclassified from AOCI into income (effective portion)(1)
15.7 15.6 (2.8)
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
Gains (losses) on derivatives designated as net investment hedges included in the Condensed Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2024, 2023 and 2022 are presented in the table below.
202420232022
Gain (loss) recognized in OCI on derivatives$72.5 $(17.5)$0.6 
Gain reclassified from AOCI into income (effective portion)(1)
17.7 19.0 11.5 
(1)Gains (losses) on derivatives reclassified from AOCI into income were included in “Interest expense” in the Consolidated Statements of Operations.
Schedule of Gains (Losses) on Derivative Instruments Not Designated as Accounting Hedges and Total Net Foreign Currency (Losses) Gains
The Company’s gains (losses) on derivative instruments not designated as accounting hedges and total net foreign currency transaction gains (losses) for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Foreign currency forward contracts gains0.1 0.3 3.4 
Total foreign currency transaction gains (losses), net(3.2)(5.1)5.9 
v3.25.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis.
December 31, 2024
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$21.0 $— $— $21.0 
Interest rate swaps(2)
— 1.4 — 1.4 
Cross-currency interest rate swaps(3)
— 27.3 — 27.3 
Foreign currency forwards(4)
— 1.8 — 1.8 
Total$21.0 $30.5 $— $51.5 
Financial Liabilities
Deferred compensation plan(1)
$28.7 $— $— $28.7 
Interest rate swaps(2)
— 1.8 — 1.8 
Contingent consideration(5)
— — 22.2 22.2 
Foreign currency forwards(4)
— 1.2 — 1.2 
Total$28.7 $3.0 $22.2 $53.9 
December 31, 2023
Level 1Level 2Level 3Total
Financial Assets
Trading securities held in deferred compensation plan(1)
$16.8 $— $— $16.8 
Interest rate swaps(5)
— 9.4 — 9.4 
Cross-currency interest rate swaps(3)
— 15.7 — 15.7 
Total$16.8 $25.1 $— $41.9 
Financial Liabilities
Deferred compensation plan(1)
$24.7 $— $— $24.7 
Cross-currency interest rate swaps(3)
— 63.1 — 63.1 
Contingent consideration(5)
— — 42.2 42.2 
Total$24.7 $63.1 $42.2 $130.0 
(1)Based on the quoted price of publicly traded mutual funds and other equity securities which are classified as trading securities and accounted for using the mark-to-market method.
(2)Measured as the present value of all expected future cash flows based on the SOFR-based swap yield curves. The present value calculation uses discount rates that have been adjusted to reflect the credit quality of the Company and its counterparties.
(3)Measured as the present value of all expected future cash flows on each leg of the contracts. The model utilizes inputs of observable market data including interest yield curves and foreign currency exchange rates. The present value calculation uses cross-currency basis-adjusted discount factors that have been adjusted to reflect the credit quality of the Company and its counterparties.
(4)Based on calculations that use readily observable market parameters as their basis, such as spot and forward rates.
(5)Measured as the present value of expected consideration payable for completed acquisitions, generally derived using probability-weighted analysis of achieving projected revenue or EBITDA targets.
Schedule of Activity for Contingent Consideration
The following table provides a reconciliation of the activity for contingent consideration for the years ended December 31, 2024 and 2023.
20242023
Balance at beginning of period$42.2 $43.9 
Acquisitions6.7 13.5 
Changes in fair value(15.3)7.3 
Payments(10.0)(23.2)
Foreign currency translation and other(1.4)0.7 
Balance at end of period$22.2 $42.2 
v3.25.0.1
Contingencies (Tables)
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Discontinued Operations
The results of operations of SVT and HPS are presented as discontinued operations for the year ended December 31, 2022 as summarized below:
Specialty Vehicle TechnologiesHigh Pressure SolutionsTotal
Revenues$6.6 $— $6.6 
Cost of sales6.5 — 6.5 
Gross Profit0.1 — 0.1 
Selling and administrative expenses0.1 — 0.1 
Gain on sale(2.8)— (2.8)
Other operating expense, net0.7 1.6 2.3 
Income from Discontinued Operations Before Income Taxes2.1 (1.6)0.5 
Provision for income taxes(13.2)(1.5)(14.7)
Income from Discontinued Operations, Net of Tax$15.3 $(0.1)$15.2 
The following table summarizes the impacts of the divestiture.
Assets divested:
Cash and cash equivalents$153.5 
Insurance recovery receivable13.9 
Liabilities divested:
Asbestos indemnity liability - current(12.3)
Asbestos indemnity liability - noncurrent(111.4)
Loss on Asbestos Sale, before transaction costs43.7 
Transaction costs15.1 
Loss on Asbestos Sale58.8 
Income tax benefit(7.6)
Loss on Asbestos Sale, net of tax$51.2 
v3.25.0.1
Other Operating Expense, Net (Tables)
12 Months Ended
Dec. 31, 2024
Other Income and Expenses [Abstract]  
Schedule of Other Operating Expense, Net
The components of “Other operating expense, net” for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Other Operating Expense, Net
Foreign currency transaction losses (gains), net$3.2 $5.1 $(5.9)
Restructuring charges, net(1)
31.2 19.9 29.3 
Acquisition and other transaction related expenses(2)
47.1 52.2 38.7 
Loss on asbestos sale(3)
58.8 — — 
Other, net
(1.7)0.5 2.8 
Total other operating expense, net$138.6 $77.7 $64.9 
(1)See Note 5 “Restructuring.”
(2)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(3)See Note 22 “Contingencies.”
v3.25.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Results
The following table provides summarized information about the Company’s operations by reportable segment and reconciles Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes for the years ended December 31, 2024, 2023 and 2022.
Industrial Technologies and ServicesPrecision and Science TechnologiesTotal
202420232022202420232022202420232022
Revenue$5,818.1 $5,632.8 $4,705.1 1,416.9 1,243.3 1,211.2 $7,235.0 $6,876.1 $5,916.3 
Segment cost of sales(1)
3,193.3 3,225.0 2,785.5 736.2 648.8 652.4 3,929.5 3,873.8 3,437.9 
Segment selling and administrative expenses(2)
868.5 818.5 702.5 264.6 222.5 212.6 1,133.1 1,041.0 915.1 
Other segment items(3)
1.5 2.0 3.1 (2.7)(0.8)(1.3)(1.2)1.2 1.8 
Segment Adjusted EBITDA$1,754.8 $1,587.3 $1,214.0 418.8 372.8 347.5 2,173.6 1,960.1 1,561.5 
(1)Segment cost of sales excludes adjustments to LIFO inventories, depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(2)Segment selling and administrative expenses excludes depreciation and amortization expense, restructuring and related business transformation costs, acquisition and other transaction related expenses and non-cash charges.
(3)Other miscellaneous segment expenses.
202420232022
Total Segment Adjusted EBITDA2,173.6 1,960.1 1,561.5 
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:
Corporate expenses not allocated to segments
155.5 173.3 126.7 
Interest expense213.2 156.7 103.2 
Depreciation and amortization expense(1)
478.0 455.4 429.4 
Impairment of other intangible assets
13.9 — — 
Restructuring and related business transformation costs(2)
32.3 22.9 32.3 
Acquisition and other transaction related expenses and non-cash charges(3)
59.8 63.9 40.7 
Stock-based compensation(4)
58.8 51.9 85.6 
Foreign currency transaction losses (gains), net3.2 5.1 (5.9)
Loss on extinguishment of debt
3.0 13.5 1.1 
Adjustments to LIFO inventories6.7 12.0 36.1 
Cybersecurity incident costs0.5 2.3 — 
Loss on asbestos sale58.8 — — 
Gain on settlement of post-acquisition contingencies(5)
— — (6.2)
Interest income on cash and cash equivalents(43.3)(28.8)(8.0)
Other adjustments(6)
0.4 0.8 (15.7)
Income from Continuing Operations Before Income Taxes$1,132.8 $1,031.1 $742.2 
(1)Depreciation and amortization expense excludes $4.0 million, $3.7 million and $3.4 million of depreciation of rental equipment for the years ended December 31, 2024, 2023 and 2022, respectively.
(2)Restructuring and related business transformation costs consist of the following.
202420232022
Restructuring charges$31.2 $19.9 $29.3 
Facility reorganization, relocation and other costs1.1 3.0 3.0 
Total restructuring and related business transformation costs$32.3 $22.9 $32.3 
(3)Represents costs associated with successful and abandoned acquisitions, including third-party expenses, post-closure integration costs and non-cash charges and credits arising from fair value purchase accounting adjustments.
(4)Represents stock-based compensation expense recognized for the year ended December 31, 2022 of $78.9 million and associated employer taxes of $6.7 million.
(5)Represents gains from settling post-acquisition contingencies related to the Merger outside of the measurement period.
(6)Includes (i) pension and other postretirement benefits (“OPEB”) plan costs other than service cost and (ii) other miscellaneous adjustments.
The following tables provide summarized information about the Company’s reportable segments.
Depreciation and Amortization Expense
202420232022
Industrial Technologies and Services$296.0 $313.8 $294.7 
Precision and Science Technologies177.1 135.4 133.6 
Corporate and other8.9 9.9 4.5 
Total depreciation and amortization expense$482.0 $459.1 $432.8 
Capital Expenditures
202420232022
Industrial Technologies and Services$83.0 $83.9 $66.3 
Precision and Science Technologies21.3 18.5 17.7 
Corporate and other44.8 3.0 10.6 
Total capital expenditures$149.1 $105.4 $94.6 
Identifiable Assets
20242023
Industrial Technologies and Services$10,369.6 $10,138.8 
Precision and Science Technologies5,884.1 3,464.7 
Corporate and other1,756.1 1,960.0 
Total identifiable assets$18,009.8 $15,563.5 
Scheduled of Property, Plant and Equipment by Geographic Region
The following table presents property, plant and equipment, net by geographic region for the years ended December 31, 2024, and 2023.
20242023
United States$381.8 $286.0 
Other Americas38.1 12.8 
Total Americas419.9 298.8 
EMEIA(1)
256.5 245.7 
China152.3 160.9 
Other Asia Pacific13.4 6.0 
Total Asia Pacific165.7 166.9 
Total$842.1 $711.4 
(1)Europe, Middle East, India and Africa (“EMEIA”)
v3.25.0.1
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share The number of weighted-average shares outstanding used in the computations of basic and diluted earnings per share for the years ended December 31, 2024, 2023 and 2022 were as follows.
202420232022
Weighted-average shares outstanding - Basic403.4 404.8 405.3 
Dilutive effect of outstanding share-based compensation awards3.8 4.2 4.9 
Weighted-average shares outstanding - Diluted407.2 409.0 410.2 
v3.25.0.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash and Cash Equivalents [Abstract]      
Restricted cash and cash equivalents $ 10.5 $ 1.2  
Goodwill and Indefinite-Lived Intangible Assets [Abstract]      
Fair value percentage of reporting units using income approach 75.00%    
Fair value percentage of reporting units using market approach 25.00%    
Guarantees and Product Warranties [Abstract]      
Warranty period after time of sale (in months) 12 months    
Income Taxes [Abstract]      
Income tax expense under the Tax Act $ 4.6    
Research and Development [Abstract]      
Research and development expense $ 116.6 $ 108.2 $ 91.3
Buildings | Minimum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 10 years    
Buildings | Maximum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 30 years    
Machinery and Equipment | Minimum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 7 years    
Machinery and Equipment | Maximum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 10 years    
Office Equipment | Minimum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 3 years    
Office Equipment | Maximum      
Cash and Cash Equivalents [Abstract]      
Estimated useful lives of property, plant and equipment (in years) 10 years    
v3.25.0.1
Discontinued Operations - Narrative (Details)
$ in Millions
12 Months Ended
Feb. 14, 2021
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2024
business
Apr. 09, 2021
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Number of businesses that comprise discontinued operations | business     2  
Discontinued Operations, Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Gain on sale   $ 2.8    
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Cash consideration for sale of business       $ 1,680.0
Gain on sale   2.8    
Discontinued Operations, Disposed of by Sale | High Pressure Solutions        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Cash consideration for sale of business $ 278.3      
Majority interest sold (as percent) 55.00%      
Common equity interest retained after disposal (as percent) 45.00%      
Gain on sale   $ 0.0    
v3.25.0.1
Discontinued Operations - Results of Operations (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Income from Discontinued Operations, Net of Tax $ 0.0 $ 0.0 $ 15.2
Discontinued Operations, Disposed of by Sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenues     6.6
Cost of sales     6.5
Gross Profit     0.1
Selling and administrative expenses     0.1
Gain on sale     (2.8)
Other operating expense, net     2.3
Income from Discontinued Operations Before Income Taxes     0.5
Provision for income taxes     (14.7)
Income from Discontinued Operations, Net of Tax     15.2
Discontinued Operations, Disposed of by Sale | Specialty Vehicle Technologies      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenues     6.6
Cost of sales     6.5
Gross Profit     0.1
Selling and administrative expenses     0.1
Gain on sale     (2.8)
Other operating expense, net     0.7
Income from Discontinued Operations Before Income Taxes     2.1
Provision for income taxes     (13.2)
Income from Discontinued Operations, Net of Tax     15.3
Discontinued Operations, Disposed of by Sale | High Pressure Solutions      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenues     0.0
Cost of sales     0.0
Gross Profit     0.0
Selling and administrative expenses     0.0
Gain on sale     0.0
Other operating expense, net     1.6
Income from Discontinued Operations Before Income Taxes     (1.6)
Provision for income taxes     (1.5)
Income from Discontinued Operations, Net of Tax     $ (0.1)
v3.25.0.1
Acquisitions - Narrative (Details)
$ in Millions
12 Months Ended
Oct. 31, 2024
USD ($)
Oct. 01, 2024
USD ($)
Jun. 03, 2024
USD ($)
Jun. 01, 2024
USD ($)
May 31, 2024
USD ($)
May 01, 2024
USD ($)
Apr. 02, 2024
USD ($)
Apr. 01, 2024
USD ($)
Feb. 01, 2024
USD ($)
Aug. 18, 2023
USD ($)
Apr. 01, 2023
USD ($)
Feb. 01, 2023
USD ($)
Jan. 03, 2023
USD ($)
Dec. 01, 2022
USD ($)
Nov. 01, 2022
USD ($)
Oct. 01, 2022
USD ($)
Sep. 01, 2022
USD ($)
Feb. 01, 2022
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
business
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]                                          
Goodwill                                     $ 8,148.1 $ 6,609.7 $ 6,064.2
Industrial Technologies and Services                                          
Business Acquisition [Line Items]                                          
Goodwill                                     4,930.7 4,753.5 4,222.5
Friulair                                          
Business Acquisition [Line Items]                                          
Cash consideration                 $ 143.3                        
Contingent consideration                 11.0                        
Amount of goodwill deductible                 $ 0.0                        
Goodwill                                     69.2    
Controlled Fluidics                                          
Business Acquisition [Line Items]                                          
Cash consideration               $ 49.9                          
Contingent consideration               $ 2.0                          
Ethafilter s.r.l.                                          
Business Acquisition [Line Items]                                          
Cash consideration             $ 15.5                            
Air Systems, LLC                                          
Business Acquisition [Line Items]                                          
Cash consideration           $ 34.9                              
Complete Air And Power Solutions                                          
Business Acquisition [Line Items]                                          
Cash consideration         $ 99.3                                
Fruvac Ltd.                                          
Business Acquisition [Line Items]                                          
Cash consideration         $ 28.0                                
Del PD Pumps & Gear Pvt Ltd.                                          
Business Acquisition [Line Items]                                          
Cash consideration       $ 25.2                                  
ILC Dover                                          
Business Acquisition [Line Items]                                          
Cash consideration     $ 2,349.7                                    
Contingent consideration     75.0                                    
Amount of goodwill deductible     0.0                                    
Goodwill     1,309.8                               1,309.8    
ILC Dover | Customer Relationships                                          
Business Acquisition [Line Items]                                          
Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles     $ 621.0                                    
Acquired finite-lived intangible assets, weighted average useful life     14 years                                    
ILC Dover | Acquired Technology                                          
Business Acquisition [Line Items]                                          
Business combination, recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles     $ 142.0                                    
Acquired finite-lived intangible assets, weighted average useful life     8 years                                    
ILC Dover | Tradenames                                          
Business Acquisition [Line Items]                                          
Business combination, recognized identifiable assets acquired and liabilities assumed, indefinite-lived intangibles     $ 207.5                                    
APSCO                                          
Business Acquisition [Line Items]                                          
Cash consideration   $ 113.2                                      
Goodwill                                     51.6    
Blutek                                          
Business Acquisition [Line Items]                                          
Cash consideration   9.6                                      
UT Pumps & Systems Private Ltd                                          
Business Acquisition [Line Items]                                          
Cash consideration   $ 11.7                                      
Penn Valley Pump Co LLC                                          
Business Acquisition [Line Items]                                          
Cash consideration $ 33.2                                        
All others                                          
Business Acquisition [Line Items]                                          
Amount of goodwill deductible                                       159.9  
Goodwill                                     237.6 126.7 151.9
Aggregate consideration                                     55.6 $ 83.3 19.9
Number of businesses acquired | business                                       10  
Acquisitions In 2024                                          
Business Acquisition [Line Items]                                          
Goodwill                                     1,668.2    
Revenue from acquisition date                                     349.6    
Net loss from acquisition date                                     5.6    
Air Treatment                                          
Business Acquisition [Line Items]                                          
Cash consideration                         $ 519.0                
Amount of goodwill deductible                         $ 0.0                
Goodwill                                       $ 279.9  
Paragon Tank Truck Equipment                                          
Business Acquisition [Line Items]                                          
Cash consideration                       $ 42.2                  
EcoPlant Technological Innovation Ltd                                          
Business Acquisition [Line Items]                                          
Cash consideration                     $ 29.5                    
Contingent consideration                     $ 17.0                    
Roots                                          
Business Acquisition [Line Items]                                          
Cash consideration                   $ 292.5                      
Goodwill                                       105.6  
Total                                          
Business Acquisition [Line Items]                                          
Goodwill                                       512.2  
Revenue from acquisition date                                     408.0 293.7  
Net loss from acquisition date                                     58.8 16.1  
Houdstermaatschappij Jorc B.V. | Industrial Technologies and Services                                          
Business Acquisition [Line Items]                                          
Cash consideration                                   $ 30.2      
Westwood Technical Limited                                          
Business Acquisition [Line Items]                                          
Cash consideration                                 $ 8.1        
Contingent consideration                                 9.3        
Holtec Gas Systems LLC                                          
Business Acquisition [Line Items]                                          
Cash consideration                                 13.0        
Hydro Prokav Pumps (India) Private Limited                                          
Business Acquisition [Line Items]                                          
Cash consideration                                 $ 14.0        
Dosatron International L.L.C                                          
Business Acquisition [Line Items]                                          
Cash consideration                               $ 89.5          
Contingent consideration                               $ 14.7          
Pedro Gil Construcciones Mecanicas, S.L.                                          
Business Acquisition [Line Items]                                          
Cash consideration                             $ 18.4            
Everest Blower Systems Private Limited                                          
Business Acquisition [Line Items]                                          
Cash consideration                           $ 75.3              
Contingent consideration                           $ 12.1              
Total Consideration                                          
Business Acquisition [Line Items]                                          
Goodwill                                         209.3
Revenue from acquisition date                                     132.3 124.4 38.4
Net loss from acquisition date                                     $ 17.0 $ 19.5 $ 3.4
v3.25.0.1
Acquisitions - Schedule of Business Acquisitions by Acquisition, Consideration (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Jun. 03, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill $ 8,148.1   $ 6,609.7 $ 6,064.2
Acquisitions In 2024        
Business Acquisition [Line Items]        
Accounts receivable 99.8      
Inventories 151.0      
Other current assets 40.8      
Property, plant and equipment 118.8      
Goodwill 1,668.2      
Other intangible assets 1,186.2      
Other noncurrent assets 25.3      
Total current liabilities (101.0)      
Deferred tax liabilities (184.1)      
Other noncurrent liabilities (29.1)      
Total consideration 2,975.9      
ILC Dover        
Business Acquisition [Line Items]        
Accounts receivable 41.4      
Inventories 84.0      
Other current assets 35.1      
Property, plant and equipment 90.8      
Goodwill 1,309.8 $ 1,309.8    
Other intangible assets 973.1      
Other noncurrent assets 15.8      
Total current liabilities (31.3)      
Deferred tax liabilities (151.5)      
Other noncurrent liabilities (17.5)      
Total consideration 2,349.7      
Friulair        
Business Acquisition [Line Items]        
Accounts receivable 14.2      
Inventories 13.2      
Other current assets 0.5      
Property, plant and equipment 7.2      
Goodwill 69.2      
Other intangible assets 84.5      
Other noncurrent assets 0.0      
Total current liabilities (11.6)      
Deferred tax liabilities (24.6)      
Other noncurrent liabilities (2.8)      
Total consideration 149.8      
APSCO        
Business Acquisition [Line Items]        
Accounts receivable 6.4      
Inventories 7.5      
Other current assets 0.5      
Property, plant and equipment 2.3      
Goodwill 51.6      
Other intangible assets 48.1      
Other noncurrent assets 3.5      
Total current liabilities (3.7)      
Deferred tax liabilities 0.0      
Other noncurrent liabilities (3.0)      
Total consideration 113.2      
All others        
Business Acquisition [Line Items]        
Accounts receivable 37.8   11.7 16.2
Inventories 46.3   21.0 20.4
Other current assets 4.7   6.2 1.3
Property, plant and equipment 18.5   5.0 8.9
Goodwill 237.6   126.7 151.9
Other intangible assets 80.5   25.4 43.0
Other noncurrent assets 6.0   0.4 0.9
Total current liabilities (54.4)   (19.5) (30.7)
Deferred tax liabilities (8.0)   (3.9) (9.7)
Other noncurrent liabilities (5.8)   (4.5) (1.9)
Total consideration $ 363.2   168.5 200.3
Total        
Business Acquisition [Line Items]        
Accounts receivable     52.3  
Inventories     99.1  
Other current assets     11.2  
Property, plant and equipment     65.4  
Goodwill     512.2  
Other intangible assets     380.9  
Other noncurrent assets     11.1  
Total current liabilities     (82.3)  
Deferred tax liabilities     (58.7)  
Other noncurrent liabilities     (13.7)  
Total consideration     977.5  
Air Treatment        
Business Acquisition [Line Items]        
Accounts receivable     26.1  
Inventories     43.9  
Other current assets     2.1  
Property, plant and equipment     18.4  
Goodwill     279.9  
Other intangible assets     238.6  
Other noncurrent assets     7.6  
Total current liabilities     (35.9)  
Deferred tax liabilities     (54.8)  
Other noncurrent liabilities     (6.9)  
Total consideration     519.0  
Roots        
Business Acquisition [Line Items]        
Accounts receivable     14.5  
Inventories     34.2  
Other current assets     2.9  
Property, plant and equipment     42.0  
Goodwill     105.6  
Other intangible assets     116.9  
Other noncurrent assets     3.1  
Total current liabilities     (26.9)  
Deferred tax liabilities     0.0  
Other noncurrent liabilities     (2.3)  
Total consideration     $ 290.0  
Total Consideration        
Business Acquisition [Line Items]        
Accounts receivable       18.0
Inventories       26.6
Other current assets       1.4
Property, plant and equipment       9.2
Goodwill       209.3
Other intangible assets       84.9
Other noncurrent assets       14.7
Total current liabilities       (34.2)
Deferred tax liabilities       (23.5)
Other noncurrent liabilities       (1.9)
Total consideration       304.5
Dosatron International        
Business Acquisition [Line Items]        
Accounts receivable       1.8
Inventories       6.2
Other current assets       0.1
Property, plant and equipment       0.3
Goodwill       57.4
Other intangible assets       41.9
Other noncurrent assets       13.8
Total current liabilities       (3.5)
Deferred tax liabilities       (13.8)
Other noncurrent liabilities       0.0
Total consideration       $ 104.2
v3.25.0.1
Restructuring (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 31.2 $ 19.9 $ 29.3
2020 Plan      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 31.2 19.9 29.3
2020 Plan | Corporate      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 2.7 0.7 0.5
2020 Plan | Industrial Technologies and Services      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 20.6 15.1 20.1
2020 Plan | Precision and Science Technologies      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 7.9 $ 4.1 $ 8.7
v3.25.0.1
Restructuring - Activity in Restructuring Programs (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve [Roll Forward]    
Balance at beginning of period $ 15.5 $ 14.9
Charged to expense - termination benefits 27.1 13.0
Charged to expense - other 2.5 4.2
Payments (21.6) (17.1)
Foreign currency translation and other (1.2) 0.5
Balance at end of period 22.3 15.5
Other operating income (expense) | 2020 Plan    
Restructuring Reserve [Roll Forward]    
Non-cash charges $ 1.6 $ 2.7
v3.25.0.1
Allowance for Credit Losses (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]      
Balance at beginning of the period $ 53.8 $ 47.2 $ 42.3
Provision charged to expense 7.5 9.4 10.1
Write-offs, net of recoveries (3.3) (3.3) (3.2)
Foreign currency translation and other (0.7) 0.5 (2.0)
Balance at end of the period $ 57.3 $ 53.8 $ 47.2
v3.25.0.1
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Inventories [Abstract]    
Raw materials, including parts and subassemblies $ 675.1 $ 590.7
Work-in-process 116.3 145.1
Finished goods 342.8 337.8
Inventories, gross 1,134.2 1,073.6
LIFO reserve (79.2) (72.5)
Inventories $ 1,055.0 $ 1,001.1
v3.25.0.1
Inventories - Narrative (Details)
Dec. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Percentage of inventory 34.00% 37.00%
v3.25.0.1
Property, Plant, and Equipment (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Abstract]    
Land and land improvements $ 62.3 $ 67.7
Buildings 385.6 337.1
Machinery and equipment 792.6 655.8
Office furniture and equipment 76.8 71.0
Construction in progress 92.3 80.6
Property, plant and equipment, gross 1,409.6 1,212.2
Accumulated depreciation (567.5) (500.8)
Property, plant and equipment, net $ 842.1 $ 711.4
v3.25.0.1
Goodwill and Other Intangible Assets - Goodwill by Segment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Goodwill [Roll Forward]    
Balance at beginning of period $ 6,609.7 $ 6,064.2
Acquisitions 1,668.2 511.5
Foreign currency translation and other (129.8) 34.0
Balance at end of period 8,148.1 6,609.7
Industrial Technologies and Services    
Goodwill [Roll Forward]    
Balance at beginning of period 4,753.5 4,222.5
Acquisitions 263.9 509.1
Foreign currency translation and other (86.7) 21.9
Balance at end of period 4,930.7 4,753.5
Precision and Science Technologies    
Goodwill [Roll Forward]    
Balance at beginning of period 1,856.2 1,841.7
Acquisitions 1,404.3 2.4
Foreign currency translation and other (43.1) 12.1
Balance at end of period $ 3,217.4 $ 1,856.2
v3.25.0.1
Goodwill and Other Intangible Assets - Goodwill by Acquisition (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Business Combination, Goodwill [Abstract]    
Goodwill acquired $ 1,668.2 $ 511.5
ILC Dover    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 1,309.8  
Friulair    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 69.2  
APSCO    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 51.6  
Air Treatment    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   279.9
Roots    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   106.6
Other acquisitions    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 237.6 125.0
Industrial Technologies and Services    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 263.9 509.1
Industrial Technologies and Services | ILC Dover    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 0.0  
Industrial Technologies and Services | Friulair    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 69.2  
Industrial Technologies and Services | APSCO    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 51.6  
Industrial Technologies and Services | Air Treatment    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   279.9
Industrial Technologies and Services | Roots    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   106.6
Industrial Technologies and Services | Other acquisitions    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 143.1 122.6
Precision and Science Technologies    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 1,404.3 2.4
Precision and Science Technologies | ILC Dover    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 1,309.8  
Precision and Science Technologies | Friulair    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 0.0  
Precision and Science Technologies | APSCO    
Business Combination, Goodwill [Abstract]    
Goodwill acquired 0.0  
Precision and Science Technologies | Air Treatment    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   0.0
Precision and Science Technologies | Roots    
Business Combination, Goodwill [Abstract]    
Goodwill acquired   0.0
Precision and Science Technologies | Other acquisitions    
Business Combination, Goodwill [Abstract]    
Goodwill acquired $ 94.5 $ 2.4
v3.25.0.1
Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Goodwill [Line Items]      
Goodwill impairment $ 0 $ 0 $ 0
Amortization of intangible assets 373,000,000.0 367,500,000 347,600,000
Anticipated amortization of intangible assets in 2025 375,000,000    
Anticipated amortization of intangible assets in 2026 315,000,000    
Anticipated amortization of intangible assets in 2027 275,000,000    
Anticipated amortization of intangible assets in 2028 275,000,000    
Anticipated amortization of intangible assets in 2029 $ 220,000,000    
Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag impairment    
Tradenames      
Goodwill [Line Items]      
Impairment of indefinite-lived intangible assets $ 0 0 0
Precision and Science Technologies      
Goodwill [Line Items]      
Impairment of indefinite-lived intangible assets     $ 13,900,000
Industrial Technologies and Services      
Goodwill [Line Items]      
Accumulated impairment loss of goodwill $ 220,600,000 $ 220,600,000  
v3.25.0.1
Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Amortized intangible assets:    
Accumulated Amortization $ (2,222.1) $ (1,897.6)
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 6,594.9 5,508.7
Accumulated Amortization (2,222.1) (1,897.6)
Net Carrying Amount 4,372.8 3,611.1
Tradenames    
Unamortized intangible assets:    
Carrying amount 1,839.3 1,643.3
Customer lists and relationships    
Amortized intangible assets:    
Gross Carrying Amount 4,010.1 3,279.3
Accumulated Amortization (1,830.1) (1,585.4)
Net Carrying Amount 2,180.0 1,693.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (1,830.1) (1,585.4)
Technology    
Amortized intangible assets:    
Gross Carrying Amount 549.1 413.8
Accumulated Amortization (243.3) (178.9)
Net Carrying Amount 305.8 234.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (243.3) (178.9)
Tradenames    
Amortized intangible assets:    
Gross Carrying Amount 63.6 52.2
Accumulated Amortization (32.4) (27.9)
Net Carrying Amount 31.2 24.3
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (32.4) (27.9)
Backlog    
Amortized intangible assets:    
Gross Carrying Amount 4.3 3.0
Accumulated Amortization (4.2) (1.3)
Net Carrying Amount 0.1 1.7
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (4.2) (1.3)
Other    
Amortized intangible assets:    
Gross Carrying Amount 128.5 117.1
Accumulated Amortization (112.1) (104.1)
Net Carrying Amount 16.4 13.0
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (112.1) $ (104.1)
v3.25.0.1
Supply Chain Finance Program (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Supplier Finance Program, Obligation [Roll Forward]    
Confirmed obligations outstanding at beginning of period $ 24.3 $ 9.7
Invoices confirmed 117.0 112.9
Confirmed invoices paid $ (116.8) $ (98.3)
Supplier finance program, obligation, statement of financial position Accounts payable Accounts payable
Confirmed obligations outstanding at end of period $ 24.5 $ 24.3
v3.25.0.1
Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accrued Liabilities [Abstract]      
Salaries, wages and related fringe benefits $ 229.5 $ 262.4  
Contract liabilities 318.6 331.2  
Product warranty 67.9 61.9 $ 46.2
Operating lease liabilities 56.3 41.6  
Restructuring 22.3 15.5  
Taxes 72.5 78.4  
Accrued interest 33.2 33.1  
Other 171.9 171.4  
Total accrued liabilities $ 972.2 $ 995.5  
Operating lease, liability, current, statement of financial position Total accrued liabilities Total accrued liabilities  
v3.25.0.1
Accrued Liabilities - Accrued Product Warranty Liability (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at the beginning of period $ 61.9 $ 46.2
Product warranty accruals 37.5 44.4
Acquired warranty 0.7 2.2
Settlements (30.7) (31.2)
Foreign currency translation and other (1.5) 0.3
Balance at the end of period $ 67.9 $ 61.9
v3.25.0.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
Dec. 31, 2024
May 31, 2024
May 10, 2024
Dec. 31, 2023
Aug. 14, 2023
Debt [Abstract]          
Short-term borrowings $ 1.7     $ 1.0  
Long-term debt:          
Finance leases and other long-term debt 14.1     15.2  
Swap valuation adjustments (0.3)     0.0  
Unamortized debt issuance costs (47.0)     (23.4)  
Total long-term debt, net, including current maturities 4,755.8     2,722.6  
Current maturities of long-term debt 1.4     29.6  
Total long-term debt, net 4,754.4     2,693.0  
Original issue discounts 11.0     9.9  
Dollar Term Loan B, due 2027          
Long-term debt:          
Long-term debt 0.0     347.7  
Weighted-average interest rate of debt instrument (as a percent)   7.18%      
Dollar Term Loan, due 2027          
Long-term debt:          
Long-term debt 0.0     892.3  
Weighted-average interest rate of debt instrument (as a percent)   7.18%      
5.197% Senior Notes Due 2027 | Senior Notes          
Long-term debt:          
Long-term debt $ 699.9     $ 0.0  
Stated interest rate of debt instrument (as a percent) 5.197%   5.197% 5.197%  
5.400% Senior Notes Due 2028 | Senior Notes          
Long-term debt:          
Long-term debt $ 498.6     $ 498.2  
Stated interest rate of debt instrument (as a percent) 5.40%     5.40%  
5.176% Senior Notes Due 2029 | Senior Notes          
Long-term debt:          
Long-term debt $ 750.0     $ 0.0  
Stated interest rate of debt instrument (as a percent) 5.176%   5.176% 5.176%  
5.314% Senior Notes Due 2031 | Senior Notes          
Long-term debt:          
Long-term debt $ 500.0     $ 0.0  
Stated interest rate of debt instrument (as a percent) 5.314%   5.314% 5.314%  
5.700% Senior Notes Due 2033 | Senior Notes          
Long-term debt:          
Long-term debt $ 993.4     $ 992.6  
Stated interest rate of debt instrument (as a percent) 5.70%       5.70%
5.450% Senior Notes Due 2034 | Senior Notes          
Long-term debt:          
Long-term debt $ 749.5     $ 0.0  
Stated interest rate of debt instrument (as a percent) 5.45%   5.45% 5.45%  
5.700% Senior Notes Due 2054 | Senior Notes          
Long-term debt:          
Long-term debt $ 597.6     $ 0.0  
Stated interest rate of debt instrument (as a percent) 5.70%   5.70% 5.70%  
v3.25.0.1
Debt - New Senior Notes (Details) - Senior Notes - USD ($)
May 10, 2024
Aug. 14, 2023
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]        
Aggregate principal amount $ 3,300,000,000 $ 1,500,000,000    
Debt Instrument, Redemption, Period One        
Debt Instrument [Line Items]        
Redemption price, percentage 100.00% 100.00%    
5.197% Senior Notes Due 2027        
Debt Instrument [Line Items]        
Aggregate principal amount $ 700,000,000      
Stated interest rate of debt instrument (as a percent) 5.197%   5.197% 5.197%
5.176% Senior Notes Due 2029        
Debt Instrument [Line Items]        
Aggregate principal amount $ 750,000,000      
Stated interest rate of debt instrument (as a percent) 5.176%   5.176% 5.176%
5.314% Senior Notes Due 2031        
Debt Instrument [Line Items]        
Aggregate principal amount $ 500,000,000      
Stated interest rate of debt instrument (as a percent) 5.314%   5.314% 5.314%
5.450% Senior Notes Due 2034        
Debt Instrument [Line Items]        
Aggregate principal amount $ 750,000,000      
Stated interest rate of debt instrument (as a percent) 5.45%   5.45% 5.45%
5.700% Senior Notes Due 2054        
Debt Instrument [Line Items]        
Aggregate principal amount $ 600,000,000      
Stated interest rate of debt instrument (as a percent) 5.70%   5.70% 5.70%
v3.25.0.1
Debt - Existing Senior Notes (Details) - Senior Notes - USD ($)
May 10, 2024
Aug. 14, 2023
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]        
Aggregate principal amount $ 3,300,000,000 $ 1,500,000,000    
Debt Instrument, Redemption, Period One        
Debt Instrument [Line Items]        
Redemption price, percentage 100.00% 100.00%    
Debt Instrument, Redemption, Period Two        
Debt Instrument [Line Items]        
Redemption price, percentage   101.00%    
5.400% Senior Notes Due 2028        
Debt Instrument [Line Items]        
Aggregate principal amount   $ 500,000,000    
Stated interest rate of debt instrument (as a percent)     5.40% 5.40%
5.700% Senior Notes Due 2033        
Debt Instrument [Line Items]        
Aggregate principal amount   $ 1,000,000,000    
Stated interest rate of debt instrument (as a percent)   5.70% 5.70%  
v3.25.0.1
Debt - Senior Secured Credit Facilities (Details) - USD ($)
$ in Millions
12 Months Ended
Apr. 21, 2023
Dec. 31, 2024
Dec. 31, 2023
Apr. 20, 2023
Revolving Credit Facility        
Debt Instrument [Line Items]        
Unused borrowing capacity $ 2,000.0     $ 1,100.0
Write-off of unamortized debt issuance costs $ 0.9      
Dollar Term Loan B, due 2027        
Debt Instrument [Line Items]        
Write-off of unamortized debt issuance costs   $ 3.0 $ 12.6  
v3.25.0.1
Debt - New Revolving Credit Facility (Details)
May 10, 2024
USD ($)
extensionOption
Dec. 31, 2024
USD ($)
Revolving credit facility, due 2020 | Ingersoll Rand    
Debt Instrument [Line Items]    
Aggregate principal amount   $ 2,600,000,000
Letters of credit outstanding   200,000,000.0
Revolving credit facility, due 2024    
Debt Instrument [Line Items]    
Letters of credit outstanding   0
Long-term debt obligations   0
Unused borrowing capacity   $ 2,600,000,000
Revolving Credit Facility | New Revolving Credit Facility    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 2,600,000,000  
Debt instrument, extension options | extensionOption 2  
Debt instrument, extension term 1 year  
Basis spread on variable rate (as a percent) 0.10%  
Debt instrument, covenant, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum 3.50  
Debt instrument, covenant, following a qualified acquisition, adjusted consolidated total net debt to consolidated adjusted ebitda ratio, maximum 4.00  
v3.25.0.1
Debt - Commercial Paper Program (Details) - USD ($)
$ in Millions
Aug. 13, 2024
Dec. 31, 2024
Debt Instrument [Line Items]    
Line of credit facility, fair value of amount outstanding   $ 0.0
Commercial Paper | Commercial Paper Notes    
Debt Instrument [Line Items]    
Maximum borrowing capacity $ 2,600.0  
Line of credit facility, expiration period 397 days  
v3.25.0.1
Debt - Fair Value of Debt and Total Debt Maturities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Debt Disclosure [Abstract]    
Fair value of debt $ 4,900.0 $ 2,800.0
Debt maturities, next twelve months 3.1  
Debt maturities, year two 1.7  
Debt maturities, year three 701.5  
Debt maturities, year four 501.5  
Debt maturities, year five 751.5  
Debt maturities, after year five $ 2,856.5  
v3.25.0.1
Benefit Plans - Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reconciliation of Fair Value of Plan Assets:      
Beginning balance $ 443.5    
Fair value of plan assets ending balance 401.5 $ 443.5  
Pension Benefits | U.S. Plans      
Reconciliation of Benefit Obligations:      
Beginning balance 294.0 319.8  
Service cost 0.1 0.1 $ 4.4
Interest cost 13.4 15.7 11.3
Participant contributions 0.0 0.0  
Plan amendments 0.0 0.0  
Actuarial losses (gains) (18.1) 6.0  
Benefit payments (22.2) (16.1)  
Acquisitions 0.0 0.0  
Plan settlements (2.5) (31.5)  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes 0.0 0.0  
Benefit obligations ending balance 264.7 294.0 319.8
Reconciliation of Fair Value of Plan Assets:      
Beginning balance 237.5 263.6  
Actual return on plan assets (6.0) 18.7  
Employer contributions 0.1 2.8  
Participant contributions 0.0 0.0  
Acquisitions 0.0 0.0  
Benefit payments (22.2) (16.1)  
Plan settlements (2.5) (31.5)  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes 0.0 0.0  
Fair value of plan assets ending balance 206.9 237.5 263.6
Funded Status as of Period End (57.8) (56.5)  
Pension Benefits | Non-U.S. Plans      
Reconciliation of Benefit Obligations:      
Beginning balance 263.2 247.5  
Service cost 2.9 2.6 3.3
Interest cost 10.7 11.1 5.9
Participant contributions 0.2 0.0  
Plan amendments 0.0 0.3  
Actuarial losses (gains) (11.3) 3.3  
Benefit payments (14.5) (13.6)  
Acquisitions 10.2 0.0  
Plan settlements 0.0 0.0  
Other 0.6 0.0  
Effect of foreign currency exchange rate changes (10.6) 12.0  
Benefit obligations ending balance 251.4 263.2 247.5
Reconciliation of Fair Value of Plan Assets:      
Beginning balance 206.0 196.4  
Actual return on plan assets (7.1) 6.7  
Employer contributions 6.5 6.6  
Participant contributions 0.2 0.0  
Acquisitions 8.5 0.0  
Benefit payments (14.5) (13.6)  
Plan settlements 0.0 0.0  
Other 0.6 0.0  
Effect of foreign currency exchange rate changes (5.6) 9.9  
Fair value of plan assets ending balance 194.6 206.0 196.4
Funded Status as of Period End (56.8) (57.2)  
Other Postretirement Benefits      
Reconciliation of Benefit Obligations:      
Beginning balance 18.3 21.0  
Service cost 0.0 0.0  
Interest cost 0.8 0.9 0.7
Participant contributions 0.0 0.0  
Plan amendments (10.9) 0.0  
Actuarial losses (gains) 0.2 (1.0)  
Benefit payments (2.4) (2.7)  
Acquisitions 0.0 0.0  
Plan settlements 0.0 0.0  
Other 0.0 0.0  
Effect of foreign currency exchange rate changes (0.1) 0.1  
Benefit obligations ending balance 5.9 18.3 $ 21.0
Reconciliation of Fair Value of Plan Assets:      
Funded Status as of Period End $ (5.9) $ (18.3)  
v3.25.0.1
Benefit Plans - Recognized as Component of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Pension Benefits | U.S. Plans    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) $ (10.8) $ (11.0)
Prior service cost 0.0 0.0
Amounts included in accumulated other comprehensive income (loss) (10.8) (11.0)
Pension Benefits | Non-U.S. Plans    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) 7.6 (1.1)
Prior service cost 2.7 2.9
Amounts included in accumulated other comprehensive income (loss) 10.3 1.8
Other Postretirement Benefits    
Amounts Recognized as a Component of Accumulated Other Comprehensive (Loss) Income [Abstract]    
Net actuarial losses (gains) (3.2) (4.3)
Prior service cost (10.9) 0.1
Amounts included in accumulated other comprehensive income (loss) $ (14.1) $ (4.2)
v3.25.0.1
Benefit Plans - Pension and Other Postretirement Benefit Liabilities in Consolidated Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Total Pension and Other Postretirement Benefit Liabilities Included in Balance Sheets [Abstract]    
Other assets $ 18.5 $ 18.8
Accrued liabilities (6.4) (6.2)
Pension and other postretirement benefits $ (132.6) $ (144.6)
v3.25.0.1
Benefit Plans - Accumulated Benefit Obligation in Excess of Plan Assets (Details) - Pension Benefits - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
U.S. Plans    
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]    
Projected benefit obligations $ 264.7 $ 294.0
Accumulated benefit obligation 264.7 294.0
Fair value of plan assets 206.9 237.5
Accumulated benefit obligation 264.7 294.0
Non-U.S. Plans    
Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]    
Projected benefit obligations 119.7 105.4
Accumulated benefit obligation 112.7 86.4
Fair value of plan assets 42.8 17.0
Accumulated benefit obligation $ 243.3 $ 254.8
v3.25.0.1
Benefit Plans - Net Periodic Benefit Cost and Other Comprehensive (Loss) Income, Before Income Tax Effects (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pension Benefits | U.S. Plans      
Net Periodic Benefit Cost:      
Service cost $ 0.1 $ 0.1 $ 4.4
Interest cost 13.4 15.7 11.3
Expected return on plan assets (12.7) (13.2) (13.0)
Amortization of net actuarial loss 0.0 0.1 0.0
Net periodic benefit cost 0.8 2.7 2.7
Loss (gain) due to settlement 0.4 (0.4) (0.5)
Total net periodic benefit cost recognized 1.2 2.3 2.2
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) 0.6 0.5 0.4
Amortization of net actuarial gain (loss) (0.4) 0.3 0.5
Total recognized in other comprehensive income (loss) 0.2 0.8 0.9
Total recognized in net periodic benefit cost and other comprehensive income (loss) 1.4 3.1 3.1
Pension Benefits | Non-U.S. Plans      
Net Periodic Benefit Cost:      
Service cost 2.9 2.6 3.3
Interest cost 10.7 11.1 5.9
Expected return on plan assets (11.2) (11.0) (11.8)
Amortization of prior-service cost 0.2 0.1 0.1
Amortization of net actuarial loss (1.3) (1.7) 0.3
Net periodic benefit cost 1.3 1.1 (2.2)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) 7.0 7.5 (33.3)
Amortization of net actuarial gain (loss) 1.3 1.7 (0.3)
Prior service cost 0.0 0.3 0.0
Amortization of prior service cost (0.2) (0.1) (0.1)
Effect of foreign currency exchange rate changes 0.4 0.3 (3.2)
Total recognized in other comprehensive income (loss) 8.5 9.7 (36.9)
Total recognized in net periodic benefit cost and other comprehensive income (loss) 9.8 10.8 (39.1)
Other Postretirement Benefits      
Net Periodic Benefit Cost:      
Service cost 0.0 0.0  
Interest cost 0.8 0.9 0.7
Amortization of prior-service cost 0.1 0.1 0.0
Amortization of net actuarial loss (0.8) (1.1) 0.0
Total net periodic benefit cost recognized 0.1 (0.1) 0.7
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income (Loss):      
Net actuarial loss (gain) 0.2 (1.0) (5.0)
Amortization of net actuarial gain (loss) 0.8 1.1 0.0
Prior service cost (10.9) 0.0 0.0
Amortization of prior service cost (0.1) (0.1) 0.0
Total recognized in other comprehensive income (loss) (10.0) 0.0 (5.0)
Total recognized in net periodic benefit cost and other comprehensive income (loss) $ (9.9) $ (0.1) $ (4.3)
v3.25.0.1
Benefit Plans - Weighted Average Actuarial Assumptions (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pension Benefits | U.S. Plans      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 5.00% 5.20% 2.70%
Expected long-term rate of return on plan assets (as a percent) 5.80% 5.40% 3.50%
Rate of compensation increases (as a percent)     3.00%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 5.50% 5.00% 5.20%
Pension Benefits | Non-U.S. Plans      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 4.20% 4.50% 1.60%
Expected long-term rate of return on plan assets (as a percent) 5.50% 5.50% 4.40%
Rate of compensation increases (as a percent) 5.00% 4.30% 4.30%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 4.50% 4.20% 4.50%
Rate of compensation increases (as a percent) 5.00% 5.00% 4.30%
Other Postretirement Benefits | Minimum      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 4.90% 4.90% 2.40%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 4.40% 4.90% 4.90%
Other Postretirement Benefits | Maximum      
Weighted-average actuarial assumptions used to determine net periodic benefit cost:      
Discount rate (as a percent) 5.10% 5.20% 3.00%
Weighted-average actuarial assumptions used to determine benefit obligations:      
Discount rate (as a percent) 5.40% 5.10% 5.20%
v3.25.0.1
Benefit Plans - Assumed Health Care Cost Trend Rate (Details) - Other Postretirement Benefits
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Weighted-average actuarial assumptions used to determine other postretirement benefit plans costs and obligations:      
Healthcare cost trend rate assumed for next year (as a percent) 5.10% 6.80% 6.80%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate) (as a percent) 4.00% 4.40% 4.50%
v3.25.0.1
Benefit Plans - Estimated Benefit Payments for the Next Five Years (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Pension Benefits | U.S. Plans  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2025 $ 26.4
2026 25.1
2027 24.9
2028 23.9
2029 23.4
Aggregate 2030-2034 98.3
Expected future employer contributions in the next year 5.2
Pension Benefits | Non-U.S. Plans  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2025 14.7
2026 14.9
2027 14.5
2028 15.1
2029 17.1
Aggregate 2030-2034 86.0
Expected future employer contributions in the next year 7.3
Other Postretirement Benefits  
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]  
2025 2.4
2026 0.4
2027 0.4
2028 0.3
2029 0.3
Aggregate 2030-2034 1.3
Expected future employer contributions in the next year $ 2.4
v3.25.0.1
Benefit Plans - Long-Term Target Allocations (Details)
12 Months Ended
Dec. 31, 2024
Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract]  
Proportion of U.S. and U.K pension plans in total benefit obligation (as a percent) 76.00%
Proportion of U.S. and U.K pension plans in total plan assets (as a percent) 87.00%
U.S. Plans  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 100.00%
U.S. Plans | Equity  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 16.00%
U.S. Plans | Fixed income  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 83.00%
U.S. Plans | Real estate and other  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 1.00%
UK Plan  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 100.00%
UK Plan | Equity  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 12.00%
UK Plan | Fixed income  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 56.00%
UK Plan | Real estate and other  
Defined Benefit Plan, Plan Assets, Allocations [Abstract]  
Long-term target allocations (as a percent) 32.00%
v3.25.0.1
Benefit Plans - Fair Values of Pension Plan Assets by Asset Category (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets $ 401.5 $ 443.5  
Total contribution to defined contribution plans 49.1 47.0 $ 46.6
Cash and cash equivalents      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 5.1 7.1  
Total equity funds      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 67.3 65.1  
U.S. small-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.9 3.7  
U.S. mid-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 2.6    
U.S. large-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 14.1 19.5  
International equity      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 49.7 41.9  
Fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 277.6 326.3  
Corporate bonds - international      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 39.6 42.7  
UK index-linked gilts      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 66.0 78.7  
U.S. fixed income - government securities      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 20.5 43.2  
U.S. fixed income - short duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 1.8 1.3  
U.S. fixed income - intermediate duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 25.2 30.9  
U.S. fixed income - long duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 122.7 122.3  
Global fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 1.8 7.2  
International real estate      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 11.6 15.4  
Other      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 39.9 29.6  
Investments Measured at NAV      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 231.2 259.1  
Investments Measured at NAV | Cash and cash equivalents      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Investments Measured at NAV | Total equity funds      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 41.6 38.4  
Investments Measured at NAV | U.S. small-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.9 3.7  
Investments Measured at NAV | U.S. mid-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 2.6    
Investments Measured at NAV | U.S. large-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 11.6 17.5  
Investments Measured at NAV | International equity      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 26.5 17.2  
Investments Measured at NAV | Fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 187.8 220.7  
Investments Measured at NAV | Corporate bonds - international      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 15.8 15.8  
Investments Measured at NAV | UK index-linked gilts      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Investments Measured at NAV | U.S. fixed income - government securities      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 20.5 43.2  
Investments Measured at NAV | U.S. fixed income - short duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 1.8 1.3  
Investments Measured at NAV | U.S. fixed income - intermediate duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 25.2 30.9  
Investments Measured at NAV | U.S. fixed income - long duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 122.7 122.3  
Investments Measured at NAV | Global fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 1.8 7.2  
Investments Measured at NAV | International real estate      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Investments Measured at NAV | Other      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 1.8 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1)      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 5.1 21.3  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 5.1 7.1  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Total equity funds      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 14.2  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. small-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. mid-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0    
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. large-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | International equity      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 14.2  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate bonds - international      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | UK index-linked gilts      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - government securities      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - short duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - intermediate duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | U.S. fixed income - long duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Global fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | International real estate      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Quoted Prices in Active Markets for Identical Assets (Level 1) | Other      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets  
Significant Observable Inputs (Level 2)      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 127.1 133.5  
Significant Observable Inputs (Level 2) | Cash and cash equivalents      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | Total equity funds      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 25.7 12.5  
Significant Observable Inputs (Level 2) | U.S. small-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | U.S. mid-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0    
Significant Observable Inputs (Level 2) | U.S. large-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 2.5 2.0  
Significant Observable Inputs (Level 2) | International equity      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 23.2 10.5  
Significant Observable Inputs (Level 2) | Fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 89.8 105.6  
Significant Observable Inputs (Level 2) | Corporate bonds - international      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 23.8 26.9  
Significant Observable Inputs (Level 2) | UK index-linked gilts      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 66.0 78.7  
Significant Observable Inputs (Level 2) | U.S. fixed income - government securities      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | U.S. fixed income - short duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | U.S. fixed income - intermediate duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | U.S. fixed income - long duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | Global fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Observable Inputs (Level 2) | International real estate      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 11.6 15.4  
Significant Observable Inputs (Level 2) | Other      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3)      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 38.1 29.6  
Significant Unobservable Inputs (Level 3) | Cash and cash equivalents      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | Total equity funds      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. small-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. mid-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0    
Significant Unobservable Inputs (Level 3) | U.S. large-cap      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | International equity      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | Fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | Corporate bonds - international      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | UK index-linked gilts      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. fixed income - government securities      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. fixed income - short duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. fixed income - intermediate duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | U.S. fixed income - long duration      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | Global fixed income      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | International real estate      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets 0.0 0.0  
Significant Unobservable Inputs (Level 3) | Other      
Defined Benefit Plan, Funded (Unfunded) Status of Plan [Abstract]      
Fair value of plan assets $ 38.1 $ 29.6  
v3.25.0.1
Stockholders' Equity and Noncontrolling Interests (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Apr. 25, 2024
Aug. 24, 2021
Noncontrolling Interest [Line Items]          
Voting common stock authorized (in shares) 1,000,000,000 1,000,000,000      
Voting common stock outstanding (in shares) 402,880,079 403,347,394      
Voting common stock, par value (in USD per share) $ 0.01 $ 0.01      
2021 Repurchase Program          
Noncontrolling Interest [Line Items]          
Amount authorized for repurchase         $ 750.0
Stock repurchased (in shares) 2,665,262 3,963,243 5,673,937    
Weighted average exercise price (in shares) $ 93.80 $ 62.98 $ 45.36    
Stock repurchased $ 250.0 $ 249.6 $ 257.3    
Repurchase Program 2024          
Noncontrolling Interest [Line Items]          
Amount authorized for repurchase       $ 1,000.0  
IR India Limited          
Noncontrolling Interest [Line Items]          
Ownership interest by parent (as a percent) 75.00%        
v3.25.0.1
Accumulated Other Comprehensive Income (Loss) - Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period $ 9,846.7 $ 9,257.2 $ 9,071.2
Other comprehensive income (loss) (238.2) 25.8 (217.3)
Balance at end of period 10,245.3 9,846.7 9,257.2
Accumulated Other Comprehensive Income (Loss)      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period (227.6) (251.7) (41.6)
Before tax income (loss) (231.4) 7.4 (174.8)
Income tax effect (9.5) 16.7 (35.3)
Other comprehensive income (loss) (240.9) 24.1 (210.1)
Balance at end of period (468.5) (227.6) (251.7)
Foreign Currency Translation Adjustments, Net      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period (248.0) (282.8) (29.9)
Before tax income (loss) (218.6) 23.0 (237.1)
Income tax effect (13.0) 11.8 (15.8)
Other comprehensive income (loss) (231.6) 34.8 (252.9)
Balance at end of period (479.6) (248.0) (282.8)
Cash Flow Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period 12.2 16.0 0.0
Before tax income (loss) (14.1) (5.1) 21.3
Income tax effect 5.0 1.3 (5.3)
Other comprehensive income (loss) (9.1) (3.8) 16.0
Balance at end of period 3.1 12.2 16.0
Pension and Other Postretirement Benefit Plans      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period 8.2 15.1 (11.7)
Before tax income (loss) 1.3 (10.5) 41.0
Income tax effect (1.5) 3.6 (14.2)
Other comprehensive income (loss) (0.2) (6.9) 26.8
Balance at end of period $ 8.0 $ 8.2 $ 15.1
v3.25.0.1
Accumulated Other Comprehensive Income (Loss) - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Foreign currency translation adjustments, net $ 2.7 $ 1.7 $ (7.2)
v3.25.0.1
Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period $ 9,846.7 $ 9,257.2 $ 9,071.2
Other comprehensive income (loss) (238.2) 25.8 (217.3)
Balance at end of period 10,245.3 9,846.7 9,257.2
Accumulated Other Comprehensive Income (Loss)      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period (227.6) (251.7) (41.6)
Other comprehensive income (loss) before reclassifications (214.8) 52.2 (203.5)
Amounts reclassified from accumulated other comprehensive income (loss) (26.1) (28.1) (6.6)
Other comprehensive income (loss) (240.9) 24.1 (210.1)
Balance at end of period (468.5) (227.6) (251.7)
Foreign Currency Translation Adjustments, Net      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period (248.0) (282.8) (29.9)
Other comprehensive income (loss) before reclassifications (218.3) 49.0 (244.3)
Amounts reclassified from accumulated other comprehensive income (loss) (13.3) (14.2) (8.6)
Other comprehensive income (loss) (231.6) 34.8 (252.9)
Balance at end of period (479.6) (248.0) (282.8)
Cash Flow Hedges      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period 12.2 16.0 0.0
Other comprehensive income (loss) before reclassifications 2.7 7.9 13.9
Amounts reclassified from accumulated other comprehensive income (loss) (11.8) (11.7) 2.1
Other comprehensive income (loss) (9.1) (3.8) 16.0
Balance at end of period 3.1 12.2 16.0
Pension and Other Postretirement Benefit Plans      
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]      
Balance at beginning of period 8.2 15.1 (11.7)
Other comprehensive income (loss) before reclassifications 0.8 (4.7) 26.9
Amounts reclassified from accumulated other comprehensive income (loss) (1.0) (2.2) (0.1)
Other comprehensive income (loss) (0.2) (6.9) 26.8
Balance at end of period $ 8.0 $ 8.2 $ 15.1
v3.25.0.1
Accumulated Other Comprehensive Income (Loss) - Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense $ 213.2 $ 156.7 $ 103.2
Provision for income taxes (262.5) (240.0) (149.6)
Net Income Attributable to Ingersoll Rand Inc. 838.6 778.7 604.7
Reclassification out of Accumulated Other Comprehensive (Loss) Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net Income Attributable to Ingersoll Rand Inc. (26.1) (28.1) (6.6)
Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive (Loss) Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense (15.7) (15.6) 2.8
Provision for income taxes 3.9 3.9 (0.7)
Net Income Attributable to Ingersoll Rand Inc. (11.8) (11.7) 2.1
Accumulated Gain (Loss), Net Investment Hedge, Including Noncontrolling Interest | Reclassification out of Accumulated Other Comprehensive (Loss) Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Interest expense (17.7) (19.0) (11.5)
Provision for income taxes 4.4 4.8 2.9
Net Income Attributable to Ingersoll Rand Inc. (13.3) (14.2) (8.6)
Pension and Other Postretirement Benefit Plans | Reclassification out of Accumulated Other Comprehensive (Loss) Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Provision for income taxes 0.4 0.7 0.0
Cost of sales and Selling and administrative expenses (1.4) (2.9) (0.1)
Net Income Attributable to Ingersoll Rand Inc. $ (1.0) $ (2.2) $ (0.1)
v3.25.0.1
Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Abstract]      
Revenues $ 7,235.0 $ 6,876.1 $ 5,916.3
Revenue recognized at point in time      
Disaggregation of Revenue [Abstract]      
Revenues 6,672.0 6,383.4  
Revenue recognized at point over time      
Disaggregation of Revenue [Abstract]      
Revenues 563.0 492.7  
Original equipment      
Disaggregation of Revenue [Abstract]      
Revenues 4,604.2 4,416.8  
Aftermarket      
Disaggregation of Revenue [Abstract]      
Revenues 2,630.8 2,459.3  
Americas      
Disaggregation of Revenue [Abstract]      
Revenues 3,653.5 3,297.3  
U.S. Plans      
Disaggregation of Revenue [Abstract]      
Revenues 3,112.3 2,895.2  
Other Americas      
Disaggregation of Revenue [Abstract]      
Revenues 541.2 402.1  
EMEIA      
Disaggregation of Revenue [Abstract]      
Revenues 2,374.9 2,267.5  
Total Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues 1,206.6 1,311.3  
China      
Disaggregation of Revenue [Abstract]      
Revenues 794.6 924.6  
Other Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues 412.0 386.7  
Industrial Technologies and Services      
Disaggregation of Revenue [Abstract]      
Revenues 5,818.1 5,632.8  
Industrial Technologies and Services | Revenue recognized at point in time      
Disaggregation of Revenue [Abstract]      
Revenues 5,295.6 5,147.2  
Industrial Technologies and Services | Revenue recognized at point over time      
Disaggregation of Revenue [Abstract]      
Revenues 522.5 485.6  
Industrial Technologies and Services | Original equipment      
Disaggregation of Revenue [Abstract]      
Revenues 3,494.0 3,425.9  
Industrial Technologies and Services | Aftermarket      
Disaggregation of Revenue [Abstract]      
Revenues 2,324.1 2,206.9  
Industrial Technologies and Services | Americas      
Disaggregation of Revenue [Abstract]      
Revenues 2,914.1 2,701.1  
Industrial Technologies and Services | U.S. Plans      
Disaggregation of Revenue [Abstract]      
Revenues 2,461.2 2,328.0  
Industrial Technologies and Services | Other Americas      
Disaggregation of Revenue [Abstract]      
Revenues 452.9 373.1  
Industrial Technologies and Services | EMEIA      
Disaggregation of Revenue [Abstract]      
Revenues 1,854.9 1,800.8  
Industrial Technologies and Services | Total Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues 1,049.1 1,130.9  
Industrial Technologies and Services | China      
Disaggregation of Revenue [Abstract]      
Revenues 680.8 785.7  
Industrial Technologies and Services | Other Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues 368.3 345.2  
Precision and Science Technologies      
Disaggregation of Revenue [Abstract]      
Revenues 1,416.9 1,243.3  
Precision and Science Technologies | Revenue recognized at point in time      
Disaggregation of Revenue [Abstract]      
Revenues 1,376.4 1,236.2  
Precision and Science Technologies | Revenue recognized at point over time      
Disaggregation of Revenue [Abstract]      
Revenues 40.5 7.1  
Precision and Science Technologies | Original equipment      
Disaggregation of Revenue [Abstract]      
Revenues 1,110.2 990.9  
Precision and Science Technologies | Aftermarket      
Disaggregation of Revenue [Abstract]      
Revenues 306.7 252.4  
Precision and Science Technologies | Americas      
Disaggregation of Revenue [Abstract]      
Revenues 739.4 596.2  
Precision and Science Technologies | U.S. Plans      
Disaggregation of Revenue [Abstract]      
Revenues 651.1 567.2  
Precision and Science Technologies | Other Americas      
Disaggregation of Revenue [Abstract]      
Revenues 88.3 29.0  
Precision and Science Technologies | EMEIA      
Disaggregation of Revenue [Abstract]      
Revenues 520.0 466.7  
Precision and Science Technologies | Total Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues 157.5 180.4  
Precision and Science Technologies | China      
Disaggregation of Revenue [Abstract]      
Revenues 113.8 138.9  
Precision and Science Technologies | Other Asia Pacific      
Disaggregation of Revenue [Abstract]      
Revenues $ 43.7 $ 41.5  
v3.25.0.1
Revenue from Contracts with Customers - Performance Obligations (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Performance Obligation [Abstract]  
Remaining performance obligation $ 742.6
Remaining performance obligation, expected timing of satisfaction 12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Performance Obligation [Abstract]  
Remaining performance obligation $ 788.6
Remaining performance obligation, expected timing of satisfaction
v3.25.0.1
Revenue from Contracts with Customers - Contract Balances (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Contract with Customer, Asset and Liability [Abstract]    
Accounts receivable, net $ 1,335.4 $ 1,234.2
Contract assets 111.2 85.6
Contract liabilities - current 318.6 331.2
Contract liabilities - noncurrent $ 0.9 $ 1.0
v3.25.0.1
Revenue from Contracts with Customers - Narrative (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Revenue from Contract with Customer [Abstract]  
Contract liabilities $ 332.2
v3.25.0.1
Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]      
U.S. $ 383.7 $ 356.0 $ 267.5
Non-U.S. 749.1 675.1 474.7
Income Before Income Taxes $ 1,132.8 $ 1,031.1 $ 742.2
v3.25.0.1
Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Current:      
U.S. federal $ 87.5 $ 111.5 $ 66.5
U.S. state and local 22.8 23.7 21.5
Non-U.S. 185.3 181.7 147.4
Deferred:      
U.S. federal (9.7) (44.0) (37.3)
U.S. state and local (5.7) (6.9) (5.5)
Non-U.S. (17.7) (26.0) (43.0)
Provision for income taxes $ 262.5 $ 240.0 $ 149.6
v3.25.0.1
Income Taxes - Effective Income Tax Rate Reconciliation (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
U.S. federal corporate statutory rate 21.00% 21.00% 21.00%
State and local taxes, less federal tax benefit 1.40% 1.30% 2.00%
Net effects of foreign tax rate differential 2.50% 1.80% 1.50%
Withholding tax 1.30% 1.50% 2.10%
Repatriation cost (1.50%) (2.00%) (3.20%)
Global Intangible Low-Tax Income (“GILTI”) 0.40% 0.70% 0.30%
ASC 740-30 (formerly APB 23) 1.50% 1.70% 1.90%
Valuation allowance changes 0.40% 1.70% 0.50%
Uncertain tax positions 0.90% 0.90% 0.20%
Equity compensation (1.30%) (0.60%) (0.60%)
Nondeductible acquisition costs 0.30% 0.40% 0.40%
Foreign Derived Intangible Income (“FDII”) deduction (1.10%) (1.40%) (1.60%)
Tax credits (0.60%) (0.70%) (1.10%)
Income not subject to tax (0.30%) (1.60%) (3.50%)
Amortization of goodwill and other intangible assets (1.30%) (0.80%) 0.00%
Interest on equity (1.80%) (0.70%) (0.40%)
Return to provision adjustment (0.20%) 0.10% 0.00%
Loss on sale 1.10% 0.00% 0.00%
Other, net 0.50% 0.00% 0.70%
Effective income tax rate 23.20% 23.30% 20.20%
v3.25.0.1
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Deferred Tax Assets:    
Reserves and accruals $ 83.4 $ 80.1
Allowance for credit losses 7.4 7.8
Inventory reserve 9.0 5.9
Pension and postretirement benefit plans 20.0 25.3
Tax loss carryforwards 112.4 81.3
Deferred taxes recorded in other comprehensive income 1.4 13.4
Foreign tax credit carryforwards 50.7 57.9
Other 22.4 32.2
Total deferred tax assets 306.7 303.9
Valuation allowance (125.6) (115.7)
Deferred Tax Liabilities:    
LIFO inventory (20.3) (20.2)
Investment in partnership (30.2) (35.7)
Property, plant and equipment (50.0) (42.5)
Intangible assets (770.4) (635.4)
Unremitted foreign earnings (41.8) (35.5)
Total deferred tax liabilities (912.7) (769.3)
Net deferred income tax liability $ (731.6) $ (581.1)
v3.25.0.1
Income Taxes - Net Operating Loss and Tax Credit Carryforwards (Details)
$ in Millions
Dec. 31, 2024
USD ($)
Tax Credit Carryforward [Line Items]  
Excess interest $ 30.0
Other deferred tax assets 5.0
Total tax carryforwards 168.6
Valuation Allowance  
Excess interest (29.7)
Other deferred tax assets (5.0)
Total tax carryforwards (125.6)
Domestic Tax Jurisdiction  
Tax Credit Carryforward [Line Items]  
Net operating loss subject to expiration 13.3
Tax credit carryforward 50.8
Alternative minimum tax credit 0.5
Valuation Allowance  
Net operating loss subject to expiration (0.1)
Tax credit carryforward (50.8)
Alternative minimum tax credit (0.1)
Domestic Tax Jurisdiction | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Capital loss 0.6
Valuation Allowance  
Capital loss (0.6)
State and Local Jurisdiction  
Tax Credit Carryforward [Line Items]  
Net operating loss subject to expiration 4.9
Valuation Allowance  
Net operating loss subject to expiration (2.1)
State and Local Jurisdiction | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0.3
Valuation Allowance  
Tax credit carryforward (0.1)
Non U.S. Tax Authority  
Tax Credit Carryforward [Line Items]  
Net operating loss not subject to expiration 62.6
Valuation Allowance  
Net operating loss not subject to expiration (36.5)
Non U.S. Tax Authority | Capital Loss Carryforward  
Tax Credit Carryforward [Line Items]  
Tax credit carryforward 0.6
Valuation Allowance  
Tax credit carryforward $ (0.6)
v3.25.0.1
Income Taxes - Valuation Allowance for Deferred Tax Assets (Details) - Valuation allowance for deferred tax assets - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Beginning balance $ 115.7 $ 107.3 $ 106.4
Revaluation or additions due to acquisitions or mergers 22.9 0.0 0.0
Charged to tax expense (10.8) 6.4 3.1
Charged to other accounts (2.2) 2.0 (2.2)
Ending balance $ 125.6 $ 115.7 $ 107.3
v3.25.0.1
Income Taxes - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2024
USD ($)
Jurisdiction
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Income Tax Disclosure [Abstract]        
Unrecognized tax benefits $ 26.4 $ 19.1 $ 10.8 $ 21.1
Unrecognized tax benefits, that would effect effective tax rate if recognized 26.4      
Interest and penalties accrued $ 3.2 $ 2.0    
Number of jurisdictions outside U.S. | Jurisdiction 48      
Income tax reconciliation withholding tax $ 41.8      
v3.25.0.1
Income Taxes - Unrecognized Tax Benefits and Other Disclosures (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]      
Beginning balance $ 19.1 $ 10.8 $ 21.1
Gross increases for tax positions of prior years 0.8 0.4 0.4
Gross decreases for tax positions of prior years (0.3) 0.0 (3.7)
Gross increases for tax positions of current year 8.1 7.9 4.1
Settlements 0.0 0.0 (9.9)
Lapse of statute of limitations (0.6) (0.2) (0.1)
Changes due to currency fluctuations (0.7)   (1.1)
Changes due to currency fluctuations   0.2  
Ending balance $ 26.4 $ 19.1 $ 10.8
v3.25.0.1
Leases - Components of Lease Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Lease, Cost [Abstract]    
Operating lease cost $ 64.5 $ 53.7
Finance lease cost    
Amortization of right-of-use assets 1.5 1.5
Interest on lease liabilities 0.9 0.9
Total finance lease cost 2.4 2.4
Short-term lease cost $ 2.2 $ 1.9
v3.25.0.1
Leases - Supplemental Cash Flows Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Paid for Amounts Included in the Measurement of Lease Liabilities    
Operating cash flows from operating leases $ 63.8 $ 53.7
Operating cash flows from finance leases 0.9 1.0
Financing cash flows from finance leases 1.3 1.2
Leased Assets Obtained in Exchange for New Operating Lease Liabilities $ 96.2 $ 62.5
v3.25.0.1
Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Operating leases    
Operating lease, right-of-use asset, statement of financial position Other assets Other assets
Other assets $ 226.6 $ 164.4
Operating Lease Liabilities, Gross Difference, Amount [Abstract]    
Operating lease, liability, current, statement of financial position Accrued liabilities Accrued liabilities
Accrued liabilities $ 56.3 $ 41.6
Operating lease, liability, noncurrent, statement of financial position Other liabilities Other liabilities
Other liabilities $ 165.5 $ 116.9
Total operating lease liabilities $ 221.8 $ 158.5
Finance Leases    
Finance lease, right-of-use asset, statement of financial position Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively Property, plant and equipment, net of accumulated depreciation of $567.5 and $500.8, respectively
Property, plant and equipment $ 11.1 $ 12.3
Finance Lease Liabilities, Gross Difference, Amount [Abstract]    
Finance lease, liability, current, statement of financial position Short-term borrowings and current maturities of long-term debt Short-term borrowings and current maturities of long-term debt
Short-term borrowings and current maturities of long-term debt $ 1.3 $ 1.3
Finance lease, liability, noncurrent, statement of financial position Long-term debt, less current maturities Long-term debt, less current maturities
Long-term debt, less current maturities $ 12.6 $ 13.6
Total finance lease liabilities $ 13.9 $ 14.9
Weighted Average Remaining Lease Term (in years)    
Operating leases 5 years 2 months 12 days 5 years 1 month 6 days
Finance leases 9 years 4 months 24 days 10 years 3 months 18 days
Weighted Average Discount Rate    
Operating leases (as a percent) 4.10% 3.60%
Finance leases (as a percent) 6.50% 6.40%
v3.25.0.1
Leases - Maturities of Lease Liabilities (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Operating Leases    
2025 $ 63.6  
2026 55.1  
2027 41.3  
2028 29.4  
2029 17.7  
Thereafter 39.2  
Total lease payments 246.3  
Less imputed interest (24.5)  
Total operating lease liabilities 221.8 $ 158.5
Finance Leases    
2025 2.2  
2026 2.1  
2027 2.1  
2028 2.1  
2029 2.1  
Thereafter 8.5  
Total lease payments 19.1  
Less imputed interest (5.2)  
Total finance lease liabilities $ 13.9 $ 14.9
v3.25.0.1
Compensation Related Costs, Share Based Payments (Details) - Continuing Operations
3 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
employee
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense   $ 58,800,000 $ 51,900,000 $ 78,900,000
Share-based payment arrangement, total equity grant to employees $ 150,000,000      
Share-based payment arrangement, total equity grant to employees, number of employees | employee 16,000      
Equity Awards | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense   58,800,000 51,100,000 80,000,000.0
Stock Appreciation Rights (SARs) | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense   $ 0 $ 800,000 $ (1,100,000)
Equity Awards - Founders Grant | 2013 Stock Incentive Plan and 2017 Omnibus Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 39,500,000      
v3.25.0.1
Stock-Based Compensation Plans - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Sep. 30, 2022
Sep. 30, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
May 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Unrecognized compensation expense       $ 110.6      
Weighted average grant date fair value of stock options granted (in USD per share)       $ 38.97 $ 25.28 $ 21.24  
Grant date and recognized in compensation expense over   4 years 3 months 18 days          
Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Issuance of common stock for stock-based compensation plans (in shares)   300,000   300,000      
Total intrinsic value of stock options exercised       $ 114.8 $ 75.0 $ 27.7  
Performance Share Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years) 3 years 5 years          
Volume-weighted average closing   60 days          
Closing price per share (in USD per share)   $ 81.85          
Restricted Stock Units              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)     2 years        
Omnibus Incentive Plan 2017 | Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award expiration period (in years)       10 years      
2013 Stock Incentive Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Capital stock reserved for future issuance (in shares)       20,900,000      
2013 Stock Incentive Plan | Tranche One              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Tranche Two              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Tranche Three              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche One              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche Two              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Performance Share Units | Tranche Three              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting rate (as a percent)       50.00%      
2013 Stock Incentive Plan | Stock Appreciation Rights (SARs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares outstanding (in shares)       0 0    
Share-Based Payment Arrangement, Option, Five Year Vesting              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)       5 years      
Share-Based Payment Arrangement, Option, Four Year Vesting              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)       4 years      
Share-Based Payment Arrangement, Option, Three Year Vesting              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)       3 years      
Minimum | Omnibus Incentive Plan 2017 | Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)       4 years      
Maximum | Omnibus Incentive Plan 2017              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Capital stock reserved for future issuance (in shares)             19,600,000
Maximum | Omnibus Incentive Plan 2017 | Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Award vesting period (in years)       5 years      
v3.25.0.1
Stock-Based Compensation Plans - Stock Option Awards (Details) - Stock Options
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 5,282
Granted (in shares) | shares 610
Exercised or settled (in shares) | shares (1,615)
Forfeited (in shares) | shares (88)
Expired (in shares) | shares (4)
Balance at end of period (in shares) | shares 4,185
Vested (in shares) | shares 2,708
Weighted-Average Exercise Price (per share)  
Balance at beginning of period (in USD per share) | $ / shares $ 31.09
Granted (in USD per share) | $ / shares 90.55
Exercised or settled (in USD per share) | $ / shares 19.96
Forfeited (in USD per share) | $ / shares 65.08
Expired (in USD per share) | $ / shares 40.22
Balance at end of period (in USD per share) | $ / shares 43.33
Vested (in USD per share) | $ / shares $ 29.34
Weighted average remaining contractual term of options outstanding (in years) 5 years 6 months
Weighted average remaining contractual term of options vested (in years) 4 years 1 month 6 days
Aggregate intrinsic value of in-the-money options outstanding | $ $ 197.4
Aggregate intrinsic value of in-the-money options vested | $ $ 165.5
v3.25.0.1
Stock-Based Compensation Plans - Assumptions Used to Estimate Fair Value (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years)     6 years 3 months 18 days
Risk-free interest rate, minimum 3.70% 3.80% 1.90%
Risk-free interest rate, maximum 4.30% 4.60% 3.90%
Assumed volatility, minimum 34.90% 35.60% 37.10%
Assumed volatility, maximum 35.20% 36.60% 38.30%
Expected dividend rate 0.10%    
Stock Options | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years) 6 years 3 months 18 days 6 years 3 months 18 days  
Expected dividend rate   0.00% 0.10%
Stock Options | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years) 7 years 6 months 7 years 6 months  
Expected dividend rate   0.10% 0.20%
Performance Share Units      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years) 2 years 9 months 18 days 2 years 10 months 24 days  
Risk-free interest rate, minimum     1.70%
Risk-free interest rate, maximum     3.40%
Risk-free interest rate 4.50% 4.40%  
Assumed volatility, minimum     35.00%
Assumed volatility, maximum     36.40%
Assumed volatility 28.90% 31.80%  
Expected dividend rate 0.10% 0.10% 0.20%
Performance Share Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years)     2 years 10 months 24 days
Performance Share Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected life of options (in years)     5 years
v3.25.0.1
Stock-Based Compensation Plans - Restricted Stock Unit Awards (Details) - Restricted Stock Units
shares in Thousands
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 957
Granted (in shares) | shares 433
Vested (in shares) | shares (469)
Forfeited (in shares) | shares (87)
Balance at end of period (in shares) | shares 834
Weighted-Average Grant-Date Fair Value  
Balance at beginning of period (in USD per share) | $ / shares $ 52.18
Granted (in USD per share) | $ / shares 90.94
Vested (in USD per share) | $ / shares 47.96
Forfeited (in USD per share) | $ / shares 68.20
Balance at end of period (in USD per share) | $ / shares $ 73.00
v3.25.0.1
Stock-Based Compensation Plans - Performance Share Unit Awards (Details) - Performance Share Units
shares in Thousands
12 Months Ended
Dec. 31, 2024
$ / shares
shares
Shares  
Balance at beginning of period (in shares) | shares 1,380
Granted (in shares) | shares 87
Change in units based on performance (in shares) | shares 122
Vested (in shares) | shares (244)
Forfeited (in shares) | shares (6)
Balance at end of period (in shares) | shares 1,339
Weighted-Average Grant-Date Fair Value  
Balance at beginning of period (in USD per share) | $ / shares $ 49.53
Granted (in USD per share) | $ / shares 132.98
Change in units based on performance (in USD per share) | $ / shares 55.84
Vested (in USD per share) | $ / shares 55.84
Forfeited (in USD per share) | $ / shares 71.81
Balance at end of period (in USD per share) | $ / shares $ 54.28
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk - Narrative (Details)
€ in Millions
12 Months Ended
May 10, 2024
USD ($)
Dec. 31, 2024
USD ($)
contract
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2024
EUR (€)
contract
May 07, 2024
USD ($)
Dec. 30, 2022
USD ($)
Feb. 29, 2020
EUR (€)
Derivatives, Fair Value [Line Items]                
Off-balance sheet derivative instruments   $ 0 $ 0          
Unrecognized gain (loss) on cash flow hedges   (9,100,000) (3,800,000) $ 16,000,000.0        
Payments of interest rate cap premiums   $ 0 0 13,400,000        
Euro Term Loan due in 2020                
Derivatives, Fair Value [Line Items]                
Amount of hedged item | €               € 601.2
Foreign currency forwards                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   9     9      
Foreign currency forwards | Minimum                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 7,700,000            
Foreign currency forwards | Maximum                
Derivatives, Fair Value [Line Items]                
Term of derivative contract (in years)   1 year            
Notional amount   $ 68,200,000            
Interest rate swap contracts                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   2     2      
Gains, net of income tax       $ 36,400,000        
Interest rate swap contracts | Fair value | 5.176% Senior Notes Due 2029                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   4     4      
Interest rate swap contracts | Fair value | 5.314% Senior Notes Due 2031                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   2     2      
Interest rate swap contracts | Fair value | 5.450% Senior Notes Due 2034                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   1     1      
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 750,000,000.0            
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.176% Senior Notes Due 2029                
Derivatives, Fair Value [Line Items]                
Notional amount   400,000,000.0            
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.314% Senior Notes Due 2031                
Derivatives, Fair Value [Line Items]                
Notional amount   250,000,000.0            
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034                
Derivatives, Fair Value [Line Items]                
Notional amount   100,000,000            
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   528,500,000 528,500,000          
Amount expected to be reclassified into earnings   $ 4,800,000            
Fixed interest rate (as a percent)   3.20%     3.20%      
Unrecognized gain (loss) on cash flow hedges   $ 4,800,000            
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.450% Senior Notes Due 2034                
Derivatives, Fair Value [Line Items]                
Notional amount   750,000,000            
Amount expected to be reclassified into earnings           $ (2,100,000)    
Interest rate swap contracts | Fair value | Derivatives Designated as Hedging Instruments | 5.700% Senior Notes Due 2054                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 500,000,000            
Amount expected to be reclassified into earnings           $ (2,300,000)    
Interest rate cap contracts | Fair value | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Derivative, cap interest rate   4.00%     4.00%      
Gain recognized in OCI on derivatives   $ 1,300,000            
Cross-currency interest rate swap contracts                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   3     3      
Cross-currency interest rate swap contracts | SOFR                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   3     3      
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 1,074,300,000 $ 1,054,200,000   € 500.0      
Fixed interest rate (as a percent)   1.60%     1.60%      
Payments of interest rate cap premiums $ 10,000,000              
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments | SOFR                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 525,700,000     € 500.0      
Payments of interest rate cap premiums $ 9,900,000              
Cross Currency Interest Rate Contract, 5.4% Fixed Rate | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 428,900,000            
Fixed interest rate (as a percent)   5.40%     5.40%      
Cross Currency Interest Rate Contract, Expiring May 2027 | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount | €         € 400.0      
Fixed interest rate (as a percent)   3.70%     3.70%      
Cross Currency Interest Rate Contract, Expiring May 2029                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   3     3      
Cross Currency Interest Rate Contract, Expiring May 2029 | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount | €         € 300.0      
Fixed interest rate (as a percent)   4.10%     4.10%      
Cross Currency Interest Rate Contract, 5.7% Fixed Rate One | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 322,700,000            
Fixed interest rate (as a percent)   5.70%     5.70%      
Cross Currency Interest Rate Contract, Expiring May 2031                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   3     3      
Cross Currency Interest Rate Contract, Expiring May 2031 | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount | €         € 300.0      
Fixed interest rate (as a percent)   4.10%     4.10%      
Cross Currency Interest Rate Contract, 5.7% Fixed Rate Two | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount   $ 322,700,000            
Fixed interest rate (as a percent)   5.70%     5.70%      
Cross Currency Interest Rate Contract, 3.2% Fixed Rate                
Derivatives, Fair Value [Line Items]                
Number of instruments held | contract   2     2      
Cross Currency Interest Rate Contract, 3.2% Fixed Rate | Net investment | Derivatives Designated as Hedging Instruments                
Derivatives, Fair Value [Line Items]                
Notional amount             $ 528,500,000  
Fixed interest rate (as a percent)             3.20%  
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk - Balance Sheets (Details)
€ in Millions, $ in Millions
Dec. 31, 2024
USD ($)
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount $ 750.0    
Interest rate swap contracts | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Notional Amount 528.5   $ 528.5
Interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0    
Interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Assets fair value     8.2
Interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 1.4    
Interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Assets fair value     1.2
Interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.9    
Interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Liabilities fair value     0.0
Interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.9    
Interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Cash flow      
Derivatives, Fair Value [Line Items]      
Liabilities fair value     0.0
Cross-currency interest rate swap contracts | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Notional Amount 1,074.3 € 500.0 1,054.2
Cross-currency interest rate swap contracts | Fair Value Other Current Assets | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Assets fair value 11.5   15.7
Cross-currency interest rate swap contracts | Fair Value Other Assets | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Assets fair value 15.8   0.0
Cross-currency interest rate swap contracts | Fair Value Accrued Liabilities | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0   0.0
Cross-currency interest rate swap contracts | Fair Value Other Liabilities | Derivatives Designated as Hedging Instruments | Net investment      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0   $ 63.1
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount 124.3    
Foreign currency forwards | Fair Value Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 1.8    
Foreign currency forwards | Fair Value Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0    
Foreign currency forwards | Fair Value Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0    
Foreign currency forwards | Fair Value Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 0.0    
Foreign currency forwards | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Notional Amount 69.0    
Foreign currency forwards | Fair Value Other Current Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0    
Foreign currency forwards | Fair Value Other Assets | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Assets fair value 0.0    
Foreign currency forwards | Fair Value Accrued Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value 1.2    
Foreign currency forwards | Fair Value Other Liabilities | Derivatives Not Designated as Hedging Instruments | Fair value      
Derivatives, Fair Value [Line Items]      
Liabilities fair value $ 0.0    
v3.25.0.1
Hedging Activities and Derivative Instruments - Schedule of Long Term Hedge (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Hedged Liability, Statement of Financial Position [Extensible Enumeration] Long-term debt, less current maturities  
Carrying amount of hedged debt $ 749.7 $ 0.0
Cumulative hedging adjustments, included in carrying amount $ (0.3) $ 0.0
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk - Cash Flow Hedges included in Accumulated Other Comprehensive Income (Loss) (Details) - Interest rate swap contracts - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Gains and Losses on Derivatives Designated as Cash Flow Hedges [Abstract]      
Gain recognized in OCI on derivatives $ 1.6 $ 10.5 $ 18.3
Gain (loss) reclassified from AOCI into income (effective portion) $ 15.7 $ 15.6 $ (2.8)
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk -Schedule of Net Investment Hedges included in Accumulated Other Comprehensive Income (Loss) (Details) - Cross-currency interest rate swap contracts - Net investment - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]      
Gain (loss) recognized in OCI on derivatives $ 72.5 $ (17.5) $ 0.6
Gain (loss) reclassified from AOCI into income (effective portion) $ 17.7 $ 19.0 $ 11.5
v3.25.0.1
Hedging Activities, Derivative Instruments and Credit Risk - Derivative Instruments not Designated as Accounting Hedges (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]      
Total foreign currency transaction gains (losses), net $ (3.2) $ (5.1) $ 5.9
Foreign currency forward contracts gains      
Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net [Abstract]      
Total foreign currency transaction gains (losses), net $ 0.1 $ 0.3 $ 3.4
v3.25.0.1
Fair Value Measurements - Fair Value Measurements (Details) - Recurring - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Financial Assets    
Trading securities held in deferred compensation plan $ 21.0 $ 16.8
Interest rate swaps 1.4 9.4
Cross-currency interest rate swaps 27.3 15.7
Foreign currency forwards 1.8  
Total 51.5 41.9
Financial Liabilities    
Deferred compensation plan 28.7 24.7
Interest rate swaps 1.8  
Cross-currency interest rate swaps   63.1
Contingent consideration 22.2 42.2
Foreign currency forwards 1.2  
Total 53.9 130.0
Level 1    
Financial Assets    
Trading securities held in deferred compensation plan 21.0 16.8
Interest rate swaps 0.0 0.0
Cross-currency interest rate swaps 0.0 0.0
Foreign currency forwards 0.0  
Total 21.0 16.8
Financial Liabilities    
Deferred compensation plan 28.7 24.7
Interest rate swaps 0.0  
Cross-currency interest rate swaps   0.0
Contingent consideration 0.0 0.0
Foreign currency forwards 0.0  
Total 28.7 24.7
Level 2    
Financial Assets    
Trading securities held in deferred compensation plan 0.0 0.0
Interest rate swaps 1.4 9.4
Cross-currency interest rate swaps 27.3 15.7
Foreign currency forwards 1.8  
Total 30.5 25.1
Financial Liabilities    
Deferred compensation plan 0.0 0.0
Interest rate swaps 1.8  
Cross-currency interest rate swaps   63.1
Contingent consideration 0.0 0.0
Foreign currency forwards 1.2  
Total 3.0 63.1
Level 3    
Financial Assets    
Trading securities held in deferred compensation plan 0.0 0.0
Interest rate swaps 0.0 0.0
Cross-currency interest rate swaps 0.0 0.0
Foreign currency forwards 0.0  
Total 0.0 0.0
Financial Liabilities    
Deferred compensation plan 0.0 0.0
Interest rate swaps 0.0  
Cross-currency interest rate swaps   0.0
Contingent consideration 22.2 42.2
Foreign currency forwards 0.0  
Total $ 22.2 $ 42.2
v3.25.0.1
Fair Value Measurements - Contingent Consideration (Details) - Contingent Consideration - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Balance at beginning of period $ 42.2 $ 43.9
Acquisitions 6.7 13.5
Changes in fair value (15.3) 7.3
Payments (10.0) (23.2)
Foreign currency translation and other (1.4) 0.7
Balance at end of period $ 22.2 $ 42.2
v3.25.0.1
Contingencies - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 05, 2024
USD ($)
subsidiary
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Loss Contingencies [Line Items]        
Number of subsidiaries that hold asbestos liabilities and assets | subsidiary 3      
Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag     after-tax loss  
Undiscounted accrual liabilities for environmental loss contingencies     $ 13.6 $ 16.7
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses $ 188.5      
Pre tax loss   $ 58.8 58.8  
Income tax benefit   7.6 7.6  
Loss after tax   $ 51.2 $ 51.2  
Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale | Insurance Settlement        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses 143.5      
Delticus Holdings LLC | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses 35.0      
Ingersoll Rand | Discontinued Operations, Disposed of by Sale | Asbestos Portfolio Sale        
Loss Contingencies [Line Items]        
Proceeds from divestiture of businesses $ 10.0      
InTelCo | Onyx TopCo LLC        
Loss Contingencies [Line Items]        
Ownership interest 100.00%      
Asbestos and Silica Related Litigation        
Loss Contingencies [Line Items]        
Estimated litigation liability       126.9
Insurance recovery receivable       $ 157.7
v3.25.0.1
Contingencies - Schedule of Discontinued Operations (Details) - Discontinued Operations, Disposed of by Sale - Asbestos Portfolio Sale - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2024
Assets divested:    
Cash and cash equivalents   $ 153.5
Insurance recovery receivable   13.9
Liabilities divested:    
Asbestos indemnity liability - current   (12.3)
Asbestos indemnity liability - noncurrent   (111.4)
Loss on Asbestos Sale, before transaction costs   43.7
Transaction costs   15.1
Loss on Asbestos Sale $ 58.8 58.8
Income tax benefit (7.6) (7.6)
Loss on Asbestos Sale, net of tax $ 51.2 $ 51.2
v3.25.0.1
Other Operating Expense, Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Other Operating Expense, Net      
Foreign currency transaction losses (gains), net $ 3.2 $ 5.1 $ (5.9)
Restructuring charges, net 31.2 19.9 29.3
Acquisition and other transaction related expenses 47.1 52.2 38.7
Loss on asbestos sale 58.8 0.0 0.0
Other, net (1.7) 0.5 2.8
Total other operating expense, net $ 138.6 $ 77.7 $ 64.9
v3.25.0.1
Segment Reporting - Narrative (Details)
12 Months Ended
Dec. 31, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.0.1
Segment Reporting - Segment Results (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting [Abstract]      
Revenues $ 7,235.0 $ 6,876.1 $ 5,916.3
Segment cost of sales 4,065.0 3,993.9 3,590.7
Segment selling and administrative expenses 1,344.4 1,272.7 1,095.8
Other operating expense, net (138.6) (77.7) (64.9)
Adjusted EBITDA 2,173.6 1,960.1 1,561.5
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:      
Interest expense 213.2 156.7 103.2
Impairment of other intangible assets 13.9 0.0 0.0
Restructuring and related business transformation costs 32.3 22.9 32.3
Stock-based compensation 58.8 51.9 78.9
Foreign currency transaction losses (gains), net 3.2 5.1 (5.9)
Loss on extinguishment of debt 3.0 13.5 1.1
Adjustments to LIFO inventories 6.7 12.0 36.1
Loss on asbestos sale 58.8 0.0 0.0
Income Before Income Taxes 1,132.8 1,031.1 742.2
Depreciation of rental equipment 4.0 3.7 3.4
Restructuring Costs [Abstract]      
Restructuring charges 31.2 19.9 29.3
Facility reorganization, relocation and other costs 1.1 3.0 3.0
Total restructuring and related business transformation costs 32.3 22.9 32.3
Stock-based compensation expense recognized in continuing operations     78.9
Increase (decrease) in stock-based compensation expense due to costs associated with employer taxes     6.7
Total depreciation and amortization expense 482.0 459.1 432.8
Total capital expenditures 149.1 105.4 94.6
Total identifiable assets 18,009.8 15,563.5  
Industrial Technologies and Services      
Segment Reporting [Abstract]      
Revenues 5,818.1 5,632.8  
Precision and Science Technologies      
Segment Reporting [Abstract]      
Revenues 1,416.9 1,243.3  
Operating segments      
Segment Reporting [Abstract]      
Segment cost of sales 3,929.5 3,873.8 3,437.9
Segment selling and administrative expenses 1,133.1 1,041.0 915.1
Other operating expense, net (1.2) 1.2 1.8
Operating segments | Industrial Technologies and Services      
Segment Reporting [Abstract]      
Revenues 5,818.1 5,632.8 4,705.1
Segment cost of sales 3,193.3 3,225.0 2,785.5
Segment selling and administrative expenses 868.5 818.5 702.5
Other operating expense, net 1.5 2.0 3.1
Adjusted EBITDA 1,754.8 1,587.3 1,214.0
Restructuring Costs [Abstract]      
Total depreciation and amortization expense 296.0 313.8 294.7
Total capital expenditures 83.0 83.9 66.3
Total identifiable assets 10,369.6 10,138.8  
Operating segments | Precision and Science Technologies      
Segment Reporting [Abstract]      
Revenues 1,416.9 1,243.3 1,211.2
Segment cost of sales 736.2 648.8 652.4
Segment selling and administrative expenses 264.6 222.5 212.6
Other operating expense, net (2.7) (0.8) (1.3)
Adjusted EBITDA 418.8 372.8 347.5
Restructuring Costs [Abstract]      
Total depreciation and amortization expense 177.1 135.4 133.6
Total capital expenditures 21.3 18.5 17.7
Total identifiable assets 5,884.1 3,464.7  
Corporate and other      
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:      
Corporate expenses not allocated to segments 155.5 173.3 126.7
Restructuring Costs [Abstract]      
Total depreciation and amortization expense 8.9 9.9 4.5
Total capital expenditures 44.8 3.0 10.6
Total identifiable assets 1,756.1 1,960.0  
Assets of discontinued operations      
Less items to reconcile Segment Adjusted EBITDA to Income from Continuing Operations Before Income Taxes:      
Interest expense 213.2 156.7 103.2
Depreciation and amortization expense 478.0 455.4 429.4
Impairment of other intangible assets 13.9 0.0 0.0
Restructuring and related business transformation costs 32.3 22.9 32.3
Acquisition and other transaction related expenses and non-cash charges 59.8 63.9 40.7
Stock-based compensation 58.8 51.9 85.6
Foreign currency transaction losses (gains), net 3.2 5.1 (5.9)
Loss on extinguishment of debt 3.0 13.5 1.1
Adjustments to LIFO inventories 6.7 12.0 36.1
Cybersecurity incident costs 0.5 2.3 0.0
Loss on asbestos sale 58.8 0.0 0.0
Gain on settlement of post-acquisition contingencies 0.0 0.0 (6.2)
Interest income on cash and cash equivalents (43.3) (28.8) (8.0)
Other adjustments 0.4 0.8 (15.7)
Restructuring Costs [Abstract]      
Total restructuring and related business transformation costs $ 32.3 $ 22.9 $ 32.3
v3.25.0.1
Segment Reporting - Property, Plant and Equipment by Geographic Region (Details) - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net $ 842.1 $ 711.4
Reportable geographical components | Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 419.9 298.8
Reportable geographical components | United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 381.8 286.0
Reportable geographical components | Other Americas    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 38.1 12.8
Reportable geographical components | EMEIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 256.5 245.7
Reportable geographical components | Total Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 165.7 166.9
Reportable geographical components | China    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net 152.3 160.9
Reportable geographical components | Other Asia Pacific    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Property, plant and equipment, net $ 13.4 $ 6.0
v3.25.0.1
Earnings Per Share - Basic and Diluted Earnings Per Share (Details) - shares
shares in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Average shares outstanding:      
Weighted-average shares outstanding - Basic (in shares) 403.4 404.8 405.3
Dilutive effect of outstanding share-based compensation awards (in shares) 3.8 4.2 4.9
Weighted-average shares outstanding - Diluted (in shares) 407.2 409.0 410.2
v3.25.0.1
Earnings Per Share - Narrative (Details) - shares
shares in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Earnings Per Share [Abstract]      
Antidilutive securities excluded from computation of earnings (loss) per share (in shares) 0.5 1.3 1.8
v3.25.0.1
Subsequent Events (Details)
€ in Millions, $ in Millions
12 Months Ended
Feb. 03, 2025
USD ($)
Trademark
Dec. 31, 2024
USD ($)
contract
Dec. 31, 2023
USD ($)
business
Dec. 31, 2022
USD ($)
Feb. 11, 2025
EUR (€)
contract
Dec. 31, 2024
EUR (€)
contract
Cross-currency interest rate swap contracts            
Subsequent Event [Line Items]            
Number of instruments held | contract   3       3
Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments            
Subsequent Event [Line Items]            
Notional amount   $ 1,074.3 $ 1,054.2     € 500.0
Subsequent Event | Cross-currency interest rate swap contracts | Net investment | Derivatives Designated as Hedging Instruments            
Subsequent Event [Line Items]            
Number of instruments held | contract         2  
Notional amount | €         € 250.0  
All others            
Subsequent Event [Line Items]            
Number of businesses acquired | business     10      
Aggregate consideration | $   $ 55.6 $ 83.3 $ 19.9    
All others | Subsequent Event            
Subsequent Event [Line Items]            
Number of businesses acquired | Trademark 4          
Aggregate consideration | $ $ 168.0